Amyloid peptide self assembly in protic ionic liquids by Debeljuh, Natalie
Amyloid Peptide Self Assembly in 
Protic Ionic Liquids 
 
 
 
 
 
Presented By 
 
 
Natalie-Josefina Debeljuh 
BForensicSc (Hons) Deakin University, Australia 
 
 
 
 
 
 
Submitted in fulfilment of the requirements for the degree of  
Doctor of Philosophy  
 
Centre for Chemistry and Biotechnology  
Faculty of Science, Engineering and Built Environment  
School of Life and Environmental Sciences  
Deakin University  
 
October 2014 
  
 
I 
 
 
DEAKIN UNIVERSITY 
ACCESS TO THESIS – A 
 
I am the author of the thesis entitled 
 
‘Amyloid Peptide Self Assembly in Protic Ionic Liquids’ 
submitted for the degree of  
 
Doctor of Philosophy  
 
This thesis may be made available for consultation, loan and limited copying 
in accordance with the Copyright Act 1968. 
'I certify that I am the student named below and that the information provided 
in the form is correct'  
  
Full Name: ............................................................................. (Please Print)  
Signed: ..................................... ............…………………………… 
Date: ...................................................……………………………… 9th January, 2015 
  
 
II 
 
 
DEAKIN UNIVERSITY 
CANDIDATE DECLARATION 
 
I certify that the thesis entitled  
 
‘Amyloid Peptide Self Assembly in Protic Ionic Liquids’ 
submitted for the degree of  
 
Doctor of Philosophy  
 
is the result of my own work and that where reference is made to the work of 
others, due acknowledgment is given.  
I also certify that any material in the thesis which has been accepted for a 
degree or diploma by any university or institution is identified in the text.   
 
'I certify that I am the student named below and that the information provided 
in the form is correct'  
 
Full Name: .............................. ...................……………………(Please Print)  
Signed: ..................................... . ............................................……  
Date: .......................................................................................…… 9th January, 2015 
  
 
III 
 
ACKNOWLEDGEMENTS 
Firstly, I must thank my supervisor Professor Colin Barrow for his persistence, support 
and constructive feedback throughout my PhD, particularly during those times where 
I felt defeated by my research. I am grateful to have had the opportunity to work with 
such a caring personality over the past 4 years. 
I especially want to thank all of my collaborators, including Dr Nolene Byrne, Dr Luke 
Henderson, Dr Alessandra Sutti and Swapna Varghese for your expertise, friendship 
and valuable ideas during my PhD; this work would not have been possible without 
your assistance. To my external collaborators including Blaine Roberts’ research 
group (Tim and Monica) at the Mental Health Research Institute, Melbourne 
University for their assistance in the brain amyloid dissolution work, and Tamar 
Greaves and Danielle Kennedy at CSIRO Molecular Health Technologies for 
introducing me to the synchrotron and x-ray scattering techniques. Although the results 
were not very successful, I am very grateful to have worked with these people in such 
an open and friendly environment and look forward to future collaborations. To 
everyone who helped proof read my thesis, your time and valuable feedback cannot be 
appreciated enough.  
Finally, I dedicate this work to my beloved family and for their unconditional love, 
especially my mother Maria who has endured the most over the last year. It has been 
a long and arduous road for everyone and I cannot thank her enough for her graceful 
smile and endless supply of proteinaceous food on the kitchen table. To my father 
  
 
IV 
 
Tony, for allowing me to play tricks on you and laugh while you unconsciously eat 
spicy Mexican salsa cashews. To my brother Denis, for reminding me to relax every 
now and then with a classic zombie film, and to my cat Zina for always welcoming me 
home with a friendly meow, followed shortly by an aggressive bite, then an apologetic 
lick. None of you have ever given up on me, and are a constant reminder that the 
simplest things in life are those that are cherished the most.  
You guys mean the world to me!  
 
  
 
V 
 
PUBLICATIONS 
Listed below are the references to publications that have resulted from the work 
presented in this thesis: 
1) Debeljuh, N. J., Barrow, C. J., Henderson, L., Byrne, N. (2011) Structure 
inducing ionic liquids – Enhancement of alpha helicity in the Aβ1-40 
peptide from Alzheimer’s disease. Chem. Commun. 47, 6371-6373. 
 
2) Debeljuh, N. J., Barrow, C. J., Byrne, N. (2011) The impact of ionic 
liquids on amyloid fibrilization of Aβ16-22: Tuning the rate of fibrilization 
using a reverse Hofmeister strategy. Phys. Chem. Chem. Phys. 13, 16534-
16536. 
 
3) Debeljuh, N. J., Varghese, S., Barrow, C. J., Byrne, N. (2012) Role of 
cation in enhancing the conversion of the Alzheimer’s peptide into amyloid 
fibrils using protic ionic liquids. Aust. J. Chem. 65, 1502-1506. 
 
4) Debeljuh, N. J., Sutti, A., Barrow, C. J., Byrne, N. (2013) Phase transition 
of poly(N-isopropylacrylamide) in aqueous protic ionic liquids: 
Kosmotropic versus chaotropic anions and their interaction with water. J. 
Phys. Chem. B. 117 (28), 8430-8435. 
  
 
VI 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ...................................................................................... iii 
PUBLICATIONS ........................................................................................................ v 
TABLE OF CONTENTS .......................................................................................... vi 
ABBREVIATIONS AND ACRONYMS ............................................................... xiv 
SYMBOLS .............................................................................................................. xvii 
ABSTRACT ............................................................................................................. xix 
CHAPTER 1: Introduction ....................................................................................... 1 
1.1 Amyloidosis - Protein misfolding and disease .............................................. 1 
1.2 Alzheimer’s disease and the amyloid-beta (Aβ) peptide ............................... 3 
1.3 Amyloid structure and fibril morphology ...................................................... 7 
1.3.1 Characteristics of amyloid fibrils ........................................................... 7 
1.3.2 NMR studies of amyloid fibril structure ................................................ 9 
1.4 Mechanisms for amyloid fibril self-assembly ............................................. 12 
1.4.1 Nucleation-dependent polymerization model ...................................... 13 
1.4.1.1 Amyloid seeding ........................................................................... 15 
  
 
VII 
 
1.4.2 Alternative models for amyloid self-assembly ..................................... 16 
1.5 Early events in amyloidosis – Toxic amyloid species ................................. 18 
1.5.1 Small oligomeric aggregates ................................................................ 19 
1.5.2 Large protofibrillar assemblies ............................................................. 20 
1.5.3 Critical structural conversions .............................................................. 21 
1.6 Ionic liquids – Solvents of the future ........................................................... 23 
1.6.1 Ionic liquids as solvents for protein studies ......................................... 25 
1.6.1.1 Thermal stability and protein refolding ........................................ 25 
1.6.1.2 Dissolution and inhibition of amyloid formation .......................... 28 
1.6.1.3 Enhancement of amyloid fibril formation ..................................... 29 
1.7 Project Aims ................................................................................................ 31 
CHAPTER 2: Materials and Methodology ............................................................ 33 
2.1 Materials ...................................................................................................... 33 
2.2 Peptide synthesis .......................................................................................... 34 
2.3 Kaiser ninhydrin testing ............................................................................... 36 
2.4 Peptide self-assembly .................................................................................. 36 
  
 
VIII 
 
2.5 Preparation of pre-formed Aβ1-40 fibrils for dissolution studies ............... 37 
2.5.1 Method 1 – pre-formed TeaMs fibrils .................................................. 37 
2.5.2 Method 2 – preformed PBS fibrils ....................................................... 37 
2.6 Protic ionic liquid synthesis ......................................................................... 38 
2.7 Time-of-flight mass spectrometry (TOF-MS) ............................................. 44 
2.8 Reverse-phase high performance liquid chromatograph (HPLC) ............... 45 
2.9 Thioflavin T (ThT) assay ............................................................................. 46 
2.10 Intrinsic tryptophan fluorescence ................................................................ 46 
2.11 Congo red staining and birefringence monitoring ....................................... 47 
2.12 1H and 31P nuclear magnetic resonance (NMR) chemical shifts ................. 47 
2.13 Measurement of spin-lattice (T1) and spin-spin (T2) relaxation times ......... 47 
2.14 Circular dichroism (CD) .............................................................................. 49 
2.15 Fourier transform infrared (FTIR) spectroscopy ......................................... 49 
2.16 Dynamic light scattering (DLS)................................................................... 50 
2.17 Determination of Kamlet-Taft solvatochromic parameters ......................... 51 
2.18 Polarity measurements ................................................................................. 53 
  
 
IX 
 
2.19 Preparation of sodium dodecyl sulfate poly-acrylamide gel electrophoresis 
(SDS-PAGE)........................................................................................................... 54 
2.20 Preparation of human tissue samples ........................................................... 54 
2.21 Western blotting ........................................................................................... 55 
2.22 Transmission electron microscopy (TEM) .................................................. 56 
2.23 Scanning electron microscopy (SEM) ......................................................... 57 
2.24 X-ray diffraction (XRD) .............................................................................. 57 
2.25 Optical microscopy ...................................................................................... 57 
2.26 ANS binding assay ...................................................................................... 58 
CHAPTER 3: Investigating Aβ16-22 Fibrilization Kinetics in Protic Ionic Liquid 
Anions and the Hofmeister Series ........................................................................... 59 
3.1 Preface ......................................................................................................... 59 
3.2 Introduction .................................................................................................. 59 
3.3 Results and Discussion ................................................................................ 62 
3.3.1 Controlling Aβ16-22 fibrilization kinetics with PILs according to a 
reverse Hofmeister strategy ................................................................................ 62 
3.3.1.1 Aβ16-22 fibrilization follows a reverse Hofmeister trend ............ 70 
  
 
X 
 
3.3.2 Amyloid self-assembly is facilitated through competitive PIL anion-
water hydrogen bonds ........................................................................................ 72 
3.3.2.1 Mechanism for PIL-water-mediated amyloid fibrilization ........... 82 
3.3.3 Formation of transient Aβ16-22 oligomeric spheres in TeaHSO4 ....... 83 
3.4 Conclusion ................................................................................................... 87 
CHAPTER 4: Enhanced Aβ Fibrilization in Protic Ionic Liquid Cations ......... 88 
4.1 Preface ......................................................................................................... 88 
4.2 Introduction .................................................................................................. 88 
4.3 Results and Discussion ................................................................................ 90 
4.3.1 Fibrilization kinetics of Aβ16-22 in cation-modified PILs .................. 90 
4.3.2 Primary PIL amines enhance the conversion of Aβ16-22 monomers to 
amyloid fibrils .................................................................................................... 92 
4.3.3 Peptide-PIL interactions influence the solution conformational changes 
in Aβ isoforms .................................................................................................... 98 
4.4 Conclusion ................................................................................................. 105 
CHAPTER 5: Structural Induction and Fibrils Dissolution of Aβ1-40 in Ionic 
Liquids through the α-Helical Intermediate ........................................................ 106 
5.1 Preface ....................................................................................................... 106 
  
 
XI 
 
5.2 Introduction ................................................................................................ 106 
5.3 Results and Discussion .............................................................................. 109 
5.3.1 Structure inducing ionic liquids – Enhancing α-helical structure in the 
Aβ1-40 peptide from Alzheimer’s disease ....................................................... 109 
5.3.2 Dissolution of pre-formed Aβ1-40 fibrils in TeaMs .......................... 118 
5.3.2.1 Brain amyloid dissolution in ionic liquids .................................. 125 
5.4 Conclusion ................................................................................................. 129 
CHAPTER 6: Crystalline to Amorphous Transition of the Central Alzheimer’s 
Aβ Dipeptide in Aqueous PIL Solution ................................................................ 130 
6.1 Introduction ................................................................................................ 130 
6.2 Results & Discussion ................................................................................. 133 
6.2.1 Characterization of NH2-FF-COOH crystalline assemblies ............... 133 
6.2.2 EAN facilitates changes in NH2-FF-COOH hydrophobic packing .... 139 
6.3 Conclusion ................................................................................................. 144 
CHAPTER 7: Evaluation of PIL Solvent Parameters on the Phase Behaviour of 
Poly(N-isopropylacrylamide) (PNIPAM) ............................................................. 145 
7.1 Preface ....................................................................................................... 145 
  
 
XII 
 
7.2 Introduction ................................................................................................ 145 
7.3 Results & Discussion ................................................................................. 149 
7.3.1 Preliminary determination of PNIPAM LCST in a PIL ..................... 149 
7.3.2 PNIPAM phase behaviour in PIL anions ........................................... 150 
7.3.3 PNIPAM phase behaviour in PIL cations .......................................... 156 
7.3.4 Kamlet-Taft solvatochromic parameters in PILs ............................... 158 
7.3.4.1 π* values ..................................................................................... 160 
7.3.4.2 β values ....................................................................................... 165 
7.3.4.3 α values ....................................................................................... 170 
7.3.5 Polarity study of aqueous PIL solutions ............................................. 172 
7.4 Conclusion ................................................................................................. 178 
CHAPTER 8: Concluding Remarks ..................................................................... 180 
8.1 General ....................................................................................................... 180 
8.2 Investigating Aβ16-22 Fibrilization Kinetics in Protic Ionic Liquid Anions 
and the Hofmeister Series ..................................................................................... 180 
8.3 Enhanced Aβ Fibrilization in Protic Ionic Liquid Cations ........................ 181 
  
 
XIII 
 
8.4 Structural Induction and Fibrils Dissolution of Aβ1-40 in Ionic Liquids 
through the α-Helical Intermediate ....................................................................... 182 
8.5 Crystalline to Amorphous Transition of the Central Alzheimer’s Aβ 
Dipeptide in Aqueous PIL Solution ...................................................................... 183 
8.6 Evaluation of PIL Solvent Parameters on the Phase Behaviour of Poly(N-
isopropylacrylamide) (PNIPAM) ......................................................................... 183 
References ............................................................................................................... 185 
 
  
 
XIV 
 
ABBREVIATIONS AND ACRONYMS 
Aβ  amyloid-beta 
Aβ1-40 Aβ fragment between aspartate 1 and valine 40 
Aβ1-42 Aβ fragment between aspartate 1 and alanine 42 
Aβ16-22 Aβ fragment between lysine 16 and glutamate 22 
Aβ3pE-40 pyroglutamate Aβ fragment between glutamate 3 and valine 40 
Aβ11pE-40 pyroglutamate Aβ fragment between glutamate 11 and valine 40 
ANS  8-anilino-1-naphthalene-sulfonic acid 
ATR-FTIR attenuated total reflectance Fourier transform infrared spectroscopy 
BaLa  butylammonium lactate 
BMIMAc 1-butyl-3-methylimidazolium acetate 
BMIMCl 1-butyl-3-methylimidazolium chloride 
Boc  tert-butoxycarbonyl 
CD  circular dichroism  
Choline dhp choline dihydrogen phosphate 
ChoLa  choline lactate 
ChoMa choline malate 
CR  Congo red 
DCM  dichloromethane  
DeaLa  diethylammonium lactate 
DeaMs  diethylammonium mesylate 
DIPEA N,N-diisopropylethylamine 
  
 
XV 
 
DLS  dynamic light scattering 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
EaLa  ethylammonium lactate 
EaMs  ethylammonium mesylate 
EAN  ethylammonium nitrate 
EMIMSO3 1-ethyl-3-methylimidazolium sulfate 
ETALa ethanolammonium lactate 
ETAMa ethanolammonium malate 
FA  formic acid 
Fmoc  9-fluorenylmethoxycarbonyl 
HBTU  O-(benzotriazol-1yl)N,N,N'N'tetramethyluronium 
 hexafluorophosphate 
HDO  deuterium oxide 
HFIP  1,1,1,3,3,3-hexafluoro-2-propanol 
HOBt  1-hydroxybenzotriazole 
HPLC  high performance liquid chromatography 
LCST  lower critical solution temperature 
TOF-MS time-of-flight mass spectrometry 
NMR  nuclear magnetic resonance (spectroscopy) 
NR  Nile Red 
PBS  phosphate buffer saline  
PNIPAM poly(N-isopropylacrylamide) 
  
 
XVI 
 
pH  power of hydrogen 
pKa  acid dissociation constant 
PIL  protic ionic liquid 
SEM  scanning electron microscopy 
TeaBF4 triethylammonium tetrafluoroborate 
TeaH2PO4 triethylammonium dihydrogen phosphate 
TeaHSO4 triethylammonium hydrogen sulfate 
TeaLa  triethylammonium lactate 
TeaMa  triethylammonium malate 
TeaMs  triethylammonium mesylate 
TeaTf  triethylammonium triflate 
TeaTfac triethylammonium trifluoroacetate 
TEM  transmission electron microscopy  
TFA  trifluoroacetic acid 
TFE  2,2,2-trifluoroethanol 
ThT  thioflavin T 
TMGLa 1,1,3,3-tetramethylguanidinium lactate 
TMS  tetramethylsilane 
UV/Vis ultraviolet-visible 
XRD  x-ray diffraction 
  
 
XVII 
 
SYMBOLS 
2θ  angle 
Å  Ångstrom 
NA  Avogadro’s number 
13C  carbon-13 
δ  chemical shift 
°C  degrees Celsius  
Δ  difference 
1H  hydrogen-1 
α  Kamlet-Taft hydrogen-bonding acidity 
β  Kamlet-Taft hydrogen-bonding basicity 
π*  Kamlet-Taft dipolarity/polarizability 
K  kelvin 
m/z  mass to charge ratio 
μL  microlitre 
ENR  molar transition energy of Nile Red 
ETN  normalized transition energy 
31P  phosphorus-31 
π  pi-orbital 
h  Planck’s constant 
c  speed of light 
T1  spin-lattice (longitudinal) relaxation 
  
 
XVIII 
 
ET(30)  transition energy of Reichardt’s dye 
ϕ  volume fraction 
v/v  volume/volume 
λmax  wavelength maximum 
ν  wavenumber 
wt%  weight percent 
 
  
 
XIX 
 
ABSTRACT 
Alzheimer’s disease (AD) is one of many debilitating human neurodegenerative 
disorders characterized by the accumulation of misfolded protein into insoluble 
amyloid deposits. The widespread implication of amyloid fibrils in this disease has 
inspired intense research efforts towards understanding the mechanisms of amyloid 
self-assembly, including the early stages of fibril formation, toxic amyloid species and 
possible methods for fibril inhibition in vivo. 
Inspired by the growing field of ionic liquids in protein research, initial investigations 
were aimed towards controlling the kinetics of Aβ self-assembly in protic ionic liquids 
(PILs). Thorough experimentation revealed that PIL anion kosmotropicity, and the 
ability to form extensive intermolecular hydrogen bonds with water molecules, was 
critical in the rapid generation of Aβ16-22 amyloid fibrils. Reversal of these anion 
properties was shown to lead to long-term solution stability and a marked inhibition 
of fibril formation. PIL cations were further tailored to accelerate or inhibit the 
fibrilization of Aβ16-22, and comprehensive circular dichroism analysis identified that 
peptide-PIL interactions in these PILs facilitated changes in the secondary structure of 
various Aβ isoforms.  
In an expansion of this work, further investigations into the fibrilization of full-length 
Aβ (Aβ1-40) showed that helical-inducing PILs could inhibit amyloid fibril formation. 
Pre-formed Aβ1-40 amyloid fibrils could be dissolved in the presence of the neat PIL 
triethylammonium mesylate (TeaMs) via the formation of intermolecular hydrogen 
  
 
XX 
 
bonds between the solvent and peptide, promoting solubilization of Aβ1-40 
monomers, in a similar manner to helical-inducing solvents such as TFE and HFIP, 
but providing an alternative to these solvents for manipulating Aβ1-40 solubilisation 
and also amyloid formation.  
Many amyloidogenic proteins display conformational or structural polymorphism 
during self-assembly as the result of changes to the secondary structure of the protein 
or various environmental stimuli. In order to understand this process, the central Aβ 
fragment (NH2-FF-COOH) was utilized as a model of the events in amyloid fibril 
formation. It was found that various polymorphs including crystalline fibrils and flat 
sheets could be self-assembled by simply altering the concentration of 
ethylammonium nitrate (EAN) in aqueous solution. The formation of these 
polymorphs was attributed to the increased exposure of hydrophobic residues on  
NH2-FF-COOH as the result of increasing EAN concentration.  
Finally, the effect of other key solvent parameters (such as acidity, basicity, polarity 
and polarizability) which are associated with protein folding in PILs were explored, 
using the thermoresponsive polymer poly(N-isopropylacrylamide) (PNIPAM) as a 
protein model. After extensive analysis of Kamlet-Taft solvatochromic parameters, the 
PIL cation basicity (reflected through the choice of anion), and the relative 
polarizability of the anion (resulting from its kosmotropicity), were identified as the 
critical properties for the rapid generation of amyloid fibrils. 
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Overall, this thesis presents the novel approach of using carefully selected PILs to both 
control amyloid fibril formation and inhibit/dissolve Aβ fibrils through induced helical 
transitions. These results provide insights into future PIL-mediated protein studies and 
the potential application of PILs in AD pathogenesis. 
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“Science never solves a problem, without creating ten more.” 
- George Bernard Shaw 
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CHAPTER 1: Introduction 
1.1 Amyloidosis - Protein misfolding and disease 
The correct folding of a protein into its native conformation plays a pivotal role in 
normal cell functioning and biological processes. However, protein folding itself is a 
complex mechanism, and in order for a protein to achieve its correct native structure, 
the protein must avoid various environmental challenges such as elevations in 
temperature and changes in pH(1). In the event of protein misfolding, such as when 
cellular repair mechanisms fail(2), a cascade of events can lead to mechanism-based 
toxicities, protein aggregation and disease.  
Since the first reported case of brain amyloid plaque formation in 1854(3), the 
accumulation of abnormally folded protein deposits has been recognized as a key 
histopathological feature in at least 25 debilitating human diseases (Table 1.1). 
Although most amyloid-derived diseases occur spontaneously, a small proportion are 
hereditary and some are transmissible(4). Furthermore, the accumulation of amyloid 
can occur systemically or localized in a specific tissue type, and manifest as both 
intracellular and extracellular deposits. Although each amyloid forming protein arises 
from very different pre-cursors, primary structures and biochemical functionalities, 
their aggregated amyloid states share common discriminating characteristics such as 
ordered β-sheet structure, fibril dimensions and x-ray diffraction patterns (see section 
1.3).  
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Table 1.1. Some proteins associated with disease and amyloid fibril formation. 
Disease Amyloid protein References 
Alzheimer’s disease Aβ peptides, τau (5-11) 
Parkinson’s disease α-synuclein (12-14) 
Huntington’s disease Huntingtin (15, 16) 
Creutzfeldt–Jakob disease & 
Transmissible spongiform 
encephalopathies (Prion diseases) 
Prion protein (PrP) (17-19) 
Adult-onset (Type II) diabetes Islet amyloid polypeptide 
(IAPP) or Amylin 
(20) 
Atrial amyloidosis Amyloid atrial natriuretic 
factor (ANF) 
(21, 22) 
Aortic medial amyloidosis Medin (23) 
Senile systemic amyloidosis & Familial 
amyloid polyneuropathy 
Transthyretin (TTR) (24-26) 
Primary systemic amyloidosis Immunoglobulin light (AL) 
and heavy (HL) chains 
(27, 28) 
Secondary systemic amyloidosis Serum amyloid A (SAA) (24, 27) 
Hereditary systemic amyloidosis Lysozyme (24, 25, 29) 
Haemodialysis-related amyloidosis β2-microglobulin (30-33) 
British familial dementia ABri (34-36) 
Finnish hereditary systemic amyloidosis Gelsolin (37) 
Cystic fibrosis CFTR protein (1, 38, 39) 
Down’s syndrome Aβ peptides (9, 40-43) 
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This suggests that these proteins follow a common folding pathway that encompasses 
a conserved intermediate state or conformational transition prior to adopting their final 
β-sheet conformation(44).  
Currently, Alzheimer’s disease (AD) is the single highest cause of dementia 
worldwide, accounting for 60-80% of all dementia cases(45). Although dementia does 
not discriminate against race or gender, age is a major risk factor, with dementia 
affecting one in nine people aged over 65 and three in ten people aged 85 or older in 
Australia(46). In 2011, an estimated 298,000 people were affected with dementia in 
Australia, and this value is expected to triple to over 900,000 by the year 2050. 
Furthermore, an estimate of $2.0 billion dollars was attributed towards the use and cost 
of health care facilities for dementia cases alone in Australia in 2009-10(46). The 
enormous medical implications of amyloidosis in AD has motivated intense research 
efforts, leading to a number of reviews on the structure and growth of amyloid  
fibrils(4, 6, 47-56).   
1.2 Alzheimer’s disease and the amyloid-beta (Aβ) peptide 
AD is a neurodegenerative disorder characterized by the intracellular formation and 
accumulation of neurofibrillar tangles and the deposition of insoluble extracellular 
amyloid plaques(57). These aggregated protein deposits appear to cause disease through 
an increase in localized toxicity that progressively affects normal brain functions such 
as memory, judgement and cognition and result in the failure of important cellular 
processes(58, 59). The amyloid cascade hypothesis proposed by Hardy et al.(60, 61) 
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suggests that the aggregation of Aβ protein induces neuronal dysfunction and the 
hyperphosphorylation of the microtubule associated τau protein, leading to neuronal 
death. This hypothesis was further supported by transgenic mice models where it was 
determined that Aβ accumulation precedes changes in the metabolism of τau  
protein(62, 63). Glenner and Wong(10) first discovered Aβ during the purification and 
sequencing of microvascular amyloid deposits from the meninges of AD brains. 
However, it was not until its isolation and characterization from plaque cores of post-
mortem AD cortices(8) when the link between Aβ protein aggregation and deposition 
into amyloid fibrils was recognized. Since then, Hardy’s amyloid cascade hypothesis 
has been revised to indicate the importance of soluble oligomeric species as being the 
most potent neurotoxins and the current paradigm in the field of AD(64, 65) (see section 
1.5). 
Aβ is produced by two sequential proteolytic cleavages of the transmembrane amyloid 
precursor protein (APP) in the lipid-rich microdomains (lipid rafts) of endosomes and 
the plasma membrane(66). Known as the amyloidogenic pathway, APP is initially 
cleaved by β-site APP cleaving enzyme 1 (BACE1) which releases a large N-terminal 
APP ectodomain fragment (APPsβ)(67), followed by cleaving with γ-secretase, which 
releases APPsβ and leads to secretion of Aβ peptides(68). This proteolytic Aβ product 
ranges between 29-43 amino acids in length depending on the β- and γ-secretase 
cleaving sites as illustrated in Figure 1.1.  
Truncated and pyroglutamate forms of Aβ, which account for a portion of the Aβ 
peptides extracted from AD human brains, have also been heavily reported(69-71) and 
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arise from the intramolecular dehydration of N-terminally exposed glutamate 
residues(72). 
 
Figure 1.1. Schematic of APP cleavage and common AD mutation sites (red) which result in 
amyloid plaque formation by increasing Aβ production. Cleaving sites of α-, β- and  
γ-secretases are presented by dashed lines. Figure adapted from Ref. (73, 74). 
Alternatively, the more dominant processing of APP occurs outside the domain of lipid 
rafts and does not result in the production of Aβ(66). During this non-amyloidogenic 
pathway, sequential proteolytic cleavaging of APP occurs first by α-secretase, a 
disintegrin and metalloprotease 10 (ADAM10)(75), then γ-secretase to yield an  
N-terminal soluble APP (sAPPα) fragment and a C-terminal fragment known as C83 
transmembrane domain(76).  
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Misprocessing of APP via the amyloidogenic pathway has been recognized as the key 
event in the pathogenesis of AD, since the accumulation of Aβ leads to amyloid fibril 
formation. Aβ fibrillogenesis studies have revealed that the carboxy-terminally 
extended variant Aβ1-42 forms insoluble amyloid fibrils more rapidly than Aβ1-40 
and increased levels of longer C-terminal forms probably contribute to causation in 
both sporadic and familial AD (FAD)(77, 78). In fact, this is evident in a number of 
studies where cultured cell systems expressing FAD-mutant forms of APP or 
presenilin overexpressed Aβ1-42(79-81). Furthermore, increases in the ratio of Aβ1-42 
production relative to Aβ1-40 were also measured in the plasma of patients diagnosed 
with FAD(82) and similarly was observed in transgenic mice models(80, 81, 83). 
Comprehensive analysis of the early stage Aβ self-assembly reveal that Aβ1-42 forms 
transient pentamer/hexamer units that assemble into beaded superstructures 
resembling early protofibrils. Though not observed for Aβ1-40, this key structural 
transition could explain the rapid assembly of Aβ1-42 in AD(84).  
Additionally, there is well documented evidence suggesting that genetic mutations in 
APP significantly lower the onset age in FAD and increase cognitive impairment and 
plaque formation(85-91). Some of these and other common mutations are illustrated in 
the red text in Figure 1.1. The involvement of lipoprotein receptors has previously 
been recognized as a key regulator for both the recycling of APP in endosomes and 
Aβ formation. Neuronal expression of the lipoprotein receptor LR11 or SorLA in brain 
regions vulnerable to AD neuropathology showed a dramatic reduction in LR11 
expression and increased Aβ production and cell death(92, 93). However, when LR11 
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was overexpressed in these brain regions, extracellular levels of Aβ were significantly 
reduced and cellular levels of APP were lowered.  
Enhancing α-secretase cleavage has been considered as a possible therapeutic 
approach for tackling AD. However, the lack of knowledge surrounding the molecular 
mechanisms for regulating α-secretase cleavage has made this approach difficult(94). 
Alternatively, the inhibition of BACE1 activity has also been extensively studied as a 
strategy to inhibit Aβ deposition in AD. Studies have shown that preventing  
β-secretase cleavage can result in the inhibition of Aβ secretion in cultured neurons 
and in brain cells(95-99). However, controversial studies have suggested that partial 
deletion of BACE1 activity leads to mild deficits in cognitive functioning and 
behavioural changes in BACE1 knockout mice(99-101). Aβ has been shown to play an 
important physiological role in normal cell functioning and modulates the activities of 
certain synapses(102). Thus inhibiting BACE1 activity could have deleterious effects 
such as mechanism-based toxicities or interference with normal cellular function. 
1.3 Amyloid structure and fibril morphology 
1.3.1 Characteristics of amyloid fibrils 
The formation of α-helices, β-strands and β-sheets is a naturally occurring process 
mediated via intra- and intermolecular hydrogen bonding, providing proteins with their 
native structure and function. What is now viewed as a property inherent to all 
amyloid-forming proteins is the formation of ordered β-sheet structure which is critical 
in the initiation of self-assembly and fibril growth(103). The β-sheets themselves are 
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created through intermolecular hydrogen bonds between individual peptide strands 
which align either in an anti-parallel or parallel configuration(104). Amyloid fibrils 
contain bundles of these β-sheets where the peptide backbone aligns orthogonal to the 
fibre axis in a cross-β-sheet configuration(6, 105, 106) (Figure 1.2). 
 
Figure 1.2. Schematic of the cross-β structure found in amyloid fibrils. (a) Hydrogen bonds 
form between β-strands (red dashed lines) either in an anti-parallel or parallel arrangement. 
(b) The common cross-β structure of an amyloid fibril with a meridional spacing of 4.7-4.8 
Å and equatorial spacing of 9-10 Å. (c) TEM of long straight Aβ16-22 fibrils. Scale bar  
200 nm. 
These characteristic cross-β-sheet structures show two distinctive X-ray diffraction 
reflections; a meridional at 4.7-4.8 Å that arises from the spacing between hydrogen 
bonded β-strands, and an equatorial between 9-10 Å that occurs from the distance 
between the β-sheets(106-109). Furthermore, the arrangement of β-strands perpendicular 
to the fibre axis is critical in defining the macrostructure of amyloid fibrils, which is 
(a)
Fibril axis
4.7-4.8 Å
9-10 Å
(b)
(c)
Anti-parallel β-sheet
Parallel β-sheet
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typically monitored by electron microscopy. These amyloid fibrils are typically long 
and straight diameters of 7-15 nm(110). Detection of the β-sheet component of amyloid 
fibrils can be also be achieved by using various histological dyes such as Congo red 
(CR) and Thioflavin T (ThT). Amyloid fibrils display an apple-green birefringence 
when stained with CR and viewed under cross-polarized light; a property that is only 
observed when CR binds to proteins with extensive β-sheet structure(111-115). When 
bound to ThT, the dye exhibits increased fluorescence intensity as the result of binding 
to β-sheet-rich deposits, and has been extensively used as a tool to monitor the 
fibrillization kinetics of various amyloid-forming proteins(116-120).   
1.3.2 NMR studies of amyloid fibril structure 
The first peptide synthesis and solution studies of full length Ab peptide was carried 
out by Barrow and Zagorski using a combination of CD and NMR  
spectroscopy(78, 121, 122). These studies showed that AE is soluble but aggregates rapidly 
in the presence of extrinsic factors such as low pH. The insoluble and heterogeneous 
nature of large amyloid fibrils has made it difficult to study the high-resolution 
structures of full length aggregated species, and so structural analysis has been 
performed on smaller fragments of these peptides. During early solid-state NMR 
(ssNMR) investigations, Lansbury et al.(123) were able to construct a model for  
Aβ34-42 amyloid fibrils. Later studies revealed that Aβ10-35 amyloid fibrils contain 
an in register cross-β structure arranged with parallel β-sheets(124, 125). Other fragments 
including Aβ16-22 (Figure 1.3) and Aβ11-25 have since become attractive due to their 
ability to form amyloid fibrils in solution. Amyloid fibrils formed by Aβ16-22 show a 
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well-ordered β-strand conformation that extends across the entire hydrophobic 
segment from L17 through to A21(126). The anti-parallel organization of these β-sheets 
suggests a high degree of structural order at the molecular level that approaches that 
of peptide and protein crystals(126). 
 
Figure 1.3. Chemical structure of the Aβ16-22 heptapeptide. 
Reports on Aβ11-25 indicate that the central hydrophobic segment (LVFFA) adopts a 
β-strand conformation and participates in anti-parallel β-sheets at both pH 7.4 and pH 
2.4, however the registry of intermolecular hydrogen bonds show a dependence to 
pH(127). Advancements in technology and the combination of various discriminating 
techniques have provided insights into the substructure and packing arrangements of 
larger amyloid residues at the atomic level(128, 129). Several ssNMR models have since 
been determined and describe the molecular organization of side chains within 
amyloid fibrils(130-132). More recent investigations using a combination of hydrogen 
deuterium (HD) exchange NMR and ssNMR have detected specific residues within 
amyloid proteins that are involved in forming the characteristic cross-β structure 
observed in fibrils(133, 134). In particular, 3D structural studies on Aβ1-42 and Aβ1-40 
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amyloid fibrils revealed the presence of two β-sheets between residues 18-26 and  
31-42 joined by a single β-turn(135). The β-sheets in the model for Aβ1-42 are stabilized 
by side chain interactions between residues F19 and G38, A21 and V36, and a salt 
bridge between D23 and K28, which are thought to contribute the peptides greater core 
stability and aggregations propensity in comparison to Aβ1-40(135). A structural model 
for Aβ1-40, based on ssNMR experimental constraints, further reveals that through 
intermolecular hydrogen bonding, parallel β-sheets are created from the β-strands 
formed between residues 12-24 and 30-40(136, 137) (Figure 1.4). 
 
Figure 1.4. (a) 3D structure of the two β-sheets and β-turn formed in the Aβ1-40 fibril and 
(b) atomic representation of a single Aβ1-40 molecule viewed down the long axis of the 
fibril. Figure modified from Tycko et al.(128, 137).  
(a)
(b)
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Although the first 10 residues remain predominantly disordered, the two β-sheets align 
via sidechain-sidechain interactions, facilitated from a bend in the peptide backbone 
arising from residues 25-29(136, 137). Further salt bridge formation occurs between the 
D23 and K28 residues(136, 137). Disulfide cross-linking experiments identified specific 
inter- and intramolecular atomic interactions (referred to as internal and external 
quaternary contacts) between specific residues in Aβ1-40(138). These residue contact 
points are critical in developing an understanding of the structural hierarchy of amyloid 
fibrils. 
1.4 Mechanisms for amyloid fibril self-assembly 
Despite many years of research, the progression of amyloid-related diseases remains 
poorly understood. Currently, there are no effective in vivo treatments that reduce or 
inhibit the aggregation of these amyloid-forming proteins, and in order to develop 
strategies to combat disease progression, a more thorough understanding of the 
intricate mechanisms involved in amyloid fibril self-assembly is required. Predicting 
the mechanisms of amyloid aggregation, however, has proven challenging despite 
numerous models being proposed for similar protein systems. A number of studies 
have identified proteins unrelated to disease state that aggregate into amyloid-like 
fibrils(139-145). Researchers suggests, in fact, that virtually any protein has the potential, 
under appropriate conditions, to form an amyloid fibril(143, 144, 146). Furthermore, in 
spite of structural differences between these proteins they all demonstrate the ability 
to form a common core cross-β-sheet structure(106) suggesting that these proteins may 
also share a common pathway towards amyloid fibrilization(147, 148). 
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1.4.1 Nucleation-dependent polymerization model 
The nucleation-dependent polymerization (NP) model was the ﬁrst model used to 
explain the results of in vitro amyloid kinetic experiments, and has since been found 
to appropriately describe the protein aggregation for a diverse assortment of structure 
forming processes including microtubule formation(149), flagellum formation(150) and 
amyloid fibril formation(151, 152). This model describes the stabilization of a number of 
protein monomers (through a series of otherwise unfavourable protein-protein 
association equilibria), into an intermediate nucleus, the spatial confinement resulting 
in a significant local increase in concentrations allowing them to polymerize into the 
very stable higher ordered fibrillar structures(153, 154) (Figure 1.5).  
 
Figure 1.5. Schematic outlining the nucleation-dependent polymerization model of amyloid 
self-assembly. 
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The lag phase is initiated through a series of thermodynamically unfavourable steps 
involving the association of several monomers into a nucleus. This stage is commonly 
observed during fibril self-assembly and is particularly sensitive to factors such as 
temperature, pH, ionic concentration and oxidation potential(127, 155-158), but more 
importantly, protein concentration and nucleus size(159-161). The main consensus behind 
the formation of an ordered nucleus is that this is the rate-limiting step in 
fibrillogenesis and that polymerization will not occur until the monomer concentration 
exceeds the critical protein concentration(153, 160). In terms of fibrillogenesis, higher 
monomer concentrations lead to a greater probability of the nuclei formation required 
to spontaneously initiate fibril assembly(160). 
In regards to AD, the Aβ1-42 peptide has a lower critical protein concentration than 
Aβ1-40, which was reflected in a four to fivefold reduction in the presence of soluble 
monomer in fibrilized solutions of Aβ1-42 in comparison to Aβ1-40(162). This finding 
is consistent with the aggregation behaviour of Aβ1-42 that forms fibrils more rapidly 
than Aβ1-40(163, 164). Only after the critical protein concentration is achieved can the 
equilibrium shift towards the favourable growth and elongation of fibrils via monomer 
addition. Through this seeded growth, pre-fibrillar aggregates and other oligomeric 
intermediates are created and recruited to assemble exponentially into higher ordered 
filaments, protofilaments and matured fibrils(165, 166). 
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1.4.1.1 Amyloid seeding 
In the event of slow nucleation, the introduction of a seed or pre-formed fibril can 
drastically accelerate the fibrilization process(77, 152, 154, 160, 167, 168). This seeding process 
significantly reduces, or in some cases eliminates the lag phase time, by providing a 
self-assembling template for fibrilization(160). Upon reduction of this lag phase period, 
seeding experiments have been observed to immediately induce fibril formation via a 
first-order growth profile as described by Harper and Lansbury(160) (Figure 1.6).  
 
Figure 1.6. Addition of a fibril seed eliminates the lag phase associated with self-assembly 
and accelerates fibril formation (figure adapted from Ref.(160)). 
Seeding to induce fibril formation is not a chemically discriminating event, as 
described by Ono et al.(169). In this recent work, strong evidence suggests fibrils and 
oligomers of Aβ1-40, Aβ1-42 and α-synuclein can act as seeds and affect the 
aggregation pathways within and among species in vitro.  
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1.4.2 Alternative models for amyloid self-assembly 
Although amyloid self-assembly is often associated with the nucleation-dependent 
process, the addition of fibril seeds do not always result in fibril formation, suggesting 
an alternative pathway for some oligomeric species and other higher ordered amyloid 
assemblies(170). Recent studies have suggested that amyloid fibril formation is a more 
dynamic and reversible process than initially anticipated(133, 171) and that a simple 
nucleated-polymerisation model does not adequately describe all aspects of amyloid 
fibril formation.(172). One such model describes the self-assembly of transthyretin, 
under partially denatured conditions, to be consistent with a non-nucleated process, 
since fibrilization was not accelerated by seeding which is commonly observed in the 
nucleated polymerization model(173). Additionally, the authors postulate that under 
these conditions, transthyretin self-assembly follows a non-nucleated polymerization 
model where the highest energy species is the native monomer and the nucleus is not 
the rate-limiting step. Comprehensive atomic force microscopy (AFM) analysis of  
β2-microglobulin fibrils by Gosal et al.(174) demonstrate the formation of flexible 
worm-like amyloid fibrils which are thought to be driven via a rapid non-nucleated 
linear assembly mechanism. The nature of these fibrils were distinctly different to 
traditional long-straight fibrils associated with classical amyloid self-assembly and 
suggests the existence of two distinct competitive pathways for amyloid fibril 
assembly.  
Serio et al.(175) proposed a new model for the transformation of soluble precursors into 
amyloid fibrils in the yeast prion Sup 35. This new model describing the formation of 
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an additional kinetic pathway via the clustering of oligomeric structures was termed 
the nucleated conformational conversion (NCC) model, and has proven more relevant 
in describing fibrillogenesis in many protein systems(159). NCC requires a structural 
conversion of a protein monomer once added to the growing fibril, as the fundamental 
mechanism of fibril elongation. Esler et al.(176) also demonstrated this through a ‘dock’ 
and ‘lock’ mechanism, whereby after the formation of a nucleus, the addition of 
structurally converted monomers becomes irreversible and fibril elongation proceeds.  
In addition to the NCC model, other models such as the monomer-derived conversion 
(MDC) model and template-assisted (TA) conversion model have been proposed(159, 
177, 178). These models similarly describe the formation of a critical intermediate state, 
which, when bound to a molecular chaperone, is able to heterodimerize and act as a 
template to assist in further conversion and fibril growth(179). Cohen et al.(180) proposed 
that a fibril-catalyzed secondary nucleation mechanism was responsible for the 
proliferation of Aβ1-42 aggregates. This was facilitated by a positive feedback loop 
between the monomeric and fibrillar forms of the peptide. Additionally, a new 
reversible model for apolipoprotein (apoC-II) amyloid fibril formation was proposed 
by Binger et al.(181, 182) which involves the reversible nucleation and elongation of 
fibrils coupled with fibril breaking and end-to-end joining. Clearly with such a diverse 
range of processes involved, it becomes challenging to identify a single unifying model 
which best describes amyloid fibrilization, and it may be, based on current 
understandings, that several models are needed to describe specific cases.   
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1.5 Early events in amyloidosis – Toxic amyloid species 
Detecting the early events in amyloid fibril formation has proven to be a difficult task 
due to the transient nature of these species and the large number of possible 
mechanistic intermediates as described in reviews by Haass and Selkoe(183), Jan  
et al.(184) and Benilova et al.(185). However, recent advances in technology have 
identified more than a dozen various intermediate states, ranging from monomer to 
dodecamers, spheres to protofibrils and crystalline to amorphous assemblies, which 
have resulted from increased knowledge of sigmoidal kinetic models and growth 
profiles(184, 185).  
There has long been debate on whether the fibrillar amyloid forms or soluble Aβ 
oligomers are responsible for initiating the toxicity that causes the loss of synaptic 
function and dementia in AD(48, 50, 186, 187). During early in vitro studies, it was believed 
that Aβ-induced neurotoxicity was the property of the amyloid fibril, and that 
neurotoxicity was only detected in Aβ peptides that adopted this fibrillar aggregated 
state(188-191). Pre-dissolved non-toxic Aβ monomers were converted to fibrillar 
aggregates after a few days incubation in buffered conditions; these aggregates then 
displayed various levels of toxicity, which was consistent with the toxic Aβ fibril 
hypothesis at that time(192). However, studies following this have argued that Aβ 
protofibrillar structures and oligomers, rather than the fibrils themselves, are the toxic 
species(193-196). This was highlighted in human and transgenic mouse models that 
displayed cognitive decline before the deposition of amyloid, correlating with changes 
in soluble Aβ oligomer levels rather than APP levels or fibrillar amyloid deposits(197). 
CHAPTER 1
 
19 
 
1.5.1 Small oligomeric aggregates 
Several pre-fibrillar aggregated states have been identified in amyloidogenic proteins. 
These so-called ‘soluble oligomers’ which precede Aβ aggregation and are believed 
by many to be the causative agents of Aβ toxicity(198-202) include various low-molecular 
weight species ranging in length from dimers through to dodecamers, and  
high-molecular weight supramolecular structures such as protofibrils, ADDLs  
(Aβ-derived diffusible ligands), and spherical and annular species(184). Like amyloid 
fibrils, Aβ oligomers also share a common anti-parallel β-sheet structure, which may 
relate to their toxicity in the pathogenesis of AD(64, 65, 203). In vivo injections of Aβ 
oligomers, in the absence of monomers and fibrils, showed a marked inhibition in 
hippocampal long-term potentiation and disrupted synaptic plasticity in rat 
cerebella(204). Remarkably, these toxic oligomers further demonstrated a 10-fold 
inhibition in neuronal viability when neuronal cells were treated with Aβ1-42 
oligomers as opposed Aβ1-42 to fibrils(205). Aβ dimers have displayed high levels of 
neurotoxicity; rat hippocampal neuron glia cells were destroyed after treatment with 
Aβ1-40 and Aβ1-42 dimers(206). A further disruption in cognitive function was 
observed in male Sprague-Dawley rats after being treated with soluble amyloid 
oligomers. This study identified that both dimers and trimers were necessary and 
sufficient to rapidly impair learned behaviour without inducing permanent 
neurological deficits(207). 
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1.5.2 Large protofibrillar assemblies 
Aβ protofibrils were first described by Harper et al.(164, 194) and Walsh et al.(163). These 
metastable structures were proposed to be on-pathway to amyloid fibrilization due to 
their rich β-sheet content. Other proteins unrelated to Aβ can also form these 
protofibrillar aggregates and increase neurotoxicity in cell cultures(147), suggesting that 
the toxicity of protofibrils is related to their bulk structure rather than the precise 
chemical nature of their amino acid sequence(208). Protofibrils share similar structural 
characteristics to amyloid fibrils and have demonstrated adverse effects on the normal 
metabolism of cultured neurons(209). In fact, their presence has led to dramatic changes 
in the electrical activity of cortical neurons, causing sharp increases in excitatory 
postsynaptic potentials, action potentials and membrane depolarizations that resulted 
in progressive neuronal loss(194). A marked reduction in cell viability was observed in 
cells treated with Aβ protofibrils, rather than monomeric or polymerized Aβ(210). The 
Arctic mutant Aβ1-40 further showed variations in both the morphology and size 
distribution of Aβ protofibrils, forming short filaments, large spherical particles and 
annular pore-like protofibrils which have potential neurotoxic implications in AD(211).  
Oligomer cytotoxicity may even be related to the formation of membrane pores and 
ion channels by amyloidogenic proteins(212-214). Under conditions that do not favour 
fibril production, nanomolar additions of small diffusible Aβ1-42 oligomers (ADDLs) 
actively bind to cell membranes and cause cytotoxicity(195). These ADDLs also 
displayed catastrophic effects on matured neurons in organotypic central nervous 
system cultures(195). ADDL-like oligomeric assemblies have been isolated from  
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post-mortem AD brains and their presence correlated strongly with memory loss(215). 
A non-fibrillar and neurotoxic form of Aβ was also identified when Aβ1-42 was 
incubated with clusterin, a multifunctional apolipoprotein, leading to inhibition of Aβ 
aggregation according to neurotoxicity assays(216). With the multitude of different 
types of oligomers, it becomes difficult to identify which species are pathologically 
relevant in human diseases since many have overlapping properties(185) and may form 
from different mechanistic pathways that are yet to be understood. Indeed, a 
continuous dynamic exchange between these different species may be relevant to their 
toxic implications in disease pathogenesis. 
1.5.3 Critical structural conversions 
Under biological conditions, most native state proteins must unfold or partially unfold 
before fibrillization can occur. This often involves the conversion of a soluble protein 
monomer into insoluble amyloid through the production of an unfolded intermediate 
species(134, 217, 218). In many cases, these native state intermediates transition from a 
random coil or α-helical conformation into ordered β-sheet and β-strand 
conformations, which initiate fibril elongation. There is strong evidence to suggest that 
helix-to-strand transitions play a prominent role in fibril self-assembly and 
neurotoxicity(163, 209, 219-223). The helical transition of Aβ1-42 has been implicated in the 
formation of membrane channels that allow the penetration of certain metal ions 
causing neuronal death(213, 224). 
CHAPTER 1
 
22 
 
In Aβ, the helix-to-strand transition is thought to be initiated in the N-terminal region, 
according to NMR studies and molecular dynamic simulations of Aβ1-28(122, 225). The 
formation of transient helical-containing intermediates were initially identified by 
Harper et al.(164) and later by Walsh et al.(163, 209) who studied the conformational 
changes in Aβ protofibrils and fibrils. Comprehensive secondary structural analysis of 
18 Aβ isoforms all demonstrated a common oligomeric helical intermediate(226). These 
partially folded intermediates have an increased propensity for fibril formation and 
have been accepted as critical species in the formation of many amyloid  
fibrils(221, 227-229). However, their detection has proven to be a difficult task due to their 
short-lived nature and relative speed at which the monomers unfold and aggregate.  
Once these helical-intermediates became recognized in the pathogenesis of disease, 
researchers focused their attention on modifying the helical propensity of these 
amyloidogenic proteins through the use of co-solvents such as trifluoroethanol (TFE) 
and 1,1,1,3,3,3-hexafluoroisopropanol (HFIP). These fluorinated solvents can create 
apolar microenvironments that mimic the lipid phase of membranes(230). In the case of 
the Aβ peptide, Aβ1-28, Aβ1-39 and Aβ1-42 isoforms all showed a preferred  
α-helical conformation in the presence of >40% TFE concentrations(121). Fezoui and 
Teplow(220) further confirmed through comprehensive circular dichroism analysis, that 
a preferred helical structure was adopted for Aβ1-40 and Aβ1-42 at 40% and 60% TFE 
concentrations respectively. The authors described this helical conversion as a 
necessary step towards decreasing the rate of fibril elongation and completely 
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suppressing fibrilization. Other studies have also suggested the β-sheet to α-helix 
transition is reversible by simply changing the composition of water and HFIP(231).  
Several solution state NMR experiments have also revealed that Aβ1-40 and Aβ1-42 
adopt a high propensity of helical structure in the presence of fluorinated  
alcohols(232-234). The identification of two helical regions in Aβ1-42 encompassing 
residues 8-25 and 28-38(235), present a possible solution model for the analysis of 
conformational transitions in Aβ, since these residues have previously been shown to 
form β-strands in the fibrilized state(132).  
1.6 Ionic liquids – Solvents of the future 
Ionic liquids (ILs) are a particular class of solvent comprised entirely of ions. These 
liquids are generally described as ‘fused’ or ‘molten’ salts with melting points below  
100°C(236). Although the first synthesis of an IL, ethanolammonium nitrate, was 
reported in 1888 by Gabriel and Weiner(237), it was not until the last three decades 
when the application of ILs became more than just an extension to the chemical solvent 
library. The enormous range of anion and cation combinations renders these solvents 
very unique and their properties can be fine-tuned to suit almost any application. 
Perhaps the most notable of these IL characteristics include their excellent chemical 
and thermal stability, non-flammability, non-volatility and high ionic  
conductivity(236, 238). ILs have found increasing utility in a vast range of applications 
from solvent systems for synthesis and heterogeneous and homogeneous catalysis 
reactions(238-241) to electrochemistry(242-246). 
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ILs are divided into two main categories: aprotic and protic ionic liquids (PILs). 
Aprotic ILs are formed from the ionization of the parent base by accepting any group 
other than a proton to its basic site(247). Alternatively, PILs are traditionally formed by 
the stoichiometric neutralization of a BrØnsted acid (HA) with a BrØnsted base (B) 
according to equation 1(247): 
 ൅  ֖ ା ൅ ି (1) 
Due to the presence of this mobile proton, PILs generally display BrØnsted acidity 
depending on the acidity of the precursor acid. The key property that sets PILs apart 
from other types of ILs is their degree of ionization; the proton transfer between acid 
and base, which can be controlled by careful selection of ion pairs. This property 
provides proton donor and acceptor sites within the PIL complex that can be used to 
alter the hydrogen bonding network of various systems. The degree of proton transfer 
in a PIL can be further estimated according to the difference between the pKaaq values 
of acid and base, as discussed by Yoshizawa et al.(247) The authors here postulate that 
for complete proton transfer to occur, a ΔpKaaq > 10 is imperative. Ideally, to achieve 
a strongly ionizable PIL (large ΔpKaaq value), combinations of a strong acid and base 
are required to shift the equilibrium in favour of ionic products; however this does not 
always occur. Alternatively, the combination of a weak acid and base pair (small 
ΔpKaaq value) results in incomplete proton transfer and can lead to the formation of 
molecular species, ion pairs or other higher ordered aggregated products(248-250).  
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The first reported synthesis of a room-temperature PIL was by Walden(251) in 1914. 
Ethylammonium nitrate (EAN), with a measured melting point of 12.5°C(252), became 
the main focus in PIL studies with researchers demonstrating its unique water-like 
properties(253-255) and its ability to form a three-dimensional hydrogen-bonded network 
with its surrounding environment(256). These properties encourage the use of EAN and 
other inspired ILs as increasingly popular ‘green’ replacement solvents for various 
protein studies encompassing protein dissolution, stabilization, denaturation and 
refolding(257, 258).  
Furthermore, knowledge on protein structure and function relationships in the presence 
of ILs became essential in understanding the mechanisms behind protein folding when 
compared with traditional solvent systems such as urea or guanidine hydrochloride. 
One such example includes recent work by Baker and Heller(259) who used a 
combination of small-angle scattering and spectroscopic techniques to measure protein 
denaturation in cytochrome c and human serum albumin (HSA) in the water-miscible 
IL, 1-butyl-3-methylimidazolium chloride (BMIMCl). Both proteins were found to 
denature in high concentrations of this IL (50 vol.%) and adopted a state that was 
consistent to that observed in the chaotropic agents urea and guanidine 
hydrochloride(260). 
1.6.1 Ionic liquids as solvents for protein studies 
1.6.1.1 Thermal stability and protein refolding  
One of the major issues contributing to a proteins’ inability to correctly refold after 
being exposed to high temperatures is disordered, irreversible aggregation as a result 
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of the exposure of surface hydrophobic residues(261). Therefore, stabilizing agents are 
generally employed to reduce or prevent aggregation and (partially) restore the 
proteins activity and native structure(262, 263). Many proteins dissolved in aqueous 
solutions become denatured at higher temperatures due to disruptions in hydrogen 
bonding and hydrophobic interactions, and thus attention has been shifted towards 
ionic liquids with little to no water content to avoid unwanted side reactions, hydrolysis 
and substrate solubility(261, 264).  
Perhaps the highlight in ionic liquid-mediated protein studies was described by 
Summers and Flowers(265, 266) who successfully used EAN as an additive for the 
refolding of hen egg white lysozyme (HEWL). The authors demonstrated that when 
HEWL was denatured and reduced in neat EAN (containing negligible water), more 
than 90% of the active protein was recovered after dilution. Additionally, when HEWL 
was denatured and reduced according to conventional procedures, followed by 
renaturation in EAN, 75% of the lysozyme activity was restored(265). It was believed 
that HEWL aggregation was prevented by electrostatic repulsion induced by the 
cationic groups adsorbed on the exposed hydrophobic domains of the protein.  
The Angell group(267) also observed similar trends in the reversible thermal 
unfolding/refolding of lysozyme in EAN. In this paper, differential scanning 
calorimetry (DSC) experiments showed that lysozyme was able to fold and unfold over 
several denaturation cycles up to 100°C. The PIL itself was found to protect against 
aggregation, with ~97% retention in refoldable protein sample per denaturation cycle, 
as opposed to aqueous buffered samples where a 70% loss of protein was measured 
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after just one cycle. The activity of the N-H proton, according to NMR spectroscopy, 
was confirmed as a principal factor in controlling protein unfolding(268). Selectively 
tuning the “effective acidity” of the PIL was found to induce maximal protein refolding 
in HEWL between the N-H chemical shifts of 7 and 9 ppm, with any N-H chemical 
shift outside this range leading to irreversible enzyme folding.  
Protein thermal stability however, is not limited to EAN alone, with researchers 
showing that simple hydroxylation of the ionic liquid cation alkyl chain is also 
effective as a refolding additive(269). In a study by Lange et al.(269), maximum refolding 
yields for HEWL were higher for hydroxylated methylimidazolium salts than those 
carrying longer hydrophobic alkyl chains. This was also noted by Atkin et al.(270) who 
found that alkyl hydroxylated ethanolammonium formate (EtAF) demonstrated 
substantial HEWL stabilization against unfolding at high temperatures. The authors 
speculated that this enhanced stability was the result of extra hydrogen bond 
donor/acceptor sites on the hydroxylated cation, which impede with the hydrophobic 
interactions on the protein. In terms of enzyme kinetics, HEWL showed a substantial 
6-fold increase in protein activity with EtAF present in comparison to buffered 
conditions, further emphasizing the role of these hydrogen bond donor/acceptor sites 
in protein stability(270).  
According to DSC experiments in recent work by Fujita et al.(271), the thermal stability 
of cytochrome c was dramatically increased in the presence of the aprotic choline 
dihydrogen phosphate (choline dhp) due to the absence of a denaturing peak in the 
DSC trace. The structural stability of cytochrome c was further emphasized by 
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temperature-induced FTIR spectroscopy, where it was found that only solutions 
containing choline dhp showed no changes in protein structure during exposure to 
temperatures of 110°C(271). Furthermore, cytochrome c structure was maintained and 
undisrupted after returning to room temperature. The authors highlight the importance 
of the ion pairs in choline dhp, which they describe as an “excellent combination of 
chaotropic cation and kosmotropic anion”, as it provides additional hydrogen bonding 
and acceptor sites as well as a similar proton activity to water, which actively 
contribute to its successful long term structural stabilization of cytochrome c(272-274).  
1.6.1.2 Dissolution and inhibition of amyloid formation 
The complex nature of amyloid fibrilization and the formation of toxic intermediate 
species has led to a number of investigations surrounding the control of aggregation 
and prevention of amyloid fibril formation. Although most of these studies utilize 
conventional solvents such as TFE and HFIP, a few studies describe the use of ILs as 
media for the dissolution and inhibition of amyloid fibrils(275, 276). A study carried out 
by Byrne and Angell(276) described the first reported case of a PIL as a solvent for 
amyloid fibril dissolution. In one particular method, the authors used additions of 
ethanol to fibrilize HEWL and then redissolved the fibrils in various PILs, discovering 
that 72% of enzyme bioactivity was restored when redissolved in EAN. This was a 
remarkable finding since non-fibrilized HEWL solutions in the same solvent showed 
80% enzymatic bioactivity(276). Shortly after this, Kalhor et al.(275) published similar 
work describing the application of several tetramethylguanidinium-based PILs as  
PIL-mediated amyloid inhibitors. Among the library of PILs synthesized, the authors 
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found that additions of tetramethylguanidinium acetate (TMGAc) inhibited the 
formation of HEWL amyloid fibrils in vitro by nearly 50% by reducing the number of 
β-sheet rich protofibrils required for self-assembly. This was confirmed by ThT 
binding assays and TEM, revealing a significant decrease in ThT intensity correlated 
with the formation of amyloid fibrils. Furthermore, the presence of intermediate 
species observed by native gel electrophoresis suggested that the PIL was selectively 
interacting with HEWL intermediates and trapping them into more stable 
conformations via cation-π interactions(275). 
1.6.1.3 Enhancement of amyloid fibril formation 
The relatively slow process of amyloid fibrilization in some proteins is a major setback 
in terms of developing drugs to regulate amyloid formation, due to the difficulty in 
developing rapid high throughput screening assays. Although strategies have evolved 
to accelerate fibrilization including acidic pH, increased temperature or directly 
modifying the proteins primary structure, ionic liquids have also found application in 
this field. For example, the fibrilization of HEWL in hydrated ammonium bisulfate 
showed enhanced amyloid fibril formation with predominant β-sheet secondary 
structure according to CD analysis, when heated to ~60°C(276); a process which would 
take several weeks to occur if held at room temperature. Kim and co-workers(277-279) 
also described that several ILs containing the methylimidazolium cation, in particular 
1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide (BIMbF3Im), could 
accelerate amyloid formation in α-synuclein, as depicted by an increase in ThT 
fluorescence intensity. The authors propose that the exposure of the hydrophobic 
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protein core facilitated by the increased interactions between solvent side chains, lead 
to extensive hydrogen bonding networks within the peptide backbone forming various 
conformational states(277). 
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1.7 Project Aims 
To date, there have been no reported cases on the self-assembly and aggregation of Aβ 
peptides in ionic liquids. The main scope of this thesis is therefore focused on how 
PILs can be used to control Aβ self-assembly.  
The result chapters are organized as follows: 
Chapter 3 discusses the controlled fibrillization of Aβ16-22, the central component of 
full-length Aβ, in anion-modified PILs. This chapter highlights the necessity of 
competitive hydrogen bonding between PIL anion and water, and its contribution to 
the rapid self-assembly of Aβ16-22 amyloid fibrils. Additionally, evidence of early 
oligomeric assemblies in a C-terminal modified Aβ16-22 analogue incubated in a PIL 
is described.  
Chapter 4 further explores the self-assembly of Aβ16-22, but as a function of  
cation-modified PILs. This chapter describes how subtle changes to the chemistry of 
the cation can facilitate amyloid fibril formation in a manner similar to that observed 
in anions. The structure-inducing effects of these PILs are further investigated on 
various Aβ isoforms linked to AD pathogenesis, showing that specific peptide-PIL 
interactions are responsible for direct changes in peptide solution conformations. 
On the basis of these observations, Chapter 5 discusses the helical-inducing properties 
of PILs on the Aβ1-40 peptide. The helical-inducing nature of PILs is confirmed as an 
essential property for inhibiting amyloid deposition and for dissolving synthetic  
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pre-formed Aβ1-40 amyloid fibrils. In order to determine the therapeutic relevance of 
this approach, some commonly studied ILs were tested as potential solvents for the 
dissolution of naturally occurring brain amyloid plaques. 
Chapter 6 describes the impact of ethylammonium nitrate (EAN) on the formation of 
various polymorphs in a key Aβ fragment, NH2-FF-COOH. The direct changes in 
hydrophobic assembly as the result of increasing EAN concentration, and its 
implication on the final supramolecular structure of the peptide are discussed.  
Finally, Chapter 7 represents a change in focus and explores the effect of the main PIL 
solvent parameters such as acidity, basicity, polarity and polarizability, on the solution 
conformation of a thermo-responsive polymer. This polymer is used to model the 
events that occur during protein folding in PILs and forms the foundation for future 
studies investigating the role that PILs play in amyloid self-assembly. This work 
illustrates that two factors; the relative acidity of the PIL anion and the solvent 
dipolarity/polarizability ratio, are critical in enabling the PIL to form extensive 
hydrogen bonds with the polymer. These results provide valuable information on  
PIL-solute interactions that strongly correlate to findings in Aβ self-assembly studies. 
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CHAPTER 2: Materials and Methodology 
2.1 Materials 
Fmoc-protected L-amino acids, 1-hydroxybenzotriazole (HOBt),  
O-(benzotriazol-1-yl)-N,N,N’N’-tetramethyluronium hexafluorophosphate (HBTU), 
piperidine and N,N-diisopropylethylamine (DIPEA) were purchased from Auspep 
(Melbourne, VIC, Australia). Commercially available Wang resin and  
Fmoc-Glu(OtBu)-Wang resin were purchased from GL Biochem (Shanghai, China). 
Triethylsilane (TES) trimethylsilane (TMS), 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFIP), phenol, ninhydrin, potassium cyanide, pyridine, Thioflavin T (ThT), dimethyl 
sulfoxide (DMSO), molecular sieves 3Å, sodium phosphate monobasic, sodium 
phosphate dibasic, Nile Red, 4-nitroaniline, Reichardt’s dye,  
8-anilino-1-naphthalene-sulfonic acid and all precursor acids and bases were 
purchased from Sigma-Aldrich (Castle Hill, VIC, Australia). Dichloromethane 
(DCM), N,N-dimethylformamide (DMF) and diethyl ether were purchased from 
ChemSupply (Port Adelaide, Australia). Acetonitrile, hydrochloric acid and sodium 
hydroxide pellets were purchased from Ajax Finechem (VIC, Australia).  
Poly(N-isopropylacrylamide) (PNIPAM) was purchased from Scientific Polymer 
(Atlanta, GA, USA). N,N-diethyl-4-nitroaniline and deuterium oxide (HDO) were 
purchased from Novachem (South Yarra, VIC, Australia). Polypeptide molecular 
ladder and mini protean 18% Tris-precast gels were purchased from Bio-Rad 
Laboratories Pty. Ltd. (Gladesville, VIC, Australia). Protein desalting columns were 
purchased from Thermo Fisher Scientific (Scoresby, VIC, Australia). Water was 
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purified and deionised using an in-house Advantage A10 Milli-Q System (Millipore) 
equipped with a 0.2 μm filter (Millipak®).  
Purified Aβ1-40, Aβ1-42, Aβ11pE-40, and Aβ3pE-40 peptides were provided by 
Professor Colin Barrow (Deakin University) and their syntheses are described 
elsewhere(280). The aprotic ionic liquids BMIMAc, BMIMCl and EMIMSO3 were 
supplied by Dr Nolene Byrne (Deakin University). 
2.2 Peptide synthesis 
Peptides were synthesised on a 0.2 mmol scale by traditional Fmoc solid-phase 
chemistry(281, 282). Solid phase support was either Rink-amide resin [loading 0.68 
mmol/g] (0.29 g, 0.2 mmol) or Wang resin [loading 0.34 mmol/g] (0.59g, 0.2 mmol). 
Amino acids were synthesized onto the solid-phase from the carboxyl terminus, in 
reverse sequence order. Freshly activated molecular sieves were added to DMF and 
allowed to dry for 4 hours. The resin beads (0.2 mmol) were pre-swelled in DMF  
(3 mL) for 15 min. After draining excess DMF, the resin was deprotected with 5 mL 
of deprotection solution (20% piperidine in DMF) for 5 min. Resin beads were washed 
with DMF (2 × 3 mL) and DCM (2 × 3 mL) before a small portion of beads were 
removed for Kaiser ninhydrin testing (see section 2.3).  
The coupling reagents HBTU (0.360 g, 0.48 mmol) and HOBt (0.136 g, 0.5 mmol) 
and a 5-fold excess of Fmoc-protected amino acid (1.0 mmol) were mixed with DMF 
(4 mL) and DIPEA (0.4 mL, 1.2 mmol) for 2 min to pre-activate the amino acid. This 
solution was transferred to the reaction vessel containing the deprotected resin and 
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allowed to mix for 20-30 min. The resin beads were drained and washed with DMF  
(2 × 3 mL) and DCM (2 × 3 mL) and a small portion of beads were removed for Kaiser 
ninhydrin testing. The resin beads were continuously deprotected and coupled with 
pre-activated amino acids until the final peptide sequence was synthesized onto the 
solid support. A final wash with DCM (2 × 3 mL) was completed to remove excess 
DMF from the resin and the product was dried under vacuum for 2 days.  
Cleaving of the peptides from the solid-phase support was achieved by suspending the 
resin beads in a 5 mL mixture of TFA (95%), TES (3%) and water (2%) (v/v/v) for 3 
hours, with occasional stirring. The resin was filtered through a pipette containing 
glass wool and the supernatant was collected in a centrifuge tube. Additional 
trifluoroacetic acid (3 × 1 mL) was used to wash the resin. The combined filtrate was 
dried under a stream of nitrogen gas to remove most of the TFA residue. Icy cold 
diethyl ether (40 mL) was added to the filtrate and precipitation of the peptide occurred 
immediately. The aqueous layer was extracted five times after centrifugation at 2,500 
rpm for 5 min. In the case of NH2-FF-COOH, icy cold distilled water (40 mL) was 
added to the filtrate instead of diethyl ether. Washed peptides were placed in a -80 °C 
freezer overnight and lyophilized the following day.  
White crude products were yielded as follows: NH2-KLVFFAE-COOH (58 mg, 
86.9%), Ms: m/z 853.48 [M+H]+, calc. 853.47. Ac-KLVFFAE-COOH (66 mg, 
76.1%), Ms: m/z 895.62 [M+H]+, calc. 895.49. Ac-KLVFFAE-NH2 (58 mg, 40.2%), 
Ms: m/z 894.63 [M+H]+, calc. 894.50. NH2-KLVWFAE-COOH (49.7 mg, 42.1%), 
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Ms: m/z 891.10 [M+H]+, calc. 891.07. NH2-FF-COOH (32 mg, 71.9%), Ms: m/z 
312.37 [M+H]+, calc. 312.36.  
2.3 Kaiser ninhydrin testing 
The Kaiser ninhydrin test(283) is a sensitive technique for the detection of primary 
amines in solution and is commonly utilized in solid-phase peptide synthesis to 
determine if coupling reactions are complete. The Kaiser ninhydrin test involves the 
preparation of three solutions: (1) ninhydrin (2.5 g) was dissolved in ethanol (40 mL), 
(2) liquefied phenol (40 g) was dissolved in ethanol (10 mL), and (3) KCN (0.001 M, 
1 mL) was diluted with pyridine (49 mL) to a final volume of 50 mL. After the 
deprotection and coupling of each amino acid during peptide synthesis, a small portion 
of resin beads were transferred into a test tube. 1 mL of each solution described above 
was added and mixed. The test tube was heated to 80 °C for 15 sec. A positive test, 
indicating the presence of free amine was represented by a dark blue/violet colour 
change of the solution and/or resin beads. A negative test was represented by no colour 
change in the solution and/or resin beads.  
2.4 Peptide self-assembly 
Peptides were dissolved in HFIP as a pre-treatment to break down aggregated material 
in the peptide lyophilisates, and prepared to a total stock concentration of 10 mg/mL. 
After 5 minutes of sonication, peptides were completely dissolved and present in 
monomeric form. An aliquot of stock solution was transferred to a vial where N2 was 
purged into the vessel to eliminate residual HFIP solvent until a dried film was 
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produced. Films were then re-dissolved in MilliQ water and diluted to the appropriate 
concentration before being transferred to PBS or PIL solution. Fresh stock solutions 
were made prior to each self-assembly to eliminate the formation of aggregates. 
2.5 Preparation of pre-formed Aβ1-40 fibrils for dissolution 
studies 
2.5.1 Method 1 – pre-formed TeaMs fibrils 
Aβ1-40 lyophilisates were pre-treated in HFIP as described above before the addition 
of 1 mL aqueous 10 wt% TeaMs solution. Fibril self-assembly was initiated within  
10 min and allowed to further self-assemble for 1 hour. After 1 hour, the peptide 
solution was centrifuged at 10,000 rpm for 10 min and the supernatant was extracted. 
Fibrils were washed with 3 x 1 mL MilliQ water to remove residual PIL solution before 
being lyophilized. Self-assembled lyophilisates were weighed and 0.2 mg was 
transferred to a vial containing neat TeaMs solution for analysis.  
2.5.2 Method 2 – preformed PBS fibrils 
Aβ1-40 lyophilisates were pre-treated in HFIP as described above before the addition 
of 1 mL aqueous PBS solution. Fibrils were allowed to slowly self-assemble over  
2 weeks. The peptide solution was centrifuged at 10,000 rpm for 10 min and the 
supernatant was extracted before the fibrils were lyophilized. Self-assembled 
lyophilisates were weighed and 0.2 mg was transferred to a vial containing neat TeaMs 
solution for analysis. 
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2.6 Protic ionic liquid synthesis 
Butylammonium lactate (BaLa). Butylamine (15.0 
g, 0.2051 mol) was added dropwise to lactic acid 
(21.73 g, 0.2051 mol). The mixture was stirred together in an ice bath for 2 hours, after 
which a clear viscous liquid remained. The neutralized product was placed under 
reduced pressure for 1 hour to remove residual solvent (yield; 34.2 g, 93.1 %).   
1H NMR (500 MHz; HDO) δ (ppm) 0.91-0.96 (t, J 7.3, 3H), 1.36-1.42 (sextet, J 6.8, 
3H), 1.49-1.52 (t, J 7, 2H), 1.65-1.71 (quint., J 7.2, 2H), 2.94-2.98 (t, J 7.5, 2H),  
4.07-4.11 (q, J 6.5, 1H), 8.04 (s, 3H). ESI-TOF-MS: calculated for C7H17O3N [M]+: 
Ms: m/z 163.23 [M+H]+, calc. 163.25. 
Choline dihydrogen phosphate (choline dhp). 
Choline hydroxide (40.0 g, 0.1485 mol) dissolved in 
methanol was added dropwise to phosphoric acid (14.55 g, 0.1485 mol). The mixture 
was stirred together in an ice bath for 2 hours, after which a clear viscous liquid 
remained. The neutralized product was placed under rotary evaporation to remove 
excess methanol from the starting material. The product crystalized into a white solid 
when transferred to reduced pressure 1 hour (yield; 53.1 g, 97.3 %). 1H NMR  
(500 MHz; HDO) δ (ppm) 3.19 (s, 9H), 3.49-3.51 (t, J 5, 2H), 4.03-4.06 (t, J 5, 2H). 
Ms: m/z 201.17 [M+H]+, calc. 201.19. 
Choline lactate (ChoLa). Choline hydroxide (40.00 
g, 0.1485 mol) dissolved in methanol was added 
dropwise to lactic acid (15.74 g, 0.1485 mol). The mixture was stirred together in an 
ice bath for 2 hours, after which a clear viscous liquid remained. The neutralized 
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product was placed under rotary evaporation to remove excess methanol from the 
starting material, then placed under reduced pressure for 1 hour to remove residual 
solvent (yield; 53.6 g, 96.2 %). 1H NMR (500 MHz; HDO) δ (ppm) 1.30-1.32  
(d, J 7, 3H), 3.19 (s, 9H), 3.49-3.51 (t, J 5, 2H), 4.03-4.11 (m, 3H). Ms: m/z 193.22 
[M+H]+, calc. 193.20. 
Choline malate (ChoMa). Choline 
hydroxide (44.16 g, 0.164 mol) was added 
dropwise to malic acid (21.95 g,  
0.164 mol). The mixture was stirred together in an ice bath for 2 hours, after which a 
yellow liquid remained. The neutralized product was placed under rotary evaporation 
to remove excess methanol from the starting material, then placed under reduced 
pressure for 1 hour to remove residual solvent. The product crystalized into a yellow 
solid after 1 hour at room temperature (yield; 59.4 g, 89.9 %). 1H NMR (500 MHz; 
DMSO) δ (ppm) 2.29-2.32 (dd, J 15.5, 11, 1H), 2.48-2.53 (dd, J 16, 3.5, 1H), 3.12  
(s, 9H), 3.40-3.42 (t, J 5, 2H), 3.83-3.86 (m, 3H). Ms: m/z 197.25 [M+H]+, calc. 197.20. 
Diethylammonium lactate (DeaLa). Diethylamine 
(15.0 g, 0.2051 mol) was added dropwise to lactic acid 
(21.73 g, 0.2051 mol). The mixture was stirred together in an ice bath for 2 hours, after 
which a yellow viscous liquid remained. The neutralized product was placed under 
reduced pressure for 1 hour to remove residual solvent (yield; 34.8 g, 94.7 %).  
1H NMR (500 MHz; HDO) δ (ppm) 1.24-1.27 (t, J 7.5, 6H), 1.31-1.33 (d, J 7, 3H), 
3.03-3.07 (q, J 7.4, 4H), 4.09-4.14 (q, J 7, 1H). Ms: m/z 163.19 [M+H]+, calc. 163.18. 
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Diethylammonium mesylate (DeaMs). Diethylamine 
(15.0 g, 0.2051 mol) was added dropwise to 
methanesulfonic acid (19.72 g, 0.2051 mol). The mixture was stirred together in an ice 
bath for 2 hours, after which a yellow viscous liquid remained. The neutralized product 
was placed under reduced pressure for 1 hour to remove residual solvent. The product 
crystalized into a yellow solid after 1 hour at room temperature (yield; 31.8 g, 91.6 %).  
1H NMR (500 MHz; DMSO) δ (ppm) 1.16-1.9 (t, J 7.3, 6H), 2.42 (s, 3H), 2.89-2.93 
(q, J 6.5, 4H), 8.38 (s, 2H). Ms: m/z 137.20 [M+H]+, calc. 137.16. 
Ethanolammonium lactate (ETALa). Ethanolamine 
(15.0 g, 0.2456 mol) was added dropwise to lactic acid 
(26.03 g, 0.2456 mol). The mixture was stirred together in an ice bath for 2 hours, after 
which a yellow viscous liquid remained. The neutralized product was placed under 
reduced pressure for 1 hour to remove residual solvent (yield; 38.9 g, 94.8 %).  
1H NMR (500 MHz; HDO) δ (ppm) 1.30-1.31 (d, J 7, 3H), 3.11-3.13 (t, J 5.3, 2H), 
3.79-3.81 (t, J 5.3, 2H), 4.07-4.11 (q, J 7, 1H), 8.15 (s, 3H). Ms: m/z 135.15 [M+H]+, 
calc. 135.14. 
Ethanolammonium malate (ETAMa). 
Ethanolamine (10.0 g, 0.164 mol) was added 
dropwise to malic acid (21.95 g, 0.164 mol). 
The mixture was stirred together in an ice bath for 2 hours, after which a yellow liquid 
remained. The neutralized product was placed under reduced pressure for 1 hour to 
remove residual solvent. The product crystalized into a yellow solid after 1 hour at 
room temperature (yield; 26.4 g, 82.6 %). 1H NMR (500 MHz; DMSO) δ (ppm)  
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2.27-2.31 (dd, J 15.4, 7.3, 1H), 2.53-2.58 (dd, J 15.4, 5.9, 1H), 2.85-2.87 (t, J 5, 2H), 
3.57-3.59 (t, J 5.3, 2H), 3.96-3.99 (t, J 6.5, 1H). Ms: m/z 195.17 [M+H]+, calc. 195.14. 
Ethylammonium lactate (EaLa). Ethylamine (15.0 g, 
0.3377 mol) was added dropwise to lactic acid (35.26 g, 
0.3377 mol). The mixture was stirred together in an ice bath for 2 hours, after which a 
clear viscous liquid remained. The neutralized product was placed under reduced 
pressure for 1 hour to remove residual solvent (yield; 44.3 g, 88.1 %).  1H NMR  
(500 MHz; HDO) δ (ppm) 1.24-1.27 (t, J 7.5, 3H), 1.31-1.33 (d, J 7, 3H), 3.00-3.05 
(q, J 7.3, 2H), 4.09-4.14 (q, J 7, 1H). Ms: m/z 123.13 [M+H]+, calc. 123.14.  
Ethylammonium mesylate (EaMs). Ethylamine (15.0 g, 
0.3327 mol) was added dropwise to methanesulfonic acid 
(31.65 g, 0.3327 mol). The mixture was stirred together in an ice bath for 2 hours, after 
which a clear viscous liquid remained. The neutralized product was placed under 
reduced pressure for 1 hour to remove residual solvent and immediately crystalized 
into a white solid (yield; 41.8 g, 89.6 %). 1H NMR (500 MHz; HDO) δ (ppm)  
1.20-1.23 (t, J 7.3, 3H), 2.75 (s, 3H), 2.97-3.01 (q, J 7.3, 2H). Ms: m/z 141.23 [M+H]+, 
calc. 141.22. 
Ethylammonium nitrate (EAN). Ethylamine (15.0 g, 0.3327 
mol) was added dropwise to nitric acid (20.96 g, 0.3327 mol) 
over a bath containing liquid nitrogen and isopropanol. The mixture was stirred 
together in an ice bath for 2 hours, after which a clear liquid remained. The neutralized 
product was placed under reduced pressure for 1 hour to remove residual solvent 
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(yield; 26.2 g, 72.9 %). 1H NMR (500 MHz; HDO) δ (ppm) 1.27-1.30 (t, J 7.3, 3H), 
3.05-3.09 (q, J 7.3, 2H). Ms: m/z 108.11 [M+H]+, calc. 108.09. 
Triethylammonium dihydrogen phosphate 
(TeaH2PO4). Triethylamine (15.0 g, 0.1482 mol) was 
added dropwise to phosphoric acid (14.52 g, 0.1482 mol). The mixture was stirred 
together in an ice bath for 2 hours, after which a clear viscous liquid remained. The 
neutralized product was placed under reduced pressure for 1 hour to remove residual 
solvent and immediately crystalized into a white solid (yield; 24.5 g, 83.0 %). 1H NMR 
(500 MHz; DMSO) δ (ppm) 1.16-1.19 (t, J 7.3, 9H), 2.95-3.00 (q, J 7.3, 6H). Ms: m/z 
199.20 [M+H]+, calc. 199.19. 
Triethylammonium hydrogen sulfate (TeaHSO4). 
Triethylamine (15.0 g, 0.1482 mol) was added 
dropwise to sulphuric acid (14.54 g, 0.1482 mol). The mixture was stirred together in 
an ice bath for 2 hours, after which a clear viscous liquid remained. The neutralized 
product was placed under reduced pressure for 1 hour to remove residual solvent and 
immediately crystalized into a white solid (yield; 25.1 g, 85.0 %).  1H NMR (500 MHz; 
HDO) δ (ppm) 1.26-1.29 (t, J 7.3, 9H), 3.18-3.22 (q, J 7.3, 6H). Ms: m/z 199.29 
[M+H]+, calc. 199.27. 
Triethylammonium lactate (TeaLa). Triethylamine 
(15.0 g, 0.1482 mol) was added dropwise to lactic acid 
(15.71 g, 0.1482 mol). The mixture was stirred together in an ice bath for 2 hours, after 
which a clear viscous liquid remained. The neutralized product was placed under 
reduced pressure for 1 hour to remove residual solvent (yield; 27.4 g, 89.2 %).  
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1H NMR (500 MHz; HDO) δ (ppm) 1.25-1.29 (t, J 7.3, 9H), 1.35-1.37 (d, J 7, 3H), 
3.17-3.21 (q, J 7.3, 6H), 4.19-4.24 (q, J 6.8, 1H). Ms: m/z 191.28 [M+H]+, calc. 191.22. 
Triethylammonium mesylate (TeaMs). 
Triethylamine (15.0 g, 0.1482 mol) was added 
dropwise to methanesulfonic acid (14.25 g, 0.1482 mol). The mixture was stirred 
together in an ice bath for 2 hours, after which a yellow liquid remained. The 
neutralized product was placed under reduced pressure for 1 hour to remove residual 
solvent. The product crystalized into a yellow solid after 1 hour at room temperature 
(yield; 26.8 g, 91.6 %).  1H NMR (500 MHz; HDO) δ (ppm) 1.28-1.31 (t, J 7.3, 9H), 
2.80 (s, 3H), 3.19-3.24 (q, J 7.3, 6H). Ms: m/z 183.32 [M+H]+, calc. 183.29. 
Triethylammonium tetrafluoroborate (TeaBF4). 
Triethylamine (30.0 g, 0.2965 mol) was added dropwise 
to tetrafluoroboric acid (54.25 g, 0.2965 mol). The mixture was stirred together in an 
ice bath for 2 hours, after which a clear viscous liquid remained. The neutralized 
product was placed under reduced pressure for 1 hour where the product crystalized 
into a white solid after 1 hour at room temperature (yield; 77.3 g, 91.8 %).  1H NMR 
(500 MHz; DMSO) δ (ppm) 1.34-1.36 (t, J 4.5, 9H), 3.25-2.31 (q, J 9, 6H), 8.99  
(s, 1H). Ms: m/z 188.96 [M+H]+, calc. 188.97.  
Triethylammonium trifluoroacetate (TeaTfac). 
Triethylamine (15.0 g, 0.1482 mol) was added 
dropwise to trifluoroacetic acid (16.90 g, 0.1482 mol) over a bath containing 
isopropanol and liquid nitrogen. The mixture was stirred together in an ice bath for  
2 hours, after which a yellow liquid remained. The neutralized product was placed 
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under reduced pressure for 1 hour to remove residual solvent (yield; 24.6 g, 77.1 %). 
1H NMR (500 MHz; HDO) δ (ppm) 1.26-1.29 (t, J 7.5, 9H), 3.17-3.22 (q, J 7.3, 6H). 
Ms: m/z 215.18 [M+H]+, calc. 215.17. 
Triethylammonium triflate (TeaTf). 
Triethylamine (15.0 g, 0.1482 mol) was added 
dropwise to triflic acid (22.70 g, 0.1482 mol) over a bath containing isopropanol and 
liquid nitrogen. The mixture was stirred together in an ice bath for an additional  
2 hours, after which a yellow viscous liquid remained. The neutralized product was 
placed under reduced pressure for 1 hour to remove residual solvent (yield; 30.4 g, 
80.6 %). 1H NMR (500 MHz; HDO) δ (ppm) 1.27-1.30 (t, J 7.3, 9H), 3.18-3.23  
(q, J 7.4, 6H). Ms: m/z 218.15 [M+H]+, calc. 218.16. 
Tetramethylguanidinium lactate (TeaLa). 1,1,3,3-
Tetramethyl-guanidine (15.0 g, 0.1302 mol) was added 
dropwise to lactic acid (13.8 g, 0.1302 mol). The 
mixture was stirred together in an ice bath for 2 hours, after which a clear viscous 
liquid remained. The neutralized product was placed under reduced pressure for 1 hour 
to remove residual solvent (yield; 26.0 g, 90.3 %). 1H NMR (500 MHz; HDO) δ (ppm) 
1.31-1.32 (d, J 7, 3H), 2.95 (s, 12H), 4.06-4.11 (q, J 6.8, 1H). Ms: m/z 205.24 [M+H]+, 
calc. 205.22. 
2.7 Time-of-flight mass spectrometry (TOF-MS) 
Mass spectra were collected on a 6210 Mass Spectral Detector TOF mass spectrometer 
(Agilent Technologies) in positive ion mode. The following instrumental conditions 
CHAPTER 2
 
45 
 
were used: drying gas, nitrogen (7 L/min, 350 °C); nebuliser gas, nitrogen (16 psi); 
capillary voltage, 4.0 kV; vaporizer temperature, 350 °C; and cone voltage, 60 V. The 
instrument was coupled to a 1200 series liquid chromatograph equipped with a binary 
pump (Agilent Technologies). Chemstation software (Agilent Technologies) 
controlled the HPLC pump and data acquisition. Samples were prepared in HFIP at a 
total concentration of 2 mg/mL and directly injected into the mass spectrometer with 
an injection volume of 20 μL. 
2.8 Reverse-phase high performance liquid chromatograph 
(HPLC) 
Chromatographic runs were performed on an 1200 Series HPLC system consisting of 
a quaternary pump, solvent degasser and autosampler (Agilent Technologies) with 
separation on a packed column (Zorbax 300SB RP-8e, 150 x 2.1 mm internal diameter, 
Agilent Technologies), equipped with a pre-column filter (Supelco™ Analytical 1/16", 
peek, 0.5 μm frit). The mobile phase was composed of [A]: aqueous TFA (0.1% v/v) 
and [B]: acetonitrile with TFA (0.1% v/v). Sample were prepared in HFIP at a total 
concentration of 2 mg/mL and directly injected into the HPLC with an injection 
volume of 5 μL. A flow rate of 0.5 mL/min was used and the column temperature 
remained constant at 25 °C. A gradient of 10% to 100% solvent [B], from 0-20 min 
was applied and peak detection was achieved with a photodiode array detector set at 
214 nm and 254 nm. 
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2.9 Thioflavin T (ThT) assay 
ThT fluorescence assays were performed on a Varian Cary Eclipse fluorescence 
spectrophotometer operating in emission mode, using a spectroscopic rectangular 
quartz cuvette (10 x 10 mm internal diameter, PTFE stopper) (Starna Scientific Ltd.). 
ThT dye was excited at 440 nm and samples were measured between the wavelengths 
of 460-600 nm, over three accumulations and from three independent sample sets. Data 
points were collected at 482 nm at a slow scan speed, with an excitation and emission 
slit window of 5 mm. Assays were carried out at room temperature, using a peptide 
and ThT concentration of 2 mg/mL and 0.5 mg/mL respectively. Aqueous PILs with 
0.5 mg/mL ThT were used as controls and samples were sealed with a teflon cap to 
prevent solvent evaporation during data collection.  
2.10 Intrinsic tryptophan fluorescence 
The fluorescence for a tryptophan-19 substituted Aβ16-22 peptide was measured on a 
Jasco J-850 CD Spectrophotometer (ATA Scientific) (Taren Point, NSW, Australia) 
using a rectangular quartz cuvette (10 x 10 mm internal diameter, PTFE stopper) 
(Starna Scientific Ltd.). The fluorescence excitation wavelength was set at 280 nm and 
the emission spectra were recorded from 300-400 nm. Measurements were carried out 
at room temperature, using a constant peptide concentration of 2 mg/mL and samples 
were prepared in triplicate. Background measurements of aqueous PILs were recorded 
prior to analysis and showed no increase in fluorescence intensity. 
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2.11 Congo red staining and birefringence monitoring  
A 10 μL aliquot of 5mM peptide solution aged for 1 day was allowed to dry overnight 
on a glass microscope slide. Congo red staining was performed by the addition of a  
10 μL suspension of saturated Congo red and NaCl in 80% ethanol (v/v) solution. 
Birefringence was determined on an optical microscope, equipped with an Olympus 
DP71 camera and cross polarizers.  
2.12 1H and 31P nuclear magnetic resonance (NMR) chemical shifts 
NMR spectra were recorded on a commercial Bruker AVANCE 500 MHz FT-NMR 
spectrometer. PIL samples were prepared in HDO and measured at 298 K. Proton and 
phosphorus chemical shifts were referenced relative to TMS and triphenylphosphine 
respectively, in the presence of HDO through an internal capillary. Data was processed 
on Bruker software version 3.1. 
2.13 Measurement of spin-lattice (T1) and spin-spin (T2) relaxation 
times 
Spin-lattice or longitudinal (T1) relaxation values were recorded on a commercial 
Bruker AVANCE 500 MHz FT-NMR spectrometer using the ‘inversion recovery’ 
pulse sequence described by Farrar and Becker(284). The inversion recovery pulse 
sequence (Figure 2.1) and measurement of the 1H-T1 signal for a 50 wt% TeaMs 
solution (Figure 2.2) is illustrated below.  
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Figure 2.1. Inversion-recovery pulse sequence for measuring T1. 
 
Figure 2.2. Inversion-recovery 1H-T1 determination of 50 wt% TeaMs at 500 MHz. 
The sequence was repeated at a range of increasing time (τ) values to give the decay 
rate of the magnetization. A time delay of 5T1 was used between measurements to 
ensure the sample returned to equilibrium without signal saturation. Measurements 
were collected by cooling solutions from 340 K to 260 K, allowing 20 min for the 
sample to equilibrate at each temperature interval. The temperature was calibrated 
within an internal accuracy of ±0.1 K. 
180° 90°
τ
FID acquisition
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Since signal linewidth is inversely proportional to the spin-spin or transverse (T2) 
relaxation time, linewidths were estimated by measuring the half-height full-width of 
each 1H signal between the temperatures of 340-260 K. These values were recorded in 
Hz and errors were less than 1 Hz. 
2.14 Circular dichroism (CD) 
Circular dichroism data was obtained on a Jasco J-815 CD Spectrophotometer (ATA 
Scientific) (Taren Point, NSW, Australia) using a rectangular quartz cuvette  
(1 x 10 mm internal diameter, PTFE stopper) (Starna Scientific Ltd.). Wavelength 
scans were collected using a 1.0 nm bandwidth, 2.0 sec averaging time, over an 
average of 5 accumulations. Samples were measured between the wavelengths of  
190-250 nm at a peptide concentration of 100 μM. Measurements below 190 nm were 
disregarded due to signal noise and interferences caused by the ionic liquids. Control 
samples consisting of solvent only were measured prior to each peptide sample and no 
baseline corrections were attempted. Circular dichroism data was analysed on Spectra 
Manager Version II (Jasco Analytical Instruments) and corrected using the  
Savitzky-Golay smoothing function at a convolution width of 9 points. Peptide 
secondary structure was further quantified by K2D2 online software(285). 
2.15 Fourier transform infrared (FTIR) spectroscopy 
FTIR measurements were performed on an Alpha FTIR spectrophotometer (Bruker 
Optik GmbH, Germany) equipped with a deuterated triglycine sulfate (DTGS) detector 
and a single-reflection diamond attenuated total reflectance (ATR) sampling module 
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(Platinum ATR QuickSnap™) consisting of 45° angle of incidence and a  
2x2 mm2 active sensing surface. A background spectrum of a clean ATR surface was 
individually acquired prior to each sample measurement using the same acquisition 
parameters. Aqueous PILs prepared in HDO were used as controls. The ATR-FTIR 
acquisition parameters used in OPUS 6.0 software suite (Bruker) throughout the study 
included a 4 cm-1 spectral resolution, 128 co-added scans, Blackman-Harris  
3-Term apodization, Power Spectrum phase correction and zero-filling factor of 2. 
Spectral post-processing including smoothing and second derivatization was 
performed using a 9-point Savitzky-Golay algorithm(286) within 1800-1500 cm-1 
spectral range. 
2.16 Dynamic light scattering (DLS) 
Lower critical solution temperature (LCST) measurements were collected on a 
Zetasizer Nanoseries (Malvern Instruments) equipped with a thermostated sample 
chamber. The LCST was measured within a temperature range of 1-70 °C. A 500 μL 
aliquot of aqueous 0.5% (w/w) PNIPAM was mixed with aqueous PIL and introduced 
into a disposable cuvette which was capped to eliminate solvent evaporation. Samples 
were stored on ice prior to analysis and were equilibrated at each temperature interval 
for 3 min over 64 accumulations per temperature point. The temperature was increased 
by increments of 0.3 °C. 
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2.17 Determination of Kamlet-Taft solvatochromic parameters 
The Kamlet-Taft solvatochromic parameters(287-289) were determined by freshly 
preparing three stock solutions of Reichardt’s dye (1) (20.0 mg, 1.2 mol/L),  
N,N-diethyl-4-nitroaniline (2) (7.0 mg, 1.2 mol/L) and 4-nitroaniline (3) (5.0 mg, 1.2 
mol/L) in methanol, and sonicated prior to use (Figure 2.3). 10 μL of the appropriate 
stock solution was transferred to each PIL solution and allowed to evaporate under 
vacuum. The λmax of each sample was measured at room temperature on a Cary 300 
Bio UV-Visible spectrophotometer, in a quartz cuvette (1 x 10 mm internal diameter, 
PTFE stopper) (Starna Scientific Ltd.) over the wavelength range of 300-800 nm for 
Reichardt’s dye and 300-600 nm for 4-nitroaniline and N,N-diethyl-4-nitroaniline. 
Reference samples were carried out in water and methanol and compared to values in 
literature.  
 
Figure 2.3. Structures of the Kamlet-Taft dyes and Nile Red polarity probe. 
1
Reichardt’s Dye
4
Nile Red
3
4-nitroaniline
2
N,N-diethyl-4-nitroaniline
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The dipolarity/polarizability parameter (π*) was calculated according to equation 2; 
ߨכ ൌ ቆ ɋ୫ୟ୶
ሺ૛ሻ
ͳͲͲͲିଵቇ െ ʹ͹ǤͷʹȀെ͵Ǥͳͺʹ (2) 
Where νmax(2) is the wavenumber at maximum absorbance for  
N,N-diethyl-4-nitroaniline (2) in the PIL. The hydrogen bond acceptor (HBA) basicity 
(β) was determined according to equation 3; 
β ൌ ͳǤͲ͵ͷν୫ୟ୶
ሺ૛ሻ
ͳͲͲͲିଵ െ
ν୫ୟ୶ሺ૜ሻ
ͳͲͲͲିଵ ൅ ʹǤ͸ͶȀʹǤͺ 
(3) 
Where νmax(2) and νmax(3) is the wavenumber at maximum absorbance for  
N,N-diethyl-4-nitroaniline (2) and 4-nitroaniline (3) in the PIL respectively. The molar 
transition energy (ET(30))(290) of Reichardt’s dye (1) in various PILs was determined 
according to equation 4; 
ܧ்ሺ͵ͲሻȀሺିଵሻ ൌ
ʹͺͷͻͳ
ɉሺ૚ሻ୫ୟ୶Ȁ
 (4) 
Where λ(1)max is the maximum π-π* absorption band of Reichardt’s dye (1) in a given 
solvent. The normalized polarity (ETN)(290) was calculated according to equation 5; 
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ܧ்୒ ൌ
ܧ்ሺ͵ͲሻȀሺିଵሻ െ ͵ͲǤ͹
͵ʹǤͶ  
(5) 
The hydrogen bond donator (HBD) acidity (α) was determined according to  
equation 6; 
Ƚ ൌ ሺܧ்ሺ͵ͲሻȀሺ
ିଵሻ െ ͳͶǤ͸ሺߨכ െ ͲǤʹ͵ሻ െ ͵ͲǤ͵ͳሻ
ͳ͸Ǥͷ  
(6) 
Random samples were selected for reproducibility of UV-visible measurements and 
mean deviations for α, β and π* parameters were calculated to be ±0.02.  
2.18 Polarity measurements 
A fresh stock solution of Nile Red (4) (1.0 mg, 0.1 mol/L) was prepared in methanol 
and sonicated prior to use. 10 μL of the stock solution was transferred to each PIL 
solution and allowed to evaporate under vacuum for 2 hours. The λmax (absorbance at 
maximum wavelength) of each PIL solution was measured at room temperature in a 
quartz cuvette (1 x 10 mm internal diameter, PTFE stopper; Starna Scientific Ltd.) by 
UV-visible spectrophotometry over the wavelength range of 300-800 nm. The molar 
transition energy of Nile Red (ENR) was calculated according to equation 7; 
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ܧ୒ୖ ൌ
݄ܿ ୅ܰ
ɉ୫ୟ୶
ൈ ͳͲ͸ (7) 
Where h is Planck’s constant, c is the speed of light, NA is Avogadro’s number and 
λmax is the wavelength of maximum absorption of Nile Red in the PIL. 
2.19 Preparation of sodium dodecyl sulfate poly-acrylamide gel 
electrophoresis (SDS-PAGE) 
Prior to running SDS-PAGE, peptides were pre-dissolved in HFIP to reduce aggregate 
formation and then dried with nitrogen gas. Ionic liquid solutions were added to the 
dried peptide films and were incubated at room temperature for 1 hour. 50 μL of 
sample was diluted with 120 μL of PBS pH 7.4 and desalted using protein desalting 
columns (Thermo Fischer Scientific) which were buffer exchanged prior to the 
addition of each sample. Samples were heated to 70 °C for 10 min, then vortexed and 
spun at 10,000 rpm for 1 min prior to loading on 16.5% Tris-Tricine gel. Samples were 
electrophoresed at 90 V for 3 hours to enhance the separation of low molecular-weight 
components. The gel was washed with 3 x MilliQ water and then stained by Coomassie 
Brilliant Blue for 30 min. The gel was destained overnight using glacial acetic acid 
and methanol buffer and imaged the following day.   
2.20 Preparation of human tissue samples 
Human brain tissues were provided by the Florey Institute of Neuroscience & Mental 
Health (FINMH). Approximately 600 mg of tissue were homogenized by razor 
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dissection and 4 volumes of TBS (10 mM Tris, 100 mM NaCl) containing protease 
inhibitors (Complete, EDTA-free; Roche) added to the tissues. Brain tissues were 
vortexed, then spun 100,000g for 30 min at 4 °C. The supernatant was collected and 
the remaining pellets were resuspended in membrane buffer and spun at 100,000g at  
4 °C for an additional 30 min. The pellets were then washed 5 × in ddH2O and 
centrifuged at 100,000g for 15 min at 4 °C. Homogenates were then prepared into 
equal aliquots and 120 μL of PIL solution was added and incubated at room 
temperature overnight. The following day, homogenates were spun at 13,200g for  
15 min to separate the supernatant from the pellets. Aliquots of the supernatant were 
then further used for western blotting analysis.  
2.21 Western blotting 
For brain dissolution studies, aliquots of the supernatant (described in section 2.20) 
were separated by SDS-PAGE using 4-20% BT gels (Criterion, Bio-rad) according to 
the manufacturer’s instructions. Briefly, 50 μL of each extraction was diluted up to 
300 μL in PBS pH 7.4 and desalted using protein desalting columns (Thermo Fischer 
Scientific) which were buffer exchanged prior to the addition of each sample. Samples 
were heated to 70 °C for 10 min, then vortexed and spun at 10,000 rpm for 1 min prior 
to loading on 4-20% blot transfer gel. Samples were electrophoresed at 180 V for  
45 min before being transferred onto pre-assembled PVDF membrane stacks using a 
Trans-Blot® semi-dry transfer apparatus (Bio-rad). The membrane was then boiled for 
2 min at 50% microwave power in PBS, pH 7.4.  
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After removing PBS, the membrane was blocked in TBST (10 mM Tris-HCl pH 8.5, 
50 mM NaCl, 0.1% Tween-20) containing 5% skim milk. Primary antibodies WO2 
and 4G8 were incubated on the membrane overnight at 4 °C. Horseradish  
peroxidase-conjugated rabbit anti-mouse immunoglobulins (Dako) were diluted 
1:10,000 in TBST and incubated for 1 hour at room temperature. The membrane was 
washed with 5 × 5 TBST after each primary and secondary antibody binding step and 
enhanced chemiluminescence (Immobilon, Millipore) was used to detect the bands. 
Images were captured and analysed by a LAS3000 chemiluminescence detector and 
Science Lab 2005 software (Fujifilm). Aβ peptides were detected using monoclonal 
mouse antibodies WO2 (diluted 1/50 from culture medium) and/or 4G8 (diluted to  
1 μg/mL). 
2.22 Transmission electron microscopy (TEM) 
Transmission electron micrographs were taken using a Jeol 2100 TEM microscope 
using an accelerating voltage of 100 kV. A 12 μL droplet of self-assembled peptide 
solution was placed on the grid and left for 5 min to adsorb before excess fluid was 
wicked off. Grids were then negatively stained by placing one droplet of freshly 
prepared and filtered 2% (w/v) uranyl acetate on the grids for 5 min and then blotted 
continuously against double folded Whatman 50 filter paper. Grids were stored in an 
air-tight vessel and dried overnight before imaging. Fibril dimensions were estimated 
using ImageJ software (version 1.48t)(291). 
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2.23 Scanning electron microscopy (SEM) 
Scanning electron micrographs were taken using a Zeiss Supra 55VP SEM. A 10 μL 
droplet was placed onto carbon tape mounted on an SEM stub (Cambridge sample 
stubs, 12.7 mm diam. x 11.4 mm ht, Tousimis) and vacuum dried. Samples were gold 
sputter coated (Leica Microsystems, BAL-TEC SDC 050 sputter coater) and further 
dried under vacuum overnight. Samples were imaged at a working distance of 3.5 mm 
using an EHT of 4.00 kV.  
2.24 X-ray diffraction (XRD) 
X-ray scattering of self-assembled NH2-FF-COOH dipeptides were performed on a 
diffractometer (X’Pert PRO from PANalytical). The normalized XRD patterns were 
obtained in symmetrical Bragg geometry with Cu-Kα radiation (40 kV, 20 mA), 
equipped with a liquid nitrogen cooled Ge solid-state detector. Approximately 20 mg 
of lyophilized sample was gently mounted onto a glass surface. Samples were scanned 
from 2° to 45° at a scanning rate of 0.02°/min. 
2.25 Optical microscopy 
Self-assembled peptides (5 wt%) in 0.1mM PBS and aqueous EAN solutions were 
imaged at magnifications of x40 on an optical microscope, equipped with an Olympus 
DP71 camera. Briefly, a 10 μL aliquot of each solution was placed on a microscope 
slide and vacuum dried over night to eliminate residual solvent.  
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2.26 ANS binding assay 
8-Anilino-1-naphthalene-sulfonic acid (ANS) binding assays were performed on a 
Varian Cary Eclipse fluorescence spectrophotometer in emission mode. ANS dye was 
excited at 350 nm and samples were measured between the wavelengths of  
400-600 nm, over three accumulations and from three independent sample sets. The 
fluorescence maximum was recorded for each sample at a slow scan speed, with an 
excitation and emission slit window of 2.5 mm. Assays were carried out at room 
temperature, using a constant ANS concentration of 20 μM. Where protein was 
required, a total concentration of 0.05 mg/mL protein was used. 
CHAPTER 3
 
59 
 
CHAPTER 3: Investigating Aβ16-22 Fibrilization Kinetics 
in Protic Ionic Liquid Anions and the Hofmeister Series 
3.1 Preface 
Sections of this work, describing the controlled fibrilization of Aβ16-22 in protic ionic 
liquids using a reverse Hofmeister strategy, have been published:  
x Debeljuh, N. J., Barrow, C. J., Byrne, N. (2011) The impact of ionic liquids 
on amyloid fibrilization of Aβ16-22: Tuning the rate of fibrilization using a 
reverse Hofmeister strategy. Phys. Chem. Chem. Phys. 13, 16534-16536. 
3.2 Introduction 
The self-assembly of soluble proteins into insoluble filamentous deposits is a 
pathological hallmark for many debilitating diseases. These filamentous deposits are 
known as amyloid fibrils and are often the result of protein misfolding(146). In 
Alzheimer’s disease (AD), the accumulation of fibrillar aggregates of amyloid-β (Aβ) 
peptide, which are produced as a result of enzymatic proteolysis of amyloid precursor 
protein (APP), triggers a cascade of cellular and molecular events that lead to synaptic 
failure, neuronal loss and eventually dementia(61). Thus, increased knowledge of the 
mechanism of Aβ aggregation and the identity of the toxic intermediate species is 
required to aid in the development of diagnostic tools for disease progression(51, 292).  
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The pathogenesis of AD is an area of active research and recent focus has been centred 
towards the process of amyloid fibrillization and the isolation and characterization of 
oligomeric species(183, 293, 294). The diverse number of these oligomeric intermediates 
presents a difficult task for researchers to identify the exact nature of the toxic species 
and mechanism by which fibril formation is achieved. Currently, the neurotoxic 
species in amyloid fibril formation is believed to be some form of soluble oligomer 
formed during the early stages of Aβ aggregation(183, 185). These soluble oligomers, rich 
in β-sheet structure, exist momentarily before they assemble into higher ordered 
structures known as amyloid fibrils(153, 154).  
Amyloid fibrilization often follows a sigmoidal kinetic growth profile(172, 295) which is 
characterized by a preliminary lag phase followed by monomer addition which 
initiates fibril growth and elongation. This sigmoidal fibril growth is strongly 
dependent on the solvent environment, including ionic strength, pH and variations in 
temperature, which are known to perturb specific protein-protein and hydrophobic 
interactions required for amyloid self-assembly. Hydrogen bonding is also important 
in amyloid fibrilization since these interactions are the main features in the formation 
of β-sheets(145).  
In this chapter, PILs are utilized as a novel solvent media to study the self-assembly 
of amyloid fibrils in Aβ16-22. This peptide fragment is one of the shortest  
fibril-forming β-amyloid fragments reported(126) and is an ideal probe to study amyloid 
fibrilization in PILs. Since PILs have a tuneable feature of proton transfer, the 
hydrogen bonding nature of the solvent will be modified through variations in anion 
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design, to better understand the mechanisms of self-assembly. Additionally, we briefly 
discuss the formation of a critical amyloid intermediate during self-assembly and 
identify a possible mechanism for amyloid fibrilization in PILs.  
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3.3 Results and Discussion 
3.3.1 Controlling Aβ16-22 fibrilization kinetics with PILs according to a 
reverse Hofmeister strategy  
The effect of PIL anion on the fibrilization of Aβ16-22 was explored using seven PILs 
designed with various anions including mesylate (Ms), triflate (Tf), trifluoroacetate 
(Tfac), hydrogen sulfate (HSO4), tetrafluoroborate (BF4), dihydrogen phosphate 
(H2PO4) and lactate (La). The common cation selected was triethylamine (Tea). 
Additionally, we included the aprotic ionic liquid choline dihydrogen phosphate 
(choline dhp) since this IL has been extensively used in protein studies(273) and 
provides a good comparison to all PIL systems and phosphate buffer saline (PBS) 
studied here.  
Since TeaHSO4, TeaH2PO4 and choline dhp have melting points above room 
temperature, preliminary ThT kinetic measurements for Aβ16-22 were recorded in 
aqueous TeaH2PO4 solutions between the concentrations of 97% to 5% (v/v) PIL. The 
ThT intensity after 1 minute revealed that solutions greater than 90% TeaH2PO4 
content demonstrated the fastest kinetics, which was also supported by the rapid 
formation of fibrils in solution displayed graphically in Figure 3.1 
(http://www.rsc.org/suppdata/cp/c1/c1cp22256b/c1cp22256b.mpg). Using the fixed 
concentration of 90% (v/v), the fibrilization of Aβ16-22 in the aforementioned PILs 
and aprotic choline dhp were measured as a function of time and the corresponding 
kinetic profiles are displayed in Figure 3.2. Measurements were stopped once the ThT 
fluorescence intensity reached a maximum signal. 
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Figure 3.1. The rapid formation of Aβ16-22 fibrils in 90% TeaH2PO4. t = 0 sec; a solution of 
monomeric Aβ16-22 is injected into the PIL media. t = 10-20 sec; gentle agitation of the 
solution shows a distribution of white precipitate (mature amyloid fibrils).   
 
 
Figure 3.2. Relative ThT intensity as a function of time for Aβ16-22 in 90 wt% TeaH2PO4 
(dark blue), TeaHSO4 (red), choline dhp (brown), TeaTfac (green), TeaLa (purple), PBS 
(black), TeaTf (pale blue), TeaMs (orange) and TeaBF4 (pale green). 
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The choice of anion has a significant influence on the fibrilization kinetics as 
illustrated, with both TeaH2PO4 and TeaHSO4 demonstrating remarkably fast kinetics. 
This is supported by a maximum ThT signal measured at the 1 minute interval. In fact, 
the fibrilization of Aβ16-22 in these two PILs is so fast that there was no obvious lag 
phase, which is interesting since traditional self-assembly models usually follow a 
sigmoidal growth profile(152). TeaTfac and choline dhp illustrate a short lag phase 
before proceeding to a maximum ThT signal after 12 hours. The relative ThT intensity 
of Aβ16-22 in choline dhp is almost double the intensity observed for TeaTfac, 
suggesting choline dhp has a greater tendency to fibrilize Aβ16-22. The differences in 
fibrilization kinetic profiles between choline dhp and TeaH2PO4 are likely attributed 
to the IL cation, since both ILs have the same anion. TeaLa and TeaTf display longer 
lag phases before the ThT fluorescence signal plateaus after 2 days and 11 days 
respectively, and both TeaMs and TeaBF4 show no obvious increase in ThT intensity 
even after 18 days. The fibrilization kinetics of Aβ16-22 was also measured in a 
0.1mM PBS and a maximum ThT signal was observed after 9 days incubation.  
The difference in ThT maximum intensity between each PIL sample also varies as a 
function of anion. In the case of TeaTfac, TeaLa and TeaTf where the relative ThT 
maximum is less than 1, different aggregated states or amyloid structures may be 
present in solution. More importantly, the lack of fibril growth determined by no 
increase in ThT intensity over time in TeaMs and TeaBF4, suggests these PILs are 
inhibiting fibrilization and possibly stabilizing pre-fibrillar oligomeric states which are 
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critical pre-cursors in amyloid self-assembly. Examination of the self-assembled 
fibrils reveal changes in the superstructure according to the PIL anion (Figure 3.3). 
 
Figure 3.3. TEM of negatively stained Aβ16-22 nanostructures in 90 wt% ILs and PBS. 
Samples were imaged immediately after reaching their maximum ThT fluorescence. No 
structures were not observed for TeaMs and TeaBF4 systems. 
200 nm
200 nm200 nm200 nm
200 nm
TeaH2PO4 TeaHSO4 Choline dhp
TeaTfac TeaLa TeaTf
200 nm
200 nm
PBS
CHAPTER 3
 
66 
 
In the TeaH2PO4 and TeaHSO4 systems, a dense network of fibrils is observed within 
several minutes of self-assembly. The rapid formation of these fibrils suggests that the 
starting product (monomer) quickly transforms into mature fibrils. This was supported 
in the ThT binding assay where both systems achieved a maximum ThT intensity 
within seconds. The fibrils formed in TeaH2PO4 are long and branched, as opposed to 
the shorter fibrils formed in TeaHSO4. No non-fibrillar aggregates were observed in 
the electron micrographs of both systems. The fibrils formed in choline dhp and 
TeaTfac are homogeneous and uniform in length, with fibril widths of  
13.9 ± 1.3 and 34.6 ± 2.4 nm respectively. In 0.1 mM PBS, the fibrils are longer in 
length and twist periodically along the fibre axis with widths of 35.5 ± 2.8 nm. Similar 
fibril morphology has previously been reported by Balbach et al.(126) in the same 
solvent system.  
Interestingly, both TeaLa and TeaTf solutions produced sheets of different 
morphologies. The sheets formed in TeaLa are 163 ± 5.8 nm in width and no striations 
are observed on the surface, which would otherwise indicate the aggregation of short 
fibrils. These are distinctively different to the TeaTf system where narrow and twisted 
sheets are formed with widths of 31.8 ± 3.2 nm. It is possible that charge screening 
effects are contributing to the twisting of Aβ16-22 fibrils formed in high concentrations 
of TeaTf. This type of fibril morphology has previously been observed in the  
self-assembly of the AAKLVFF peptide in 300 mM NaCl solution(158). There was no 
evidence of nanostructures in the TeaMs and TeaBF4 systems that was supported by 
the results in ThT assay. Even after 4 months incubation, both solutions remained 
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transparent suggesting that the fibrilization of Aβ16-22 is inhibited and that the 
monomeric state or some form of soluble oligomer is stabilized in solution. The 
changes observed in fibril superstructure when assembled in PILs may be the result of 
direct changes to the secondary structure of the peptide. This chiral ordering was 
further investigated by CD (Figure 3.4). 
 
Figure 3.4. CD spectra of Aβ16-22 in 90 wt% TeaH2PO4 (dark blue), TeaHSO4 (red), 
TeaMs (orange), TeaBF4 (green), TeaTf (pale blue) and PBS (black). 
 
The preliminary structure of Aβ16-22 in PBS solution displays a negative maximum 
at 217 nm and 225 nm, and a positive band at 202 nm, which is consistent with  
α-helical structure. Alternatively, in the PIL solutions Aβ16-22 predominantly forms 
a random coil structure with a slight α-helical character. This is represented by a 
positive π-π* absorption band near 195 nm, a negative band near 207 nm and a positive 
band near 222 nm(296). Since the preliminary conformation of the peptide is similar in 
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all PIL solutions, we propose that the changes in fibril ultrastructure and difference 
observed in the ThT binding assays, are the result of specific anion-water interactions. 
This is particularly evident in the comparison of Aβ16-22 in TeaHSO4 and TeaMs 
where both PILs induce a random coil conformation, but only TeaHSO4 leads to 
amyloid fibril production. Additionally, FTIR analysis of the amide I band reveals 
features in the secondary structure of Aβ16-22 after self-assembly (Figure 3.5).  
 
Figure 3.5. FTIR spectra of the Aβ16-22 amide I region in (a) 90 wt% TeaH2PO4, (b)  
90 wt% TeaMs and (c) 0.1 mM PBS (pH 7.0). Main amide I features are identified by black 
dashed lines. The blue spectra represent solution + Aβ16-22 and the orange spectra represent 
the solution on its own. 
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The FTIR spectra of the fibrils isolated from 90 wt% TeaH2PO4 show two dominant 
features of amide I bands at 1678 and 1624 cm-1, which are indicative of β-turn and 
parallel β-sheet structures, respectively(297). Quantitative analysis of the amide I 
components suggests that Aβ16-22 preferably adopts β-type conformations since they 
yield more than 67% of the total structure (Table 3.1).  
Table 3.1. FTIR amide I features and calculated percentage secondary structure of Aβ16-22. 
Solvent 
Conformation 
β-sheet α-helical Unordered β-turn 
TeaH2PO4 1624 (24.1) 1646 (9.5) 1638 (22.5) 1678 (43.9) 
TeaMs 1612 (16.3) 1646 (31.1) 1637 (34.4) 1674 (18.2) 
PBS 1628 (52.1) 
*1693 (15.0) 
- 1638 (25.8) 1676 (7.1) 
Values indicate location of amide I band (cm-1) with percentage structure reported in 
parentheses. *The presence of this higher energy band denotes anti-parallel β-sheet structure.  
To confirm that this was not the result of the PIL solution, a control measurement was 
performed using 90 wt% TeaH2PO4 in HDO, and no presence of these spectral features 
was observed in the FTIR spectrum. Since no fibrils were formed in TeaMs, an aliquot 
was subsequently analyzed and the collected FTIR spectrum showed a distinctive 
broad single band at 1651 cm-1 indicating the presence of α-helical structure, different 
from those observed in the control solution. After spectral deconvolution, it was found 
that less than 35% of the amide I bands contributed to β-type conformations. More 
importantly, there was an increase in α-helical structure, which could explain why 
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fibrilization was not observed in the ThT binding assay, since ThT is sensitive to  
β-sheet structure.  
The fibrils collected from the PBS sample show typical anti-parallel β-sheet features 
through the presence of the strong band at 1628 cm-1 and a weaker band at  
1693 cm-1(298). The relatively narrower width of the major peak at 1628 cm-1 has 
previously indicated the presence of stable and/or long β-strands and strong hydrogen 
bonds, which are commonly found in amyloid fibrils(299). Although Aβ16-22 in  
90 wt% TeaH2PO4 does not display these sharp anti-parallel β-sheet features, the 
formation of parallel β-sheet structure provides the essential molecular transition for 
the peptide to rapidly convert from monomer to amyloid fibril. 
3.3.1.1 Aβ16-22 fibrilization follows a reverse Hofmeister trend 
To describe how these anions are influencing fibrilization, we considered the 
possibility of Hofmeister anion effects(300). The empirical Hofmeister series relates to 
the minimal concentrations of various salts required to precipitate a given protein from 
aqueous solution, where the effectiveness of these salts are dominated by specific 
properties relating to the anion. These effects are typically pronounced at low salt 
concentrations (0.01 M to 0.1 M), where salts can dissociate into individual ions in 
water. Ranking the anions from fibril forming to fibril inhibiting behaviour, the 
following series is obtained: 
H2PO4- > HSO4- > Tfac- > La- > Tf- ǀǀ Ms- > BF4- 
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The double bar (ǀǀ) indicates the crossover from destabilizing to stabilizing PILs. In 
terms of monomer stabilization, the dihydrogen phosphate and hydrogen sulfate anions 
are the most destabilizing, whereas the mesylate and tetrafluoroborate anions are the 
most stabilizing. Salts which enhance the stability of native proteins usually drive 
‘salting-out’ of the protein(300, 301), that is, they promote aggregates, or in this case 
amyloid fibrils. However, we find that the PILs enhancing Aβ16-22 stability are in fact 
those that are ‘salting in’ the peptide; the mesylate and tetrafluoroborate anions.  
It is difficult to explain these reverse Hofmeister effects since common arguments 
reflecting ion surface charge density, relative ion size and hydrophobicity are not 
interrelated by this series(302-305). In fact, some researchers have shown that proteins do 
not follow the typical Hofmeister behaviour(306) and question whether it is actually a 
suitable explanation for the stability of proteins in ionic liquids(307). Others have shown 
that proteins exhibit opposite Hofmeister effects, which may contribute to the protein’s 
net charge and specific interactions(308). In some studies involving ‘neat’ ionic liquids 
as solvents, the relative ion effects on enzyme activity and stability become more 
complicated than a ranking of ions, as described in a review by Zhao(309).  
Since the Hofmeister series best describe salt effects at low concentration, we propose 
that the accelerated fibrilization observed is likely the result of competitive hydrogen 
bonding between the anion of the PIL and water. In this scenario, the hydrogen bonds 
between Aβ16-22 monomers and water molecules are broken (destabilized) due to the 
strong water-attracting nature of the kosmotropic anions. These kosmotropic anions 
then enhance amyloid fibrilization through a ‘salting out’ scenario by lowering the 
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peptides solubility in solution. Alternatively, weak interactions between chaotropic 
anions and water facilitate the ‘salting in’ process and render long-term solubility and 
stability of the peptide in solution. Alternative explanations including ion solvation 
could suggest that the PIL ions may not completely dissociate into individual ions and 
instead co-exist as ion pairs, higher order aggregates, or a microsegregated ionic liquid 
phase(249, 250, 310).  
3.3.2 Amyloid self-assembly is facilitated through competitive PIL anion-
water hydrogen bonds 
NMR spectroscopy offers valuable information about the phase changes, structural 
character and reorientational dynamics of molecules under a magnetized field(311). In 
particular, solvent relaxation constants, which are used to evaluate the dynamics and 
molecular interactions of a substance under various thermal conditions, can provide 
sufficient detail about competing effects between components in solution(312-314), 
particularly when slow dynamics dominate in ionic liquids. Therefore, to gain insight 
into the hydrogen bonding environment between water and PIL anions, we first 
investigated the proton chemical shifts of each PIL as a function of concentration by 
1H NMR spectroscopy.  
Evidently, all PILs containing anions with at least one available hydroxyl group 
(H2PO4-, HSO4- and La-) showed an increased proton shift of water, reflecting the 
formation of hydrogen bonds. For comparative measures, the proton stack plots of 
TeaH2PO4 and TeaMs are illustrated in Figure 3.6, since these two systems 
CHAPTER 3
 
73 
 
demonstrated extreme time scale differences in Aβ16-22 fibrilization kinetics and are 
expected to form different hydrogen bond networks with water.  
 
Figure 3.6. 1H NMR chemical shift of water as a function of (a) TeaH2PO4 and (b) TeaMs 
concentration. The small sharp peak at ~4.8 ppm and 0 ppm correspond to HDO and TMS, 
respectively. 
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In aqueous TeaH2PO4, there is a large downfield chemical shift of water from  
4.90 ppm at 10 wt% to 8.02 ppm at 90 wt% concentration. The smaller peak at  
~4.8 ppm corresponds to HDO in the internal capillary. This downfield shift suggests 
that the proton nuclei of water are becoming less electron dense(315) as the 
concentration of the PIL is increased. In effect, this causes the nuclei to become less 
shielded and shift downfield in the spectrum as the result of increased hydrogen 
bonding with the hydrated hydroxyl groups. Additionally, since the formation of 
hydrogen bonds causes a resonance shift towards the lower field, the gradual 
broadening of this peak further implies it is undergoing chemical exchange with the 
surrounding environment.  
The change in the chemical shift of water is negligible in TeaMs, which is anticipated 
due to the PIL’s chaotropic nature. However, some chemical exchange is still 
occurring, as evidenced by broadening of the water signal at ~4.8 ppm. Interestingly, 
the protons corresponding to the methyl group on the mesylate anion (~2.8 ppm) 
progressively shift upfield at higher PIL concentration and suggest that the anion is 
weakly interacting with water. The TeaH2PO4 anion has no measurable protons and so 
the chemical shift of phosphorus was investigated using 31P NMR (Figure 3.7).  
A difference of almost 3 ppm is measured for the chemical shift of phosphorus as a 
function of TeaH2PO4 concentration. This contrasts the shift observed for the mesylate 
anion in TeaMs and further suggests the prevalence of strong anion-water interactions 
in TeaH2PO4. 
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Figure 3.7. Difference in chemical shift of phosphorus as a function of TeaH2PO4 
concentration, probed by 31P NMR. 
To further probe the dynamics of the protons in each PIL system, the spin-lattice 
relaxation times (T1) of TeaMs and TeaH2PO4 were measured as a function of 
temperature (Figure 3.8). Measurements were performed at a concentration of 90 wt% 
PIL since these conditions were previously described in the fibrilization kinetic assay. 
The most useful information gained from T1 values is the relaxation time and location 
of the T1 minimum during changes in temperature. Values below 263 K for TeaMs and 
268 K for TeaH2PO4 could not be measured due to significant signal broadening owing 
to the slow motion of the PILs.  
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Figure 3.8. 1H relaxation times ((T1) sec) of (a) 90 wt% TeaMs and (b) 90 wt% TeaH2PO4 as 
a function of temperature (K). Note the difference in y-axes values. 
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The CH3 protons located on the mesylate anion did not reach a minimum within the 
temperature range investigated and this indicates that the 1H nuclei are continuing to 
undergo relatively unrestricted rotation. The triethylammonium cation contains three 
different sets of protons; the N-H proton reaches a T1 minimum of 0.412 sec at  
298 K, the CH2 protons reach T1 of 0.448 sec at a lower temperature of 292 K and the 
terminal CH3 protons reach T1 of 0.555 sec at an even lower temperature of  
273 K. As the protons move further out from the nitrogen, their relative mobility 
increases at a given temperature. This increase in proton mobility suggests a longer 
time is required to achieve relaxation, which is consistent with our findings here. The 
slower motion of the water protons in solution results in faster relaxation of the nuclei, 
measuring the lowest T1 value of 0.357 sec at 292 K in this system. 
Alternatively, the 1H-T1 values in TeaH2PO4 differ substantially from those observed 
in TeaMs. As mentioned earlier, the mobility of the proton nuclei increase as one 
moves from the CH2 to CH3 protons on the triethylammonium cation, however their 
T1 values and minima occur at higher temperatures; 0.552 sec at 320 K for CH2 and 
0.684 sec at 298 K for CH3. The water protons reach a T1 minimum of 0.673 sec at  
304 K. This also coincides with the relaxation of the N-H proton. Whilst we would 
have expected the N-H proton to reach a T1 minimum at higher temperatures than the 
CH2 protons on the same cation, this was not the case. This trend may be facilitated by 
chemical exchange between the N-H and water protons as illustrated earlier. Rapid 
intermolecular exchange between these groups often prevents their coupling with 
adjacent C-H groups, which is demonstrated by the faster relaxation of the  
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CH2 protons(316). Furthermore, these variations in proton dynamics, which lead to 
differences measured in T1 values, are unlikely the result of intramolecular segmental 
motion as suggested for other ionic liquid systems bearing aromatic protons(314). This 
was confirmed by measuring the linewidths of each proton signal for 90 wt% TeaMs 
(Figure 3.9 and Table 3.2) and 90 wt% TeaH2PO4 (Figure 3.10 and Table 3.3).  
 
Figure 3.9: 1H NMR spectra of 90 wt% TeaMs during cooling. Protons are designated 
according to the molecular structure above. 
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Figure 3.10: 1H NMR spectra of 90 wt% TeaH2PO4 during cooling. Protons are designated 
according to the molecular structure above. 
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Table 3.2: The linewidths (Hz) of 1H signals in 90 wt% TeaMs as a function of temperature.  
Temperature 
(K) H1 H2 H3 H4 H5 
330 37 38 44 57 38 
320 34 34 36 44 32 
310 32 32 35 38 26 
304 32 32 35 35 25 
298 31 32 35 32 22 
292 29 32 33 32 19 
286 29 32 32 32 16 
280 29 32 32 32 15 
273 28 32 34 32 12 
268 29 32 35 32 19 
263 34 36 52 39 26 
 
Table 3.3: The linewidths (Hz) of 1H signals in 90 wt% TeaH2PO4 as a function of 
temperature. 
Temperature 
(K) H1 H2 H3 H4 
340 38 22 21 255 
330 19 23 21 97 
320 16 24 25 44 
310 12 25 28 36 
304 9 26 29 29 
298 7 26 29 28 
292 11 28 31 29 
286 18 32 34 35 
280 29 35 39 52 
273 39 45 45 61 
268 45 52 65 87 
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In TeaMs, the estimated linewidths decrease as the temperature is cooled from 330 K 
to 268 K. When cooled to 263 K, the linewidths of all proton nuclei begin to broaden 
due to slower proton dynamics in solution(314). In the supercooled region, the mesylate 
CH3 protons show narrower linewidths due to greater mobility, which is consistent 
with the T1 values measured earlier. With the exception of the mesylate CH3 protons, 
there is no significant difference between the linewidths of the remaining protons to 
confirm that segmental motion is contributing to changes in T1.  
This is also observed for the TeaH2PO4 system, where the linewidths between different 
proton groups are very similar. The broad linewidth measured for the N-H proton at 
340 K is likely due to chemical exchange as described earlier, while the narrowing of 
water protons between the temperature range of 330 K and 286 K suggests that these 
protons are very mobile. The greater mobility of these water protons implies their 
susceptibility to hydrogen bonding with the surrounding environment, which is in 
agreement with the longer T1 values observed earlier.   
Additionally, the total relaxation time of each proton nuclei in the PIL systems 
provides useful information. TeaMs exhibits a slightly lower, but longer T1 range at 
room temperature (0.36-0.72 sec), in comparison with TeaH2PO4 (0.58-0.68 sec). We 
have established that strong hydrogen bonds between the hydroxyl, water and N-H 
species exists in solution, and as such the relatively fast dynamics of these protons 
require a longer time for relaxation to occur. Increases in van der Waals and hydrogen 
bond interactions are known to affect the viscosity of PIL solutions(317-319) and can also 
contribute to slower proton dynamics and longer T1 relaxation times. Therefore, it 
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cannot be ruled out that viscosity could impact the T1 values measured. The strong 
evidence of chemical shifting and exchange between proton groups in TeaH2PO4, 
which are absent in TeaMs, further confirm why rapid amyloid self-assembly in 
TeaH2PO4 is achieved. 
3.3.2.1 Mechanism for PIL-water-mediated amyloid fibrilization  
We have identified that hydrogen bond formation between specific PIL anions and 
water molecules is essential in driving the self-assembly of Aβ16-22. This  
PIL-mediated mechanism of amyloid fibril formation is illustrated in Figure 3.11.  
 
Figure 3.11. Schematic of the proposed PIL-mediated self-assembly pathway. (a) The 
enhancement of Aβ16-22 amyloid fibrils by the addition of a kosmotropic anion, and (b) the 
inhibition of amyloid fibrils by the addition of a chaotropic anion. Straight blue arrows 
indicate the formation of ordered hydrogen bonds and distorted blue arrows represent the 
formation of unordered hydrogen bonds. 
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In the presence of a kosmotropic anion at high PIL concentration, competitive 
hydrogen bonding between the PIL anion and surrounding water molecules causes the 
hydrogen bonds between water and peptide monomers to be broken. As a consequence, 
new hydrogen bonds are formed between water molecules and PIL anions, which 
create a more ordered microenvironment around the peptide monomers. These peptide 
monomers then rapidly form on-pathway nuclei that further assemble into amyloid 
fibrils.  
In the presence of a chaotropic anion, unfavourable interactions between water and 
anion cause disordering of the bulk water-anion complex. This unordered environment 
slows down or inhibits the folding and self-assembly of the amyloid monomer, such 
that it remains stabilized in a hydrated soluble state. Although it is unclear the nature 
of this species, we anticipate this species to be some form of pre-fibrillar assembly 
such as an oligomer or a lower molecular weight species. Additionally, the ability to 
inhibit fibrilization holds promise in terms of developing therapeutic drugs for the 
treatment of Alzheimer’s disease and will be expanded upon in Chapter 5.  
3.3.3 Formation of transient Aβ16-22 oligomeric spheres in TeaHSO4   
In addition to the native Aβ16-22 peptide, an N-terminal variant was synthesized to 
determine the impact of the N-terminal charge on the self-assembly process. 
Previously, the N-terminal acetylated Aβ16-22 variant was shown to assembling into 
either nanotubes or fibrils depending on solvent pH(320, 321). In the presence of PILs 
where it is expected that charge screening effects predominate(322), changes in protein 
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self-assembly are likely attributed to increased ion-water interactions through the 
formation of hydrogen bonds. 
The fibrilization kinetics of the acetylated Aβ16-22 peptide was measured in a solution 
of 90 wt% TeaHSO4 since TeaHSO4 is very kosmotropic and the ThT fluorescence 
assay is displayed in Figure 3.12.  
 
Figure 3.12. ThT fluorescence assay of Ac-Aβ16-22 in 90 wt% TeaHSO4. Electron 
micrographs of negatively stained Ac-Aβ16-22 nanostructures sampled from the 1 minute 
and 24 hour interval of fibrilization.    
After 1 day incubation, a maximum ThT intensity was achieved before the 
fluorescence signal plateaued. Investigation through TEM analysis revealed no fibrils 
during the initial stages of fibrilization, but rather small spherical nanostructures, 
which were densely populated across the grid. These structures have previously been 
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termed spherical oligomers(84, 184, 323) and are known to be critical precursors in amyloid 
self-assembly that are rich in β-sheet structure. This supports the abnormally high ThT 
intensity measured during the first hour of self-assembly, since ThT is sensitive to  
β-sheet structure. The formation of these oligomeric nanostructures is an important 
finding as it has been suggested that oligomers play a key role in the cytotoxicity 
associated with the formation of amyloid fibrils and consequently, amyloidosis in 
neurodegenerative disorders such as Alzheimer’s disease(55, 148, 183, 215, 323, 324).  
After 24 hours incubation, another micrograph was taken and this showed the 
formation of short amyloid fibrils that appeared to elongate outward from a common 
centre. The small spherical structures are still observed after 24 hours, and were 
stabilized in aqueous TeaHSO4. This is an interesting finding since β-sheet-rich 
oligomeric aggregates generally disappear upon fibril formation due to their transient 
and unstable nature. Furthermore, a noticeable inflection point occurs approximately 
2 hours into self-assembly. Although we did not sample this time interval, we postulate 
that this is due to a sudden structural conversion from spherical oligomers to early 
stage fibrillar structures, which would account for the observed increase in  
β-sheet formation and greater ThT fluorescence intensity. 
Subtle changes to the chemistry of the peptide monomer do not appear to affect the 
final morphology of the amyloid fibril, since similar structures were observed in native 
Aβ16-22 in the same solvent. This implies that both native and acetylated Aβ16-22 
follow a similar self-assembly mechanism. However, preliminary stages of  
self-assembly differ for these peptides. Native Aβ16-22 showed no lag phase and 
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proceeded to form mature amyloid fibrils within minutes of incubation in 90 wt% 
TeaHSO4, whereas Ac-Aβ16-22 has a distinctive 1 day lag phase and forms spherical 
oligomers before proceeding to mature fibrils. By simply replacing the N-terminal 
amino group with an uncharged acetyl group, the peptide loses a key hydrogen bonding 
site and the total net charge of the peptide is reduced. Although further analysis of this 
system is required, the co-existence of these oligomeric spheres and amyloid fibrils is 
consistent with the complexity of the amyloid fibrilization process(163, 168, 325). 
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3.4 Conclusion 
Our findings with the PIL anion series are consistent with previous reports that indicate 
that anions have a significant impact on biomolecules(326, 327). The choice of PIL anion 
is critical in the fibrilization of Aβ16-22. Kosmotropic anions such as H2PO4- and 
HSO4- significantly enhance fibrilization via a ‘salting out’ scenario, whereas 
chaotropic anions such at Ms- and BF4- completely inhibit fibrilization via a ‘salting 
in’ scenario. The chaotropic PILs were more likely to stabilize the monomeric form of 
Aβ16-22 while kosmotropic PILs were better for accelerating amyloid fibrilization, at 
a shorter time scale in comparison to conventional solvent systems. NMR chemical 
shift analysis revealed that the fibrilization kinetics in Aβ16-22 were driven by 
competitive hydrogen bonding between the anion of the PIL and water.  
In a modified Aβ16-22 analogue, both amyloid fibrils and oligomeric spheres co-exist 
in solutions of 90 wt% TeaHSO4. These oligomeric spheres are believed to be a critical 
toxic intermediate in the pathogenesis of Alzheimer’s disease. The accelerated 
fibrilization of Aβ16-22 fibrils observed in 90 wt% TeaH2PO4 holds considerable 
promise for biotechnological applications(328) since amyloid fibrils are exceptionally 
strong materials.  
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CHAPTER 4: Enhanced Aβ Fibrilization in Protic Ionic 
Liquid Cations 
4.1 Preface 
Sections of this work, describing the enhanced conversion of amyloid fibrils in protic 
ionic liquids with primary amines, have been published:  
x Debeljuh, N. J., Varghese, S., Barrow, C. J., Byrne, N. (2012) Role of cation 
in enhancing the conversion of the Alzheimer’s peptide into amyloid fibrils 
using protic ionic liquids. Aust. J. Chem. 65, 1502-1506. 
4.2 Introduction 
Although there is still ongoing debate, the interactions between biomolecules and 
cations are lower than with anions of the same charge density(326, 327). This is thought 
to be caused by factors such as polarizability and hydration, which are lower in cationic 
species(326, 327). Others have proposed that cations exhibit Hofmeister activity and, 
depending on the kosmotropic or chaotropic character of the cation in question, are 
more likely to display their effects through ion pairing with the conjugate anion 
species(329). In fact, this indirect approach exhibited by cations can likely change the 
behaviour of the anion and consequently the PIL system(329).  
Since anion interactions are more readily understood, most protein folding and  
self-assembly studies have focussed on the effect of anions in bulk solutions. To date, 
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only a handful of studies have actually explored changes in PIL cations and their 
impact on biomolecules(265, 270). Most recently, Byrne et al.(330) described a simple 
modification of the cationic PIL group that could significantly enhance the stability of 
the native structure of tobacco mosaic virus in the presence of ethylammonium 
mesylate (EaMs), in contrast to aqueous buffered conditions where a loss of structure 
was observed over the same experimental time scale.  
In an expansion of the approach demonstrated by the PIL anion series discussed in 
Chapter 3, this chapter aims to investigate the impact of cation-modified PILs on the 
self-assembly of Aβ16-22. We describe how PILs designed with primary amines can 
facilitate amyloid fibril formation and use this information to determine structural 
changes in pathologically related isoforms of the Aβ peptide.  
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4.3 Results and Discussion 
4.3.1 Fibrilization kinetics of Aβ16-22 in cation-modified PILs 
The effect of PIL cation on the self-assembly of Aβ16-22 was explored using six PILs 
designed with the lactate anion and various cations including ethanolammonium 
(ETA), ethylammonium (Ea), diethylammonium (Dea), triethylammonium (Tea), 
butylammonium (Ba) and tetramethylguanidinium (TMG). Additionally, the aprotic 
choline lactate (ChoLa) was also synthesized as a comparison to the protic cations. 
The self-assembly of Aβ16-22 in 90 wt% ILs was monitored over time by ThT 
fluorescence assay and is illustrated in Figure 4.1.  
 
Figure 4.1. Relative ThT intensity as a function of time for Aβ16-22 in 90 wt% ILs. ETALa 
(black), TeaLa (purple), ChoLa (pale blue), BaLa (blue), DeaLa (red), EaLa (green) and 
TMGLa (orange). Error bars are within 5%. 
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When Aβ16-22 is self-assembled in ETALa, a maximum ThT intensity is observed 
after 4 days incubation, with very little changes in ThT intensity thereafter. In 
comparison to the other PILs, the relative ThT intensity is highest in ETALa and 
suggests that the Aβ16-22 monomers are almost completely converted to mature fibrils 
after 4 days. Despite the similarities in molecular structure between the ETALa and 
EaLa PILs, the absence of the hydroxyl group on the ethylammonium cation shows a 
significant impact on the fibrilization of Aβ16-22, with a relative ThT intensity almost 
10-fold greater in ETA+. This additional hydrogen bond donor/acceptor site in ETA+ 
allows the PIL to co-ordinate more efficiently with the assembling peptide. Similar 
observations have been made by Atkin et al.(270), where protein secondary structure 
was stabilized by cations with multiple hydroxyl groups. Additionally, a  
7-fold enhancement in ThT intensity is observed when the cation alkyl chain length is 
increased from ethylamine to butylamine. Although we assume the strength of 
electrostatic interactions between the ethylammonium cation-protein and 
butylammonium cation-protein to be similar, hydrophobic interactions are in fact more 
significant in the butylammonium cation due to its longer alkyl chain length. This 
effectively increases the PILs interaction with Aβ16-22 as it assembles.  
The effect of hydrogen bonding through the amine protons is demonstrated by EaLa, 
DeaLa and TeaLa. In the presence of TeaLa, a maximum ThT intensity is measured 
after 2 days incubation, with a significantly reduced lag phase in comparison to DeaLa 
and EaLa. This outcome was not expected since the addition of hydrogen bonding sites 
are thought to enhance protein folding and self-assembly(270). A possible reason for 
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this could be explained by the PIL anion and cation combination. Eggers and 
Valentine(329) proposed that kosmotropic cations, as opposed to chaotropic ones, have 
a higher tendency of ion pairing with the kosmotropic anions in solution and results in 
a reduction of free anions in solution.  
4.3.2 Primary PIL amines enhance the conversion of Aβ16-22 monomers 
to amyloid fibrils 
To further explore the effects of hydrogen bonding in primary, secondary and tertiary 
PIL cations, new PILs were synthesized containing the mesylate anion, since this anion 
displayed chaotropic properties (Chapter 3), and ThT fluorescence assays were 
performed at various PIL concentrations (Figure 4.2).  
It is immediately evident that in most mesylate-containing PILs at various 
concentrations, the self-assembly of Aβ16-22 does not follow typical sigmoidal 
growth as observed previously in the lactate anion PIL series. At 10 wt% PIL 
concentration, both EaMs and TeaMs show a maximum ThT intensity at 1 minute 
before the fluorescence intensity decays, while DeaMs displays a maximum after  
2 hours incubation. Blank measurements were recorded for each PIL concentration at 
each time interval and this fluorescence decay was not observed. The interesting 
feature of this figure is the difference in absolute intensity where EaMs demonstrates 
a five-fold increase in ThT intensity when compared to TeaMs, suggesting that 
amyloid fibrils are five times more likely to form in the presence of EaMs.  
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Figure 4.2. ThT intensity of Aβ16-22 in various PIL concentrations. EaMs (black), DeaMs 
(red) and TeaMs (blue). 
When the PIL concentration is increased to 30 wt%, the ThT intensity in EaMs is 
increased to almost double that observed at 10 wt% concentration. TeaMs shows a 
four-fold increase in ThT intensity in comparison to the 10 wt% solution, with a 
maximum intensity again measured at 1 minute. The ThT maximum in 30 wt% DeaMs 
is measured at 2 hours, which is slightly quicker than that observed in the 10 wt% 
solution. At 50 wt% concentration, EaMs again demonstrates rapid fibrilization with 
a maximum ThT intensity proceeding at 1 minute incubation, and shows a similar 
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fibrilization kinetic profile to that measured at 30 wt%. DeaMs illustrates a substantial 
increase in the kinetics of fibrilization with a maximum intensity measured at  
5 minutes whereas TeaMs significantly decreases to 1 hour.  
At higher PIL concentrations (70 wt%), the kinetics of fibrilization slows down 
significantly in EaMs and DeaMs, where a maximum ThT intensity was observed at 
45 minutes. More importantly, TeaMs displays no increase in ThT intensity and there 
were no signs of fibrillar aggregates in solution according to TEM analysis. This 
inhibition of fibrilization may be driven by the structure-inducing capabilities of the 
mesylate anion, which will be discussed further in Chapter 5. This is a contrast to lower 
PIL concentrations where no evidence of structural-inducing effects were observed. 
For all PIL concentrations of EaMs and TeaMs, the relative ThT intensity is 
significantly higher for EaMs than for TeaMs, owing to the availability of amine 
hydrogen bonds in EaMs. The formation of ion pairs between the ethylammonium 
cation and the mesylate anion is also significantly reduced due to the chaotropic nature 
of the anion, allowing the cation to freely interact with the assembling peptide. Since 
the proton activity in EaMs, DeaMs and TeaMs is very similar (pKa = 11.2, 11.3, 11.3 
respectively)(331), the solution pH is not a critical factor for enhancing fibrilization. 
To further investigate the changes in amyloid fibrilization, intrinsic fluorescence of a 
tryptophan-19 substituted Aβ16-22 peptide was examined in both PILs, containing the 
primary and tertiary amines. Tryptophan fluorescence is widely used as a tool to 
monitor protein folding in regards to changes in local structure and dynamics(332). The 
substitution of the tryptophan group in position 19 has previously been shown not to 
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impact amyloid fibrilization(333) and thus, provides a more sensitive measurement of 
the local hydrophobic environment since tryptophan has a stronger fluorescence 
intensity and higher quantum yield than the phenylalanine residue. The fluorescence 
emission spectra of the tryptophan substituted Aβ16-22 peptide as a function of EaMs 
and TeaMs concentration is shown in Figure 4.3.  
The emission spectrum was also recorded in PBS and is illustrated in both PIL systems. 
A gradual blue shift is observed in the emission spectrum of EaMs as a function of PIL 
concentration. At 10 wt% EaMs, the λmax occurs at 350 nm and shifts to 342 nm in  
70 wt% EaMs. Blue shifts are often attributed to an increase in hydrophobicity around 
the tryptophan residue(332) and imply direct changes to the local environment of the 
residue. Control measurements of the aqueous PIL solution without the tryptophan 
substituted peptide showed no λmax confirming that the signal obtained is the result of 
changes surrounding the tryptophan residue.  
In comparison to TeaMs, no blue shift was observed in the tryptophan emission spectra 
upon increasing the PIL concentration, and all TeaMs concentrations measured a  
λmax of 364 nm. Interestingly, the signal measured at 10 wt% TeaMs superimposes that 
of the PBS which also has a λmax of 364 nm. The fluorescence intensity of the 
tryptophan residue also increased as a function of TeaMs concentration, with the 
exception of 30 wt%, and in comparison to EaMs, the fluorescence intensity is almost 
three times larger at the same concentration. 
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Figure 4.3. Fluorescence emission of the tryptophan residue as a function of (a) EaMs 
concentration and (b) TeaMs concentration. PBS (black), 10 wt% (blue), 30 wt% (red),  
50 wt% (green) and 70 wt% (orange). Excitation wavelength 280 nm. 
Glutamic acid is known to quench the tryptophan signal when protonated(334). 
Therefore, the tryptophan residues may be shielded from glutamic acid by TeaMs, 
resulting in the enhanced tryptophan emission. In terms of amyloid self-assembly, 
these hydrophobic tryptophan residues are buried deep within the hydrophobic core of 
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assembling peptide. The blue shift observed in EaMs suggests a tighter packing density 
of tryptophan, which may affect the final packing of individual β-sheets and the 
formation of amyloid fibrils. Furthermore, the absence of a blue shift in TeaMs could 
imply that this PIL is altering the fibrilization pathway of Aβ16-22 or potentially 
inhibiting amyloid fibril formation completely. Electron micrographs were taken to 
illustrate the degree of fibrilization in EaMs and TeaMs and are illustrated in  
Figure 4.4.  
 
Figure 4.4. Overview of a TEM grid section outlining the degree of Aβ16-22 fibrils in  
10 wt% EaMs and TeaMs. 
The coverage of fibrillar material across the grid section clearly shows EaMs ability 
to induce Aβ16-22 fibrils. This is in contrast to TeaMs where only trace amounts of 
fibrils are observed. These micrographs validate the differences measured in the 
fibrilization kinetic assays for both systems, where EaMs induces up to a five-fold 
enhancement in ThT fluorescence intensity, and this result emphasizes the impact of 
hydrogen bonding through the N-H proton(s) of the cation on amyloid formation. 
These protons behave similarly to the hydroxyl protons previously described for 
10 wt% EaMs 10 wt% TeaMs
100 μm 100 μm
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TeaH2PO4 and other hydroxyl-containing ionic liquids(335), and demonstrates that 
subtle modifications to the chemistry of the cation can be just as effective in enhancing 
peptide amyloid fibrilization as anion species. The direct peptide-PIL interactions 
measured by differences in the tryptophan environment likely accounts for the 
differences observed in the ability to convert Aβ16-22 monomers into amyloid fibrils.  
4.3.3 Peptide-PIL interactions influence the solution conformational 
changes in Aβ isoforms 
The consequence of these peptide–PIL interactions likely causes a change in peptide 
secondary structure. In this section, the impact of varying EaMs and TeaMs 
concentrations are explored on other key Aβ variants that have direct implications in 
AD. These isoforms include Aβ1-40 and Aβ1-42, naturally occurring components in 
amyloid deposits, and Aβ3pE-40 and Aβ11pE-40 which are endogenous  
N-terminally truncated pyroglutamate fragments suspected to be important  
post-translational products found in amyloid plaques(280, 336-338). Changes in the 
secondary structure of Aβ1-40, Aβ1-42, Aβ11pE-40 and Aβ3pE-40 were examined 
using circular dichroism in 10 wt%, 30 wt%, 50 wt% and 70 wt% concentrations of 
TeaMs and EaMs. Each spectrum is depicted graphically in Figure 4.5 with their 
corresponding percentage secondary structures outlined in Table 4.1. These values 
were determined using K2D2 deconvolution software(285) in addition to percentage 
error estimates, which were less than 1.7 % in all cases.  
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Figure 4.5. CD spectra of Aβ peptides as a function of EaMs and TeaMs concentration. PIL 
concentrations are 10 wt% (blue), 30 wt% (red), 50 wt% (green) and 70 wt% (black). 
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Table 4.1. Estimates of Aβ percentage secondary structure using K2D2 online software. 
Values are rounded off to the nearest whole number. 
Peptide Solvent Composition α-helix  (%) 
β-sheet  
(%) 
Random 
Coil (%) 
Aβ1-42 10 wt% EaMs 8 44 48 
 30 wt% EaMs 9 43 48 
 50 wt% EaMs 23 27 50 
 70 wt% EaMs 31 15 54 
 10 wt% TeaMs 9 40 51 
 30 wt% TeaMs 13 32 55 
 50 wt% TeaMs 20 25 55 
 70 wt% TeaMs 25 19 56 
Aβ1-40 10 wt% EaMs 12 49 39 
 30 wt% EaMs 19 36 45 
 50 wt% EaMs 22 31 47 
 70 wt% EaMs 30 28 42 
 10 wt% TeaMs 26 31 43 
 30 wt% TeaMs 32 29 39 
 50 wt% TeaMs 39 25 36 
 70 wt% TeaMs 47 15 38 
Aβ3pE-40 10 wt% EaMs 4 48 48 
 30 wt% EaMs 4 48 48 
 50 wt% EaMs 6 47 47 
 70 wt% EaMs 37 12 51 
 10 wt% TeaMs 20 27 53 
 30 wt% TeaMs 20 29 51 
 50 wt% TeaMs 32 16 52 
 70 wt% TeaMs 29 15 56 
Aβ11pE-40 10 wt% EaMs 2 51 47 
 30 wt% EaMs 5 47 48 
 50 wt% EaMs 28 25 48 
 70 wt% EaMs 28 36 36 
 10 wt% TeaMs 12 40 48 
 30 wt% TeaMs 13 39 48 
 50 wt% TeaMs 20 31 49 
 70 wt% TeaMs 24 29 47 
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As a general observation, the structure inducing effect of each PIL becomes more 
apparent at higher PIL concentrations with increasing in CD ellipticity with 
concentration. Higher PIL concentrations induce folding due to specific PIL-peptide 
interactions, which are less noticeable at high water content due to ion solvation. The 
presence of isodichroic points at 202-204 nm in various CD spectra implies there is a 
direct structural conversion between the β-sheet and α-helix conformational states. The 
D-helix content may be overestimated, since a shift to longer wavelength E-structure 
occurs on aggregation. This can result in an overestimation of D-helical content, 
particularly for the more rapidly aggregating species. 
Analysis of the estimated secondary structural components reveals distinct differences 
between the α-helical and β-sheet components of each Aβ isoform. When Aβ1-40 is 
compared with full-length Aβ1-42 in various EaMs concentrations, both peptides show 
a gradual loss in β-sheet structure and a gain in α-helical structure, with little change 
in the total amount of random coil. However, at least part of this apparent gain in  
D-helical structure may be a shift to more soluble E-sheet species with an observed 
increase in the single minima intensity around 216 to 222 nm, with artificial calculates 
as an increase in D-helical content (refer to shape of curves in Figure 4.5). At high 
EaMs concentrations, Aβ1-40 has almost double the estimated amount of  
β-sheet content than Aβ1-42. This is particularly interesting since it is well known that 
Aβ1-42 forms amyloid fibrils more rapidly through the formation of β-sheets that are 
contributed by the C-terminal hydrophobic residues(77, 79, 164).  
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Aβ3pE-40 also shares a similar ratio of secondary structural components in 
comparison with Aβ1-42 at 70 wt% EaMs, however below this concentration,  
Aβ3pE-40 exhibits equal ratios of β-sheet and random coil structure and demonstrates 
very little helical content. These results suggest that β-sheet structure for Aβ3pE-40 is 
more stable in aqueous solutions of EaMs than the β-sheet structure for any other Aβ 
isoform in this study.  
In Aβ11pE-40, there is a gradual increase in helical structure that coincides with the 
loss of β-sheet structure as the concentration of EaMs is increased to 50 wt%. During 
this transition, there is no significant variation in random coil content. However at  
70 wt% concentration, the percentage of helical structure remains unchanged, while 
an abrupt increase in β-sheet structure is measured overlapping with the loss of random 
coil structure. Electron micrographs were taken for Aβ11pE-40 at various EaMs 
concentrations to determine the impact of this structural transition on the aggregate 
superstructure (Figure 4.6). 
 
Figure 4.6. TEM of Aβ11pE-40 aggregates in 30 wt%, 50 wt% and 70 wt% EaMs solutions. 
200 nm
70 wt% EaMs
200 nm
50 wt% EaMs30 wt% EaMs
100 nm
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As expected, Aβ11pE-40 fibrils were clearly observed at low EaMs concentrations, 
which supports the high percentage of β-sheet secondary structure. At 50 wt% EaMs 
concentrations, where helical content is at its maximum, fibrillar aggregates are in  
co-existence with larger amorphous structures. More interesting are the structures 
formed at 70 wt% EaMs concentration. These globular aggregates range in size from 
22 to 96 nm in diameter and appeared in large clusters across the grid surface. 
Recently, similarly sized structures termed spherical aggregates, were found in 
submicellar concentrations of SDS according to atomic force microscopic imaging(339). 
These aggregated structures were thought to act as nucleation sites to form larger 
aggregated species. In this context, the high β-sheet content measured during assembly 
in high EaMs loadings is equivalent to larger pre-fibrillar oligomeric species described 
by Cerf et al.(203) that are also rich in β-sheet structure.  
The ability to promote β-sheet structure in high EaMs concentrations emphasizes that 
intermolecular hydrogen bonding between the PIL and water are preferred over 
intramolecular hydrogen bonding required to promote α-helix conversion. This varies 
from the behaviour of α-helical inducing solvents such as TFE and HFIP, since these 
solvents are weaker proton donors than water and preferably induce α-helical structure 
by allowing intramolecular hydrogen bond formation to occur. Barrow et al.(121) 
determined a higher propensity of α-helical structure in the Aβ1-39 isoform than in the 
larger Aβ1-42 isoform, in various concentrations of TFE and HFIP. In this case,  
Aβ1-40 adopted a higher percentage of helical structure at 70 wt% TeaMs 
concentration in comparison to Aβ1-42. This result was expected since Aβ1-42 forms 
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more stable β-sheet structures than Aβ1-40, and suggests similarities between the 
helical-inducing behaviour of TeaMs and the conventional solvent systems TFE and 
HFIP. Furthermore, the difference in α-helix and β-sheet ratios between 70 wt% EaMs 
and 70 wt% TeaMs also supports the helical-inducing structure of TeaMs, which is 
likely attributed to increased intramolecular hydrogen bond formation. Aβ3pE-40 
again illustrates similar secondary structural ratios to that observed in Aβ1-42. 
Aβ11pE-40 is least affected by the helical-inducing nature of TeaMs out of all Aβ 
isoforms investigated, which is evident by a higher percentage ratio of β-sheet in 
relation to α-helical content up to 70 wt% TeaMs. This is also indicated by the absence 
of any noticeable absorption at 208 nm according to the CD spectra, suggesting that 
little α-helical structure exists in solution. This may be explained by the 
hydrophobicity of the Aβ11pE-40 peptide, since the absence of the N-terminal 
hydrophilic residues renders it the most hydrophobic peptide investigated in this study.  
Previous reports on the thermal unfolding of C-peptide, the terminal peptide fragment 
of RNase A, have suggested that the formation of α-helices are an enthalpy-driven 
process in which unfolding of the helix is triggered by an increase in temperature(340). 
This study indicated that peptide hydrophobic interactions were not as important in the 
stabilization of helices, and instead may be more important in the formation and 
stabilization of β-sheet conformations, as suggest by Barrow et al.(121). Since 
hydrophobic interactions are more prevalent in Aβ11pE-40, it is likely that these 
interactions are supporting the stabilization of β-sheet structure, even in the presence 
of helical-inducing TeaMs. 
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4.4 Conclusion 
We have demonstrated that PILs designed with a primary amine can significantly 
enhance the conversion of Aβ16-22 monomers to amyloid fibrils. Solutions of EaMs 
resulted in a five-fold enhancement in ThT fluorescence in comparison to TeaMs. 
Through intrinsic fluorescence measurements of tryptophan-substituted Aβ16-22, we 
revealed that the aqueous PIL directly interacts with the peptide. This was confirmed 
by a significant blue shift in the fluorescence spectrum in the presence of EaMs, which 
suggested that the tryptophan residues become exposed to a more hydrophobic 
environment as the concentration of the PIL is increased. The additional hydrogen 
bonding sites on the primary amine could cause a tighter β-sheet packing density 
within the peptide, resulting in the enhanced production of fibrils rather than 
monomers. This was clearly illustrated in electron micrographs highlighting the dense 
network of fibrils assembled in EaMs. 
The PIL-peptide interactions of EaMs and TeaMs were further explored in a series of 
Aβ isoforms and it was determined that each PIL demonstrated greater structural 
inducing effects at higher concentrations. The ratio of secondary structural constituents 
vary between different Aβ isoforms and suggests the importance of N- and C-terminal 
residues and peptide hydrophobic interactions when exposed to structure-inducing 
PILs.     
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CHAPTER 5: Structural Induction and Fibrils Dissolution 
of Aβ1-40 in Ionic Liquids through the α-Helical 
Intermediate 
5.1 Preface 
Sections of this work, describing the inhibition and enhancement of amyloid fibril  
self-assembly, have been published:  
x Debeljuh, N. J., Barrow, C. J., Henderson, L., Byrne, N. (2011) Structure 
inducing ionic liquids – Enhancement of alpha helicity in the Aβ1-40 peptide 
from Alzheimer’s disease. Chem. Commun. 47, 6371-6373. 
5.2 Introduction 
In amyloidogenic proteins, the underlying mechanism of fibril formation involves a 
partial destabilization of the protein’s native conformation, either through changes in 
the local environment or through point mutations(24, 341). The amyloid-β protein (Aβ) 
found in Alzheimer’s disease self-assembles into β-sheet rich fibrils from its 
irregularly structured monomeric precursor. Although large fibrillar aggregates are 
important in clinical determination, it is aggregation to smaller oligomeric species that 
appears to result in a neurotoxic species that play a role in disease  
progression(198, 200, 204). Studying the formation of oligomers is complex since these 
early stage aggregates are highly unstable and usually very difficult to isolate. 
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The ability to manipulate a protein’s secondary structure and study the interactions and 
mechanisms responsible for conformational change has attracted significant attention 
in the field of protein folding. Solvent additives such as urea and guanidine 
hydrochloride (GndHCl) have been long known as protein denaturants, and to this day 
are still extensively used in protein folding studies(342-345). Whether these denaturants 
are directly interacting with the protein through van der Waals forces or hydrogen 
bonding, or indirectly by altering the structure of water through the solvation of 
hydrophobic groups, is still debateable(346, 347). In addition to this, other additives such 
as hexafluoroisopropanol (HFIP), and trifluoroethanol (TFE)(121, 220, 348-351) have been 
used as protein stabilizing agents. Both solvents are known to induce or stabilize  
α-helical conformations in a diverse range of proteins and peptides including  
β-lactoglobulin and various Aβ isoforms(220, 349).  
In aqueous solutions of TFE and HFIP, both Aβ1-40 and Aβ1-42 isoforms 
predominantly exhibit α-helical structure without fibrilization occurring(121). The 
formation of α-helical intermediates was described as a critical structural transition in 
the fibrillogenesis of proteins and was further confirmed through studying the 
fibrilization of 18 different Aβ peptide fragments, all of which contained the helical 
intermediate(209, 226). Furthermore, it was proposed by Kallberg et al.(221) that the 
stabilization of an α-helical conformation could supress the formation of amyloid 
fibrils. A series of proteins including Aβ were studied and showed an inhibition in 
fibril formation when residues were removed or modified to a non-discordant 
sequence.  
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Following on from the preliminary structural induction studies outlined in chapter 4, 
the research described in this chapter aimed to investigate the effect of aqueous TeaMs 
PIL on the α-helical content of Aβ1-40 and its consequences on amyloid fibril  
self-assembly. Additionally, we discuss how synthetic amyloid fibrils, pre-formed in 
PBS and aqueous TeaMs solutions, can be dissolved in neat PIL media.  Finally, we 
briefly investigate a series of aprotic and protic ionic liquids as potential solvents for 
the dissolution of naturally occurring brain amyloid plaques. 
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5.3 Results and Discussion 
5.3.1 Structure inducing ionic liquids – Enhancing α-helical structure in 
the Aβ1-40 peptide from Alzheimer’s disease 
Due to its role in the pathogenesis of Alzheimer’s disease, the Aβ1-40 peptide was 
investigated in TeaMs to determine if any changes in secondary structure and fibril 
formation could be induced by an increase in PIL concentration. Previously, low 
concentrations of TFE have been shown to convert predominantly unstructured Aβ 
monomers into partially ordered conformers which exhibit significantly reduced lag 
phases and greater propensities for fibril elongation(220). To determine if TeaMs had a 
similar effect, the secondary structure of Aβ1-40 was investigated in aqueous solutions 
of TeaMs (Figure 5.1).  
At TeaMs concentrations of 10-50 wt%, Aβ1-40 adopts a classical β-sheet secondary 
structure identified by the negative ellipticity at 218 nm. Furthermore, this β-sheet 
content increases in intensity as the concentration of TeaMs is increased from  
10 wt% to 50 wt%. At 60 wt% concentration, there is no further increase in β-sheet 
structure, however a shoulder at 209 nm equal to the 218 nm minimum can be seen 
and suggests the formation of some α-helical structure. The overlayed signals between 
10-60 wt% TeaMs reveals an isodichroic point at 203 nm, which is the point where 
the elliptical intensities are equal. This isodichroic point is indicative of the presence 
of only two conformational states that are populating the TeaMs  
concentration-dependent assembly pathway; the transition from β-sheet to α-helix.  
CHAPTER 5
 
110 
 
 
Figure 5.1. CD spectra of Aβ1-40 peptide in (a) 10-60 wt% and (b) 70-80 wt% TeaMs 
concentrations. Black arrows indicate direction of increasing TeaMs concentration. 
Visual observations of these solutions revealed the presence of aggregated precipitates 
that redissolved upon the addition of >60 wt% TeaMs, coinciding with the diminishing 
β-sheet content in Aβ1-40.  
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When TeaMs concentration is increased to 70-80 wt%, the intensity of the 209 nm 
minimum also increases, suggesting that Aβ1-40 predominantly adopts an α-helical 
conformation since there is no longer a clear minimum at 218 nm. Furthermore, at the 
concentrations of 90-100 wt% TeaMs, Aβ1-40 is predominantly disordered  
(Figure 5.2) and no longer possesses an isodichroic point.  
 
Figure 5.2. CD spectrum of Aβ1-40 in 90 wt% (red) and 100 wt% TeaMs (black). 
This indicates that electrostatic screening abilities of concentrated TeaMs at higher 
concentrations prevents the formation of sufficient intermolecular and intramolecular 
hydrogen bonds that are required for folding. The induction of α-helical structure by 
TeaMs and its relative effect on Aβ1-40 fibrilization was examined by TEM  
(Figure 5.3).  
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Figure 5.3. TEM of Aβ1-40 in aqueous solutions of TeaMs after 1 week incubation in  
10 wt%, 50 wt% and 100 wt% TeaMs. 
In 10 wt% and 50 wt% TeaMs solutions, Aβ1-40 shows a dense population of fibrillar 
aggregates across the entire grid section. In both aqueous TeaMs solutions, long 
homogeneous fibrils are observed with similar morphologies that are consistent with 
the enhanced β-sheet secondary structure observed using CD spectroscopy. In addition 
to this, both TeaMs solutions in the presence of Aβ1-40 showed a positive ThT 
fluorescence intensity, further confirming the presence of β-sheet structure.  
In contrast, the micrograph of Aβ1-40 in 100 wt% TeaMs shows no sign of fibrillar 
aggregates and ThT binding assays also revealed no fluorescence intensity, indicating 
the absence of fibril formation and no β-sheet structure. At TeaMs concentrations 
above 60 wt% there were no fibrils observed in solution, indicating that the inhibition 
of fibrils is likely due to TeaMs stabilizing the monomeric state of Aβ1-40 through  
α-helical induction. To screen the presence of these monomers in high concentrations 
of TeaMs, SDS-PAGE was performed on Aβ1-40 incubated in various concentrations 
of TeaMs (Figure 5.4).  
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Figure 5.4. SDS-PAGE of Aβ1-40 monomers in various concentrations of TeaMs and neat 
TFE. Lane M contains molecular-weight markers. Lanes 1-5 contain Aβ1-40 incubated in  
10 wt%, 30 wt%, 50 wt%, 70 wt% and 90 wt% TeaMs respectively; Lane 6 contains Aβ1-40 
incubated in neat TFE.  
It is observed that Aβ1-40 monomers (~4.3 kDa) are present in all TeaMs 
concentrations, however the intensity of the bands increased upon the addition of more 
PIL. This is interesting since the initial amount of Aβ1-40 monomers incubated were 
the same in all samples. The low concentration of monomers formed in 10 and 30 wt% 
TeaMs implies that the equilibrium shifts in favour of fibril formation. Earlier we 
observed predominant β-sheet structure by CD when Aβ1-40 assembled at these 
TeaMs concentrations, leading to the formation of amyloid fibrils. The presence of 
monomers indicates that at low wt% TeaMs, a small percentage of Aβ monomers do 
not completely convert into fibrils, perhaps due to the peptide interacting with the 
hydrated TeaMs molecules. This equilibrium shifts in favour of monomer formation, 
particularly in the presence of 70 wt% and 90 wt% TeaMs concentrations, which 
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complements the absence of β-sheet structure and fibril formation determined earlier. 
Although it is understood that SDS induces oligomer dissociation and alternative 
techniques such as CD spectroscopy are more conclusive at the secondary level of 
peptide assembly, it is likely that this enhancement in α-helical structure by TeaMs 
could replicate the structural inducing effects exhibited by TFE. 
Indeed, the ability to induce α-helical structure in Aβ, a predominantly α-helical 
peptide in its native state, is a critical step towards understanding the folding 
mechanisms associated with the peptides self-assembly. Induction of α-helical 
structure in high concentrations of TeaMs shows similarities to the conformations 
induced in high concentrations of TFE (>40 vol%)(352). The exact mechanism of how 
TFE induces α-helical structure is still debateable. Some explanations incorporate the 
role of solvent polarity, where low polarity solvents are thought to weaken the 
hydrophobic interactions that stabilize native protein structure and simultaneously 
strengthen local hydrogen bonds(349, 350). Hong et al.(230) discuss that relative dielectric 
constants and hydrogen bond strengths are important factors and suggests that the 
formation of dynamic clusters of the alcohol side groups via hydrophobic interactions 
are responsible for the enhanced structural stability observed in protein and peptide 
systems. Molecular dynamic studies have previously shown that TFE molecules can 
aggregate around peptides, displacing water molecules and consequently remove 
alternative hydrogen bonding neighbours, in addition to providing a low dielectric 
environment that is favourable in the formation of intra-peptide hydrogen bonds(353). 
It is generally accepted that the balance between nonpolar and polar groups in TFE 
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disrupt the intramolecular hydrogen bonds which are essential for β-sheet formation, 
while simultaneously promoting hydrogen bonding in the monomeric helical species.  
We propose that the mechanism by which TeaMs can alter the hydrogen bonding 
nature of Aβ1-40, such that the α-helical intramolecular bonds are favoured over the 
β-sheet forming intermolecular bonds, may be the consequence of the unique hydrogen 
bonded network system of the PIL. Other conventional solvent systems including TFE, 
HFIP and SDS have shown to induce α-helical structure in different amyloid-forming 
peptides by creating a membrane-like environment(230, 339, 354). It is therefore also 
possible that the presence of aggregated species within the ionic liquid could be 
creating a bilayer effect. There have been reports which suggest that ionic liquids in 
aqueous solution are not completely dissociated into ions, and these molecules can 
form clusters in aqueous solution(355). Recent studies have demonstrated that 
aggregated species do indeed exist in PILs, and ‘poorly ionic liquids’ which describe 
many PILs have a tendency to form aggregates in aqueous solution, while still 
retaining their nanostructured features(250, 356).  
The structural induction of TeaMs is not limited to Aβ1-40. The α-helical inducing 
effects of TeaMs was examined on a modified Aβ fragment, Ac-KLVFFAE-NH2 
which has previously shown to form fibrils and nanotubes in various solvent 
conditions(320, 321, 357) and is identified as a key sequence involved in the β-sheet fibril 
formation of full-length Aβ1-40. This fragment is based on the Aβ16-22 sequence, but 
contains a C-terminal and an acetylated N-terminus. The structure-inducing effect of 
TeaMs as a function of concentration is illustrated in Figure 5.5.  
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Figure 5.5. CD spectrum of Ac-KLVFFAE-NH2 peptide (a) as a function of TeaMs 
concentration and (b) as a function of pH in aqueous 0.1 mM PBS (pH 2 to pH 11.5). Black 
arrow indicates direction of increasing TeaMs concentration. 
Upon increasing TeaMs concentration from 10 wt% to 50 wt%, an increase in  
α-helical structure is indicated by the increased signal at 206 nm. The presence of an 
isodichroic point at 201 nm further suggests that there is a mixture of only two 
conformations; α-helical and random coil, which is observed at higher TeaMs 
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loadings. Although pH is an important factor in protein folding and aggregation, the 
changes induced by TeaMs are not the consequence of pH variation in solution. To 
confirm this, the secondary structure of the modified Aβ16-22 peptide was measured 
in various phosphate buffer solutions of different pH and is shown in Figure 5.5. In all 
ten solutions ranging from pH 2 to 11.5, there was no change in peptide secondary 
structure which indicates that the structural induction observed for these Aβ peptides 
is not driven by pH.  
The relative magnitude of ellipticity in both spectra is also noteworthy. In TeaMs a 
considerably higher molar ellipticity was observed, in comparison to that observed in 
aqueous phosphate buffer solutions of different pH values. This may be due to reduced 
chiral ordering as a result of increased intramolecular hydrogen bonding in the 
presence of the PIL. Ionic liquids have previously been shown to increase the solubility 
of difficult to solubilize molecules due to the electrostatic nature of the ionic liquid(358).  
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5.3.2 Dissolution of pre-formed Aβ1-40 fibrils in TeaMs 
The ability to reverse the formation of amyloid fibrils is currently an area of active 
research. Several approaches have been identified to inhibit amyloid fibril formation 
including the use of aromatic dyes such as Congo red, curcumin, and macrocyclic  
β-sheet mimics to disrupt fibril self-assembly(359, 360). Since we have identified that a 
number of mesylate-containing PILs could inhibit the formation of Aβ1-40 fibrils 
through the formation of an alternative structure via the induction of disruptive 
intramolecular hydrogen bonds, we next investigated whether TeaMs had the ability 
to dissolve pre-formed Aβ1-40 amyloid fibrils.  
In this study, Aβ1-40 amyloid fibrils were prepared according to the two methods 
outlined in Chapter 2, section 2.5. Briefly, method 1 involved the rapid self-assembly 
of Aβ1-40 fibrils in an aqueous solution containing 10 wt% TeaMs and method 2 
involved the slow self-assembly of Aβ1-40 fibrils in PBS solution. Each sample was 
lyophilized and 0.2 mg of fibrils from each method were transferred to 1 mL solutions 
of neat TeaMs for analysis. The change in chiral ordering during the dissolution of 
Aβ1-40 fibrils formed according to method 1 is illustrated in Figure 5.6.  
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Figure 5.6. Time-dependent CD spectra of (a) Aβ1-40 fibrils generated according to method 
1, during dissolution in neat TeaMs and (b) the CD signal at 216 nm. The line is added as a 
visual aid. 
During analysis, solutions were gently agitated to ensure sedimentation did not result 
in the loss of CD signal by removing the structures from the measurement light path. 
A marked reduction in ellipticity at 216 nm represents the progressive loss of β-sheet 
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structure in the fibrils as they dissolve in the presence of neat TeaMs. This is clearly 
illustrated above where the β-sheet content rapidly decreased and plateaus after  
12 hours. During this time an increase in α-helical content is observed, as indicated by 
the increase in ellipticity at 206 nm. To probe the solubilization of Aβ1-40 fibrils 
during dissolution, an aliquot of sample was removed during the early, middle and late 
stages of dissolution and these sample were imaged using TEM (Figure 5.7).  
 
Figure 5.7. TEM of method 1 pre-formed Aβ1-40 fibrils dissolved in neat TeaMs at different 
time intervals. 
The degree of fibrilized material decreased as a function of incubation time in TeaMs. 
During the early stages of dissolution, Aβ1-40 fibrils appear dispersed across the grid 
section. These fibrils are homogenous and very short or ‘fragmented’ in comparison 
to those described earlier in section 5.3.1. After 12 hours incubation, a reduced number 
of fibrils were observed, albeit with conserved morphologies. This reduction in 
number of fibril is consistent with the gradual loss in β-sheet structure indicated by 
CD analysis. The fibril dissolving property of neat TeaMs becomes apparent during 
the late stages of dissolution, where after 24 hours incubation there is very little to no 
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evidence of fibrillar aggregates in the micrograph. This observation in addition to the 
gain in helical structure implies that the fibrils have dissolved in neat TeaMs. The 
conformational conversion from β-sheet to α-helix suggests that this dissolution 
proceeds via the formation of an α-helical intermediate in Aβ1-40, the stability of 
which is likely facilitated by increased TeaMs-peptide interactions. 
Conversely, analysis of the dissolution of method 2 pre-formed Aβ1-40 fibrils by CD 
reveals the formation of a random coil conformation with a partial β-structure(361) over 
a 48 hour incubation period (Figure 5.8).  
 
Figure 5.8. Time-dependent CD spectra of Aβ1-40 fibrils generated according to method 2, 
during dissolution in neat TeaMs.  
This structural transition is significantly different to the sheet-helix transition observed 
for the method 1 fibrils. A decrease in the 196 nm and 220 nm minima imply greater 
ordering into a possible β-structure as incubation time is increased. It is not clear if this 
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is related to increased solubility or actual structural change over time Analysis of the 
electron micrographs taken show the presence of Aβ1-40 fibrils at both time points, 
with shorter fibrils observed after 48 hours (Figure 5.9).  
 
Figure 5.9. TEM of method 2 pre-formed Aβ1-40 fibrils dissolved in neat TeaMs at different 
time intervals. 
Although the fibrils at longer incubation appear shorter, their abundance on the grid 
does not change in comparison to shorter incubation periods in TeaMs. Additionally, 
there are differences in morphology between these fibers and those generated 
according to method 1. The rapid formation of fibrils in 10 wt% TeaMs leads to shorter 
fragmented fibrils whereas forming these structures slowly in PBS produces longer 
homogenous fibrils. 
By allowing Aβ1-40 monomers to assemble in an environment that is not disrupted by 
the structure breaking properties of TeaMs, monomer polymerization and fibril 
elongation is favoured. This has implications on the packing density of individual  
200 nm
10 min
200 nm
48 hrs
CHAPTER 5
 
123 
 
β-sheets, since well-developed amyloid fibrils have a greater propensity to form tightly 
packed intermolecular β-structures. This packing density can be monitored by FTIR 
analysis of the amide I region, where greater inter and intramolecular ordering is 
usually indicated by a lower energy shift of the secondary structure. The pre-formed 
Aβ1-40 fibrils formed by both methods were analysed by FTIR and the results are 
depicted in Figure 5.10.  
 
Figure 5.10. FTIR spectra of the amide I region for Aβ1-40 fibrils pre-formed according to 
method 1 (blue) and method 2 (red). 
The Aβ1-40 fibrils formed according to method 1 show two prominent FTIR spectral 
features including a sharp peak at 1628 cm-1 and a shoulder band centred at  
~1654 cm-1, which represents β-sheet and α-helical structures, respectively. This 
shoulder is not observed for the spectra of the fibrils generated from method 2. Instead 
the main band is observed at 1623 cm-1 indicating the presence of β-sheet structure. 
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Analysis based on second derivative spectra within the amide I region further 
identified an additional small peak at 1694 cm-1 assignable to anti-parallel β-sheet 
structure. In particular, the main absorbance band centred at 1623 cm-1 is significantly 
shifted to lower wavelength when compared to that observed in the pre-formed TeaMs 
fibrils, indicating that there is a tighter packing density of β-sheets within the fibril 
network. Furthermore, the absence of a band at 1654 cm-1 indicates that PBS formed 
Aβ1-40 fibrils preferably adopt β-sheet structure, which is consistent with the longer 
fibrils observed by TEM.  
The tighter packing density of these β-sheets in the PBS formed Aβ1-40 fibrils implies 
that these fibrils exist in a higher ordered state. In terms of dissolution, it may be 
difficult for neat TeaMs to disrupt this network of organized intermolecular hydrogen 
bonds and that would explain why fibril degeneration was not observed. On the other 
hand, dissolution is enhanced for the pre-formed TeaMs fibrils since the intermolecular 
arrangement of hydrogen bonds are more loosely packed. The presence of a band at 
1654 cm-1 indicates that TeaMs does induce α-helical structure, even at low PIL 
concentrations. It is also possible that Aβ1-40 peptide oligomers are trapped in TeaMs 
during self-assembly, leading to restricted fibril growth. In fact, this has been 
previously reported by Kalhor et al.(275) where it was determined that HEWL protein 
oligomers were not converted into protofilaments and fibrils because they were 
trapped by the ionic liquid in a more stable conformation. The ability for TeaMs to 
fibrilize and subsequently dissolve Aβ1-40 fibrils confirms the multifunctional 
properties of this PIL system, which can be modified according to water content. 
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5.3.2.1 Brain amyloid dissolution in ionic liquids 
In collaboration with researchers from the Mental Health Research Institute, 
Melbourne University, a selection of ionic liquids, both aprotic and protic in nature, 
were tested on their ability to dissolve brain amyloid plaques. Aprotic ionic liquids 
were synthesized with the 1-butyl-3-methylimidazolium (BMIM) and  
1-ethyl-3-methylimidazolium (EMIM) cations since these have shown increased 
solubility and dissolution of biomaterials including lysozyme, native silk fibroin and 
cellulose(269, 362, 363). Additionally, the PIL cation 1,1,3,3-tetramethylguanidine (TMG) 
was selected, as this cation was previously used in the dissolution of HEWL(275). It is 
difficult to dissolve amyloid plaques from brain and separate Aβ components since 
other components present and post-translational modifications contribute to the 
amyloid structure. Masters et al.(8) previously described the solubility of plaques 
consisting of various proportions of amyloid cores in >70% formic acid (FA) solution, 
and for this reason we have tested the dissolution ability of our ionic liquid systems 
against FA. Western blots of the Aβ1-40 peptide derived from dissolving brain 
amyloid plaques in neat ionic liquids and FA are shown in Figure 5.11.  
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Figure 5.11. Western blot profiles of Aβ derived from brain amyloid plaques after 24 hours 
incubation at room temperature in ionic liquids and formic acid. Plaques were pre-treated (a) 
with urea buffer or (b) without urea buffer prior to blotting. Samples were separated on  
4-12% tris-tricine polyacrylamide gels and probed with 4G8 and WO2 antibodies. 15s and 
30s correspond to the enhanced chemiluminescence imaging time. 
The profiles of ionic liquid-dissolved Aβ1-40 showed a marked increase in low 
molecular weight oligomers ranging from monomers to tetramers, after overnight 
incubation at room temperature, and are clearly observed after 30 seconds of enhanced 
chemiluminescence (ECL). Although all ionic liquid samples show a distribution of 
low molecular weight oligomers, BMIMAc shows a greater formation of tetramers due 
to the intensity of the 16 kDa band. Interestingly, TMGLa showed the largest 
distribution of low molecular weight aggregates around the 4 kDa mark, suggesting 
that the dissolution of Aβ1-40 monomeric species is favoured. TMGLa is the only 
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protic ionic liquid investigated here and results indicate that the proton transfer 
property of this PIL enhances the formation of Aβ1-40 monomers. The lactate anion 
has previously shown enhanced dissolution of Candida Antarctica lipase B, thought 
to be contributed to preferential hydrogen bond formation between the PIL anion with 
the polypeptide backbone(306). Despite the presence of these low molecular weight 
bands in each ionic liquid system, the intensity of these bands is significantly greater 
in 80% FA. In terms of proton availability between these solutions, the acid protons in 
the PIL systems have all been neutralized, whereas in FA there is no neutralized acid 
proton. This indicates that FA can readily donate/accept protons in solution, allowing 
it to actively dissolve various Aβ components as illustrated. Additionally, an extremely 
high molecular mass Aβ (~250 kDa) remained in the stacking gel of the samples  
pre-treated in urea buffer. This species is particularly stronger in the BMIMCl, 
EMIMSO3 and FA samples as illustrated by the darker band. This high molecular mass 
Aβ corresponds to fibrils(203).  
However, the influence of SDS on the aggregation and migration behaviour of proteins 
has also been reported(364), and these unwanted solvent interactions are usually 
overcome by the addition of small volumes of urea to the sample matrix. Therefore, to 
determine whether the presence of urea in solution is affecting the dissolution of the 
Aβ plaques in ionic liquids, another blot was prepared in the absence of urea. As 
depicted in Figure 5.11, the majority of low molecular weight bands have disappeared 
from the blot, leaving only trace amounts of Aβ1-40 monomers (4 kDa) detectable in 
each ionic liquid sample after 30 seconds of ECL. Furthermore, there are no high 
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molecular weight species in the stacking gel as previously noticed for the samples 
treated with urea buffer. In FA, the monomeric band is maintained and only trace 
amounts of oligomers between 8-16 kDa are seen. The absence of urea in the 
preparation of each sample appears to largely affect the ability of the ionic liquid 
samples to dissolve the Aβ components. Without urea present, Aβ1-40 likely forms 
unordered aggregates that are harder to dissolve by the aprotic ionic liquids since their 
proton availability is negligible. This does not affect the dissolution in FA since the 
monomeric species was easily formed. Quantification of these species is necessary, 
but may be difficult in the urea-treated samples since fibrils remaining in the stacking 
gel could be underestimated(203). 
CHAPTER 5
 
129 
 
5.4 Conclusion 
In this chapter, the structural inducing effect of TeaMs was explored for the Aβ1-40 
peptide. Aβ1-40 amyloid fibrils were formed in aqueous TeaMs solutions (<50 wt%) 
and showed distinctive β-sheet structure by CD analysis. When incubated at higher 
TeaMs concentrations (>60 wt%), α-helical structure was preferentially formed which 
resulted in the inhibition of fibrilization. The helical-inducing effects of TeaMs, which 
are also characteristic of other mesylate containing ionic liquids, are driven by the 
preferred formation of intramolecular hydrogen bonds, and behaves similarly to other 
solvent systems such as TFE and HFIP which are commonly used to induce helical 
structure in proteins.  
Synthetic Aβ1-40 pre-formed fibrils that were self-assembled rapidly in aqueous 
TeaMs conditions can also be dissolved in neat TeaMs through the structural 
conversion of β-sheets to α-helices. However, when these fibrils are slowly assembled 
in normal aqueous conditions in the absence of a chaotropic PIL, intermolecular 
hydrogen bonding in the amyloid fibril becomes more organized and the packing 
density of β-sheets is greatly increased. Evidently, this tighter β-sheet network makes 
dissolution more difficult for TeaMs. Furthermore, although our selected ionic liquid 
series showed only a partial dissolution of naturally occurring brain amyloid in 
comparison to formic acid, the presence of urea during the preparation of the plaques 
is likely influencing the formation of these oligomeric species in the ionic liquid 
solvents and requires further investigation. 
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CHAPTER 6: Crystalline to Amorphous Transition of the 
Central Alzheimer’s Aβ Dipeptide in Aqueous PIL Solution  
6.1 Introduction 
It is well established that amyloid fibrils result from the unfolding or denaturation of 
the native state protein. Once unfolded, protein monomers self-assemble via various 
on-pathway intermediates leading to amyloid fibril formation(153, 154). However, there 
have been documented cases of various stable supramolecular structures, or 
polymorphs, that aggregate as the result of protein unfolding under different 
conditions(104, 365, 366). Some of these assemblies include the formation of  
nano-crystalline fibrils(158, 367) and spherulites(368) which have previously been 
identified in post-mortem tissue of diseased brains, and may suggest their relevance in 
the disease state(369). In particular, a recent study identified the formation of small 
transient nano-crystalline Aβ assemblies which preceded amyloid fibril formation(370). 
These ordered structures were viewed as critical intermediates in the early stages of 
the fibrilization process. 
Polymorphism in amyloid proteins has been known for some time(371, 372), however 
there is ongoing debate as to whether variations in the supramolecular assembly or 
changes in the internal structure of protein monomers during assembly are the 
contributing cause(128, 138, 373, 374). Proteins rely heavily on the formation of several 
weak non-covalent bonds including ionic, van der Waals, hydrogen bonding, 
hydrophobic and π-π interactions(375-379). For smaller peptides containing aromatic 
CHAPTER 6
 
131 
 
moieties, the contribution of hydrophobic and π-π interactions are particularly 
important(380) since geometrical restrictions of the aromatic residues can promote 
directional and orientational growth into fibrillar structures that are essential for 
amyloid fibril formation(380, 381).  
One of the most versatile synthetic peptides to date is the structural recognition motif 
for Alzheimer’s Aβ peptide. NH2-FF-COOH (Figure 6.1), which consists of two 
consecutive phenylalanine residues, plays a decisive role in fibril formation, attributed 
to the π-stacking interactions of the phenylalanine rings(382). Numerous reports 
describe the formation of various polymorphic structures including nanowires(383, 384), 
nanotubes(385-387) and nanospheres(388-390), which carry their own unique chemical and 
physical properties.  
  
Figure 6.1. Chemical structure of the NH2-FF-COOH dipeptide. 
Recently, peptide nanotubes designed from the NH2-FF-COOH dipeptide showed a 
thermally induced phase transition from a linear assembly exhibiting hexagonal 
nanocrystalline structure, to a cyclic assembly displaying orthorhombic 
nanocrystalline structure(391). This thermally induced polymorphism causes profound 
changes at the molecular level that influence the final morphology of the assembled 
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structures. The same peptide sequence capped with an N-terminal tert-butoxycarbonyl 
(Boc) group could form nanotubes or nanospheres depending on the solvent 
composition(389). Since short aromatic peptides contain all the necessary molecular 
information required for amyloid formation, they are viewed as excellent models to 
study the mechanistic issues of polymorphism in amyloid formation(392, 393). 
This chapter aims to investigate the various structural transitions of NH2-FF-COOH 
when self-assembled in aqueous ethylammonium nitrate (EAN) solutions. EAN was 
selected as a peptide precipitating agent due to its hydrophobic and ionic character, as 
well as its ability to hydrogen bond with water, and has previously been identified as 
a successful medium for lysozyme crystallization in both neat and aqueous  
state(266, 394). Additionally, the impact of aqueous EAN solutions on NH2-FF-COOH 
hydrophobicity during self-assembly will also be discussed. 
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6.2 Results & Discussion 
6.2.1 Characterization of NH2-FF-COOH crystalline assemblies 
Pre-dissolved monomeric NH2-FF-COOH dipeptide was self-assembled over one 
week in PBS and various concentrations of EAN. In PBS, 0.1 M and 0.5 M 
concentrations of EAN, NH2-FF-COOH assembled into visible microstructures within 
the first few hours, while no visible structures were observed for solutions containing 
1.0 M and 2.0 M EAN after one week. Aliquots of each solution were imaged via 
optical microscopy and SEM to determine the morphology of the assembled structures 
(Figure 6.2).  
In aqueous PBS conditions, there is a clear formation of long thin crystal-like  
NH2-FF-COOH fibrils. The corresponding SEM image highlights the surface 
uniformity, which closely resembles that observed in amyloid fibrils. Additions of 
EAN to the solution matrix cause the dipeptide to form various polymorphic 
assemblies. At 0.1 M EAN concentration, similar crystal-like fibrils are observed by 
SEM. Upon increasing the PIL concentration to 0.5 M, another clear morphological 
change to short flat fibrils is observed during self-assembly. SEM analysis shows the 
alignment of several short fibrils along the longitudinal axis that create clusters of 
microsheets.  
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Figure 6.2. Optical microscopic images (top) and SEM images (bottom) of the self-
assembled NH2-FF-COOH dipeptide in PBS and aqueous 0.1 M, 0.5 M, 1.0 M and 2.0 M 
EAN solutions. 
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At 1.0 M EAN concentration, there was almost no visible precipitate in solution, and 
optical microscopy revealed the formation of small circular microspheres. A closer 
examination of these structures by SEM revealed aggregates of thin flaky sheets. At 
2.0 M EAN concentration, only unstructured aggregates were observed in solution, 
confirmed by the absence of fibrillar material by SEM. 
Previous studies have identified that this dipeptide is capable of forming amyloid-like 
structures(395). To confirm whether the PIL-assembled structures exhibit amyloid 
characteristics, samples were stained with Congo red (CR) dye and viewed under cross 
polarizers on an optical microscope (Figure 6.3).  
 
Figure 6.3: Optical microscopic images of CR stained NH2-FF-COOH assemblies in 
aqueous 0.1 M and 0.5 M EAN solutions under cross-polarizers. 
NH2-FF-COOH assembled in 0.1 M and 0.5 M EAN showed a clear gold-green 
birefringence, suggesting a high molecular level order that is commonly observed in 
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the amyloid state. No birefringence was evident in the assemblies at 1.0 M and 2.0 M 
EAN solutions, which indicates very little structural order at the molecular level. 
To confirm the crystalline or amorphous state of these structures, the normalized  
x-ray diffraction patterns of each lyophilized sample were obtained and these are 
depicted in Figure 6.4. The presence of sharp diffractive peaks at low angle 2θ 
correlate to a high degree of molecular crystallinity, whereas no diffraction peaks and 
broad spanning regions indicate amorphous structure(396).  
 
Figure 6.4. XRD patterns of the self-assembled NH2-FF-COOH dipeptide in PBS (blue) and 
aqueous 0.1 M (green), 0.5 M (orange), 1.0 M (red) and 2.0 M (black) EAN solutions. Miller 
indices (hkl) assignments correspond to the hexagonal unit cell, P61. 
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The diffraction array for NH2-FF-COOH assembled in PBS has previously been 
identified by Gorbitz et al.(397, 398). The authors correlated the NH2-FF-COOH 
diffraction peaks to a P61 space grouping which is indicative of a hexagonal crystal 
system. Analysis of the Miller indices (hkl) indicate similar 2θ diffraction peaks, which 
agree with the hexagonal symmetry identified for the single crystal structure of  
NH2-FF-COOH(399). This is further supported by the presence of crystals according to 
SEM and optical microscopy discussed earlier. The molecular and morphological 
transitions in NH2-FF-COOH as a function of EAN concentration are accompanied by 
distinctive changes in the XRD crystal structure of the assemblies. 
When self-assembled in 0.1 M EAN concentration, NH2-FF-COOH exhibits similar 
Bragg reflections to those observed in PBS despite the reduction of several peak 
intensities, and suggests that the dipeptide remains predominantly crystalline. At  
0.5 M EAN concentration, most of the low angle 2θ diffraction peaks have disappeared 
although crystalline structures were still observed by optical microscopy. A noticeable 
broad band spanning across angle 2θ of 8° to 25° is observed at 1.0 M and 2.0 M EAN 
concentrations, which indicates the structures are predominantly amorphous. The 
impact of EAN also illustrates significant changes to NH2-FF-COOH secondary 
structure as shown by CD analysis (Figure 6.5).  
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Figure 6.5. CD spectra of NH2-FF-COOH dipeptide in PBS (blue) and aqueous 0.1 M 
(green), 0.5 M (orange), 1.0 M (red) and 2.0 M (black) EAN solutions. 
In PBS, there is evidence of β-turn structure that is characterized by a strong positive 
band at 198 nm and a second positive band at 218 nm. These bands correspond to the 
π-π* and n-π* transition, respectively, in the phenylalanine residues and are common 
features in β-turn peptides containing aromatic residues(400-402). Upon the addition of 
EAN, there is a gradual increase in ellipticity which implies an increase in chiral 
ordering as the result of increased solubility in solution. Furthermore, the ratio of the 
π-π* band relative to n-π* increases as a function of EAN concentration and indicates 
a direct change in the rotation of the phenylalanine residues during assembly. The 
intermolecular arrangement of the NH2-FF-COOH phenylalanine residues, driven by 
hydrophobic π-π stacking interactions, is a critical feature for the formation of 
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nanotubes and crystals, as discussed by Gazit et al.(380, 383). Thus, during crystal growth, 
molecules of EAN may interfere with the assembling peptide monomers by altering 
the orientation of the aromatic residues. This causes changes in the intermolecular  
π-π* associations between neighbouring phenylalanine residues, as illustrated by the 
band ratio change above, and ultimately disrupt the potential for self-assembly and 
crystal growth.  
6.2.2 EAN facilitates changes in NH2-FF-COOH hydrophobic packing  
Interactions between particular hydrophobic side chain residues are thought to play a 
key role in protein aggregation and stability. However, the non-specific nature of 
hydrophobic interactions can facilitate polymorphism within amyloid fibrils(138, 403). 
To further investigate how EAN influence the morphological transitions in  
NH2-FF-COOH, changes in the hydrophobic environment were probed by  
8-anilino-1-naphthalene-sulfonic acid (ANS) binding assays. ANS is commonly 
employed as a fluorescence probe for the determination of surface hydrophobicity and 
actively binds to hydrophobic regions in protein(404-407). Hydrophobic changes on 
protein surfaces are indicated by two factors; a distinctive blue-shift in the ANS 
emission maximum, and an enhancement in the ANS fluorescence intensity signal. 
Figure 6.6 illustrates the main emission band for ANS when bound to NH2-FF-COOH 
in each solvent condition, corrected by subtracting the PIL signal.  
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Figure 6.6. ANS fluorescence spectra for NH2-FF-COOH after 30 min incubation in PBS 
(blue) and aqueous 0.1 M (green), 0.5 M (orange), 1.0 M (red) and 2.0 M (black) EAN 
solutions. Black arrow indicates a hypsochromic shift in the ANS fluorescence spectra. 
Excitation wavelength 350 nm.   
In PBS, a maximum ANS emission is recorded at the wavelength of 502 nm, which is 
in close agreement with the reported 505 nm maximum for protein-bound ANS 
molecules in aqueous conditions(404). Increasing the concentration of EAN causes a 
significant blue-shift in the emission maximum of peptide-bound ANS molecules, 
measuring a wavelength shift to 483 nm at 2.0 M concentration. The fluorescence 
intensity of ANS also shows a noticeable increase from 543 a.u to 588 a.u upon 
increasing EAN concentration. Since the PIL signal was subtracted, changes in the 
fluorescence intensity are directly correlated to changes in the ANS binding to  
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NH2-FF-COOH. Variations in ANS fluorescence intensity were further examined over 
a 5 hour incubation period in each solution and are displayed in Figure 6.7. 
 
Figure 6.7. ANS binding assay for NH2-FF-COOH during self-assembly in PBS (blue) and 
aqueous 0.1 M (green), 0.5 M (orange), 1.0 M (red) and 2.0 M (black) EAN solutions. 
Excitation wavelength 350 nm. 
In both PBS and 0.1 M EAN solutions, ANS demonstrates a strong binding affinity 
for NH2-FF-COOH, which is marked by an increase in the fluorescence intensity over 
the first 30 minutes. This suggests that during the initial stages of self-assembly,  
NH2-FF-COOH is predominantly unfolded such that hydrophobic residues on the 
peptide surface are exposed to binding with surrounding ANS molecules. After  
30-45 minutes incubation, there is a sudden decay in fluorescence intensity that 
coincides with the formation of crystalline fibrils in solution. This observation, which 
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can be viewed as the start of monomer polymerization, indicates that ANS molecules 
are becoming unbound as the result of peptide folding into a higher organized state. 
As NH2-FF-COOH self-assembles, the phenylalanine residues assemble via strong 
intermolecular hydrophobic π-π interactions, causing ANS molecules to become 
displaced. NH2-FF-COOH shows a similar trend during self-assembly in 0.5 M EAN, 
where a maximum fluorescence signal is measured after 45 minutes, before gradual 
signal decay is measured.  
Interestingly, at 1.0 M and 2.0 M concentrations, there is no evidence of signal decay 
even after 5 hours incubation. Instead, the fluorescence intensity gradually plateaus, 
suggesting that the hydrophobic residues on the peptide surface are predominantly 
exposed. Furthermore, at higher EAN concentrations, the relative fluorescence 
intensity measured for the 2.0 M EAN solution is significantly greater than that 
observed for PBS and 0.1 M EAN solutions. This suggests that at higher EAN 
concentrations, hydrophobic and hydrogen bond interactions between the PIL and 
peptide are increased, which may help stabilize the unfolded state of the peptide. In 
fact, Summers and Flowers(265) previously described that during lysozyme unfolding 
in EAN, the exposed hydrophobic core of the protein favourably interacts with the 
hydrophobic alkyl side chain of the ethylammonium cation; an interaction that 
becomes more dominant as the concentration of EAN is increased. Thus, the 
stabilization of these hydrophobic peptide residues with molecules of EAN prevents 
their self-assembly into higher order structures. 
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Structural polymorphism in amyloid ﬁbrils has important implications in disease 
progression. For example, prion proteins have found to give rise to multiple disease 
strains in both mammalian and yeast studies(408, 409) as the result of different structural 
forms of the prion protein during aggregation. Indeed, the formation of structurally 
and morphologically distinct forms of NH2-FF-COOH may help explain why 
polymorphism exists in Aβ1-40. Although a correlation between AD cognitive 
impairment and total amyloid deposition has yet to be observed(55), some studies 
postulate that certain Aβ polymorphs could be more toxic than others(132).  
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6.3 Conclusion 
The work described in this chapter relates to polymorphism in the AE peptide related 
NH2-FF-COOH dipeptide. In aqueous solution, NH2-FF-COOH forms large amyloid 
fibril-like microstructures with a highly ordered hexagonal crystal structure. 
Increasing the concentration of EAN in solution leads to the formation of various 
polymorphs including amyloid crystals, flat sheets and porous spherical assemblies, 
with noticeable changes in the chiral arrangement of phenylalanine residues.  
Analysis of the hydrophobic environment during self-assembly showed that higher 
concentrations of EAN inhibited the formation of crystalline fibril growth by 
stabilizing the unfolded state of NH2-FF-COOH. This supported by the high ANS 
fluorescence intensity measured during self-assembly. Alternatively, in diluted EAN 
solutions, strong hydrophobic and π-π interactions between peptide monomers 
predominate, causing NH2-FF-COOH to unfold and self-assemble into ordered 
crystalline structures.  
CHAPTER 7
 
145 
 
CHAPTER 7: Evaluation of PIL Solvent Parameters on the 
Phase Behaviour of Poly(N-isopropylacrylamide) 
(PNIPAM) 
7.1 Preface 
Sections of this work, describing the key interactions between water and PIL and their 
impact on polymer phase behaviour, have been published: 
x Debeljuh, N. J., Sutti, A., Barrow, C. J., Byrne, N. (2013) Phase transition of 
poly(N-isopropylacrylamide) in aqueous protic ionic liquids: Kosmotropic 
versus chaotropic anions and their interaction with water. J. Phys. Chem. B. 
117 (28), 8430-8435. 
7.2 Introduction 
Ionic liquids (ILs) have found application in a diverse range of fields from 
electrolytes(410, 411) to solvents for biomolecule stabilization(271, 412). Protic ionic liquids 
(PILs) are a subclass of the IL(236) family that have an additional tuneable feature as a 
result of the proton transfer, the proton activity(413). The proton activity can be linked 
to the pH of the PIL and has been used as a relative scale to select appropriate PILs for 
organic transformation reactions(414, 415) and the solvation of biomolecules(268). 
However, the proton activity is not the only parameter that determines protein stability 
and solubility.  
CHAPTER 7
 
146 
 
The empirical Hofmeister series, which describes the ability of ions to ‘salt in’ or ‘salt 
out’ proteins(258, 416), has recently been used to describe the influence of ionic liquids 
on biomolecule stabilization, in which major attention has been centred on 
imidazolium-based cations in the aprotic ionic liquid family. These ions are regarded 
as kosmotropic or chaotropic depending on their relative abilities to induce the 
structuring of water(300, 417, 418). Kosmotropes (structure makers) are thought to enhance 
the solubility of proteins whereas chaotropes (structure breakers) reduce the solubility 
of proteins(302, 419-421). The Hofmeister effect does not always explain these 
observation, and other factors such as specific ion binding and relative polarizabilities 
have been implicated(327, 422).    
Poly(N-isopropylacrylamide) [PNIPAM] is a thermo-responsive amphiphilic polymer 
which has often been used as a model system for the cold denaturation of peptides and 
proteins(423, 424), as it contains both hydrophilic (amide) and hydrophobic (isopropyl) 
groups. PNIPAM has shown to follow the Hofmeister trend in a number of  
studies(425-428), including ionic liquids(429, 430). It is well-known that PNIPAM develops 
a lower critical solution temperature (LCST) at 32 °C in aqueous solution(431), which 
is the result of the polymer’s transition from a soluble hydrophilic random coil at lower 
temperatures, to an insoluble hydrophobic globule at high temperatures. The 
hydrophobic collapse of the polymer chain is thought to be directly related to the 
arrangement of intramolecular and intermolecular hydrogen bonds within 
PNIPAM(432). 
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In the work previously described in Chapter 3, the stabilization of Aβ16-22 monomers 
was observed to follow a reverse Hofmeister trend in which kosmotropic anions 
enhanced the fibrilization process. Since fibrilization is directly linked to protein 
destabilization, and in the case of Aβ16-22, the formation of amyloid fibrils, it 
therefore becomes important to understand which solvent parameters are contributing 
to this observation and how this can be used to correctly select appropriate PILs for 
biomolecule stabilization. Since the diversity of ionic liquids is endless, choosing the 
appropriate cation and anion combination permits fine-tuning the solvent properties 
for a particular purpose. The polarity of ionic liquids is sensitive to the nature of anions 
and cations, and given the complexity of interactions that arise from a solvent’s 
polarity, most single parameter approaches cannot describe the system accurately.  
Kamlet and Taft developed a multi-parameter system that probes particular solvent 
properties based on the interaction between a set of closely related dyes by UV/visible 
spectrophotometry. These properties include hydrogen bond acceptor (HBA) basicity 
(β)(287), hydrogen bond donor (HBD) acidity (α)(289) and dipolarity/polarizability 
effects (π*)(288). Numerous studies have investigated these parameters in ionic liquid 
systems(429, 433-437). For instance, Lee et al.(436) describe how distinct variations in the 
HBA basicity and HBD acidity arise from modifying the methyl group on  
pyridinium-based ionic liquids. Furthermore, Nayak et al.(429) were able to measure the 
degree of hydrogen bonding and ion pairing within their ionic liquid systems in 
relation to how ionic liquids interact with polymers.  
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In PILs, the hydrogen bond donating and accepting abilities become particularly 
important, particularly when studying the effects of protein self-assembly, since 
protein self-assembly relies heavily on the extended hydrogen bond network between 
individual peptide strands. Solvent polarity also has a profound influence on the 
outcome of many chemical reactions and is known to play an important role in 
influencing the phase behaviour of polymers(438, 439). The polarity of the 
microenvironment surrounding the main chain of PNIPAM changes significantly at 
phase transition and results in changes in polymer structure(440, 441). Parameters such as 
dielectric constant, dipole moment and refractive index are available to help select the 
right ionic liquid for a given purpose. However, these parameters do not take into 
account specific solvent-solute interactions which exist in determining the polarity of 
solvents. This led to the development of solvent polarity empirical scales, which are 
described by Deye et al.(442). There are various methods for measuring the polarity of 
solvents, particularly in ionic liquid systems(443, 444), including the solvatochromic dyes 
pyridinium N-phenolate betaine(445) (Reichardt’s dye), which was made popular by 
Reichardt and co-workers(290, 446-448), and Nile Red(443-445).  
In this chapter, the phase behaviour of PNIPAM is investigated in a series of aqueous 
PIL solutions. In addition, other key solvent parameters including the HBA basicity, 
HBD acidity, dipolarity/polarizability effects and polarity will be discussed in order to 
identify the critical interactions between water and PIL complexes, and compare these 
relative to observations found with respect to biomolecule stabilization. 
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7.3 Results & Discussion 
7.3.1 Preliminary determination of PNIPAM LCST in a PIL 
Numerous studies discuss the phase behaviour of PNIPAM in aqueous salt  
solutions(426, 427, 449) and solvents(450-452). However, very few actually describe these 
changes in ionic liquids, particularly PILs. Since we are interested in how PILs affect 
polymer phase behaviour, we initially measured the phase transition in a  
1.48 M aqueous solution of DeaMs as a function of temperature to determine the LCST 
(Figure 7.1).  
 
Figure 7.1. Typical LCST transition of PNIPAM in 1.48 M DeaMs. The insert illustrates the 
LCST. Pictures illustrate the transition from soluble coil (left) to insoluble globular (right) 
state. 
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The LCST is clearly seen at 19.3 °C in the insert. Leading up to this temperature 
interval, the polymer remains in a hydrophilic coil structure and is completely miscible 
in solution. However, beyond this temperature point, the polymer becomes immiscible 
and restructures into a hydrophobic globular state that can clearly be observed by eye. 
7.3.2 PNIPAM phase behaviour in PIL anions 
Using the results from DeaMs described in the previous section, we next explored a 
library of PILs designed with various anions and cations using the aprotic choline dhp 
as a comparison. Starting with selectively modifying the PIL anion, the impact of PIL 
concentration on the LCST of PNIPAM is depicted in Figure 7.2.  
 
Figure 7.2. LCST of 0.5% (w/w) aqueous PNIPAM solution as a function of IL anion; 
TeaBF4 (pale blue), TeaTf (orange), TeaTfac (green), TeaMs (black), TeaHSO4 (red), TeaLa 
(purple), TeaH2PO4 (dark blue) and choline dhp (white). 
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At high water content there is almost no difference observed in the LCST between 
various PILs, however as the PIL concentration is increased the LCST points spread 
out depending on the type of anion. In fact, the impact of choice of anion on the LCST 
is dramatic, with a 20 °C difference observed between TeaH2PO4 and TeaTfac at a 
fixed PIL concentration of 2 mol/L. The trend of most to least LCST inducing PIL 
anion is as follows; 
H2PO4- > HSO4- > La- > Ms- > Tfac- > Tf- > BF4- 
Similarly with Aβ16-22 fibrilization as discussed in Chapter 3, this series identifies 
the kosmotropes as the most LCST-inducing anions and the chaotropes as the least 
LCST-inducing anions, although some changes in the ordering of the chaotropic 
anions are observed. From this observation, it is highly likely that Hofmeister anion 
affects are enforced and that the hydrogen bonding environment of these anions may 
be influencing PNIPAM phase behaviour. Interestingly, choline dhp exhibits the most 
LCST-inducing effect on PNIPAM, requiring only 1.62 M of the IL to reach an LCST 
of 1 °C. This suggests that the composition of anion and cation has a greater ability to 
convert the polymer from a hydrophilic coil to a hydrophobic globule under thermal 
conditions.  
Interestingly, there are two distinct trends occurring. Firstly, PILs containing 
nonfluorinated anions such as H2PO4-, HSO4-, La- and Ms- show a constant reduction 
in LCST as a function of concentration. Secondly, the fluorinated anions Tfac-, Tf- and 
BF4- gradually increase the LCST. Although it is not illustrated in Figure 7.2, TeaTfac 
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requires a concentration of >10.8 mol/L before the LCST starts to increase. Both TeaTf 
and TeaBF4 raise the LCST above that of PNIPAM in water, with TeaBF4 
demonstrating the greatest enhancement. Previous studies using aprotic ILs with the 
BF4- anion have reported an increase in the LCST and the presence of a UCST(429). 
However, in this study there was no observation of a UCST within the temperature 
range studied, or across the entire PIL-water phase diagram for any of the fluorinated 
PILs investigated. Wang et al.(453) previously reported that the LCST of PNIPAM in 
the aprotic IL BMIMBF4 disappears at higher IL concentrations. This finding was 
attributed to the increase in intermolecular hydrogen bonds between the IL-water and 
polymer complex, which enhances the polymers stability at higher temperatures. Since 
a similar increase in PNIPAM LCST was observed in the TeaBF4 and TeaTf systems, 
it is likely that the stability exhibited by PNIPAM at higher temperature is caused by 
the increased hydrophobicity of the PIL, in which surrounding water molecules are 
being pushed away from the polymer. Costa et al.(451) noticed a similar reversal in 
LCST behaviour at different mole fractions of cononsolvents. Solvent mixtures 
comprising of methanol-water and in particular acetone-water showed a sudden 
increase in PNIPAM solubility, which the authors describe are contributed to the 
stronger hydrophobic hydration effects of the cononsolvent mixtures.  
Since we suspect hydrogen bonding interactions to play a critical role here, the proton 
chemical shift of water was probed by 1H NMR at various PIL concentrations  
(Figure 7.3).  
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Figure 7.3. Proton chemical shift of water as a function of IL anion concentration. 
TeaH2PO4 (dark blue), choline dhp (white), TeaHSO4 (red), TeaLa (purple), TeaMs (black), 
TeaTfac (green), TeaTf (orange) and TeaBF4 (pale blue). 
Evidently, the shift in the HDO peak is highly dependent on the PIL anion. The 
kosmotropic anions H2PO4- and HSO4- demonstrate a significant downfield shift in 
comparison to other PILs in this study, with TeaH2PO4 exhibiting the greatest 
downfield shift. In comparison with TeaMs, little to no chemical shift was measured 
at various concentrations. Furthermore, all fluorinated PILs display an upfield shift, 
with TeaBF4 exhibiting the most upfield shifted water protons. 
These observations reinforce that the water-PIL hydrogen bond network is dependent 
on the choice of PIL, with this difference being reflected in the LCST of PNIPAM. 
The PILs with the greatest impact on water (kosmotropic) lower the LCST of PNIPAM 
more efficiently. An interesting comparison can be made between the two ILs 
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containing the dihydrogen phosphate anion, the protic TeaH2PO4 and the aprotic 
choline dhp. Although choline dhp reduces the LCST of PNIPAM at lower 
concentrations, it is TeaH2PO4 that has the strongest interaction with water according 
to 31P NMR chemical shift analysis (Figure 7.4).  
 
Figure 7.4. Difference in chemical shift of phosphorus as a function of IL concentration, 
probed by 31P NMR. TeaH2PO4 (dark blue) and choline dhp (white). 
The reduced LCST of PNIPAM in the presence of choline dhp can be best explained 
by the combined influence of the kosmotropic H2PO4- anion and the hydroxyl group 
on the cation. Since both H2PO4- anion and hydroxyl group are competing for water 
molecules, PNIPAM can reach lower phase transition temperatures in choline dhp than 
in TeaH2PO4. Additionally, the marked trend in the proton chemical shift of water, in 
relation to the hydrophobic character of the fluorinated anions, is further depicted in 
the LCST of PNIPAM, where anions of a stronger hydrophobic nature  
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(BF4- > Tf- > Tfac-) cause an enhancement in polymer solubility. From these results, 
these fluorinated anions show a greater repulsion towards water molecules, as depicted 
by the upfield proton chemical shifts, and suggest they interact weakly with 
surrounding water molecules. Recently, Reddy et al.(454) determined that the BF4- anion 
in BMIMBF4 strongly attracts the protons of water molecules surrounding PNIPAM. 
This interaction was responsible for the polymer’s collapse in solution. Our results 
disagree with this study since we have clearly shown that the BF4- anion in the TeaBF4 
PIL is not attracted to the protons on water. A comparison between the proton chemical 
shifts of water for the PILs against their precursor acids (Figure 7.5) also emphasizes 
the unique chemical environment of the PIL systems.  
 
Figure 7.5. Proton chemical shift of water as a function of acid concentration. Ms- (black), 
HSO4- (red), Tf- (orange), BF4- (pale blue), Tfac- (green) and H2PO4- (dark blue). 
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In all cases, the precursor acid causes a downfield shift in the water peak. The largest 
downfield shift was observed for methanesulfonic acid and the least downfield shift 
was observed for phosphoric acid. The PIL-water trend is remarkably different to the 
acid-water trend and this is most likely attributed to the presence of freely available 
protons. In the PIL state, the base has neutralized the acid proton, whereas in the acid 
state, this proton is still available to interact with water molecules. 
7.3.3 PNIPAM phase behaviour in PIL cations 
Following the anion series, we next investigated a series of ILs designed with different 
cations and their impact on PNIPAM LCST (Figure 7.6).  
 
Figure 7.6. LCST of 0.5% (w/w) aqueous PNIPAM solution as a function of IL cation; 
TMGLa (black), DeaLa (red), BaLa (dark blue), ETALa (pale blue), EaLa (orange) and 
ChoLa (green). 
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The trend of most to least LCST inducing IL cation is as follows; 
Choline+ > Ea+ > ETA+ > Ba+ > Dea+ > TMG+ 
Similarly to the anions investigated earlier, differences in LCST are more prominent 
as the concentration of PIL is increased, with the aprotic ChoLa and protic TMGLa 
illustrating the strongest and weakest effects on LCST, respectively. Interestingly, the 
phase behaviour of PNIPAM in this series of PILs never increases above that of water, 
indicating that the effect of cations on the LCST behaviour is less important than that 
of the anions. In fact, cations in aqueous salt mixtures are known to have a minimal 
effect on the LCST of PNIPAM(426, 455). Their less dominant nature in comparison to 
anions of the same charge density, are believed to be the result of their reduced 
polarizable nature and lowered hydration effects(326, 327). The corresponding proton 
chemical shift analysis also indicates that the degree of chemical shift is much less 
than that observed for the anion series (Figure 7.7). However, it is interesting to note 
the impact of the cation hydroxyl groups in ETALa and ChoLa. Although both cations 
carry a single hydroxyl group, ETA+ results in the largest chemical shift of water, 
whereas choline+ results in the smallest shift. Both ILs are structurally similar, 
however the addition of three methyl groups to the central nitrogen atom in the aprotic 
choline cation causes the PIL to weakly interact with water. 
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Figure 7.7. Proton chemical shift of water as a function of IL cation concentration. ETALa 
(pale blue), TMGLa (black), EaLa (orange), BaLa (dark blue), DeaLa (red) and ChoLa 
(green). 
Nevertheless, the choline cation is a known chaotrope and is expected to have a weak 
association with water due to its ‘structure breaking’ nature. Alternatively, ETA+ is a 
primary amine containing up to three N-H hydrogen bonds which are freely available 
to interact with water molecules. Since ChoLa has the greatest influence on lowering 
the phase transition of PNIPAM, it is likely that strong ion pairing between the anion 
and cation occurs in this aprotic IL, which may be responsible for the polymer’s state 
changes at lower ChoLa concentrations. 
7.3.4 Kamlet-Taft solvatochromic parameters in PILs 
Differences in PIL design suggest that there are specific properties of PILs that 
strongly influence the phase behaviour of PNIPAM. Therefore, to understand these 
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properties, solvatochromic analysis of the hydrogen bond donor (HBD) acidity α, 
hydrogen bond acceptor (HBA) basicity β and dipolarity/polarizability effects π* were 
measured using the spectroscopic Kamlet-Taft dyes 4-nitroaniline,  
N,N-diethyl-4-nitroaniline and Reichardt’s dye. This technique utilises UV-visible 
spectroscopy to measure differences in the wavelength shift of certain probe dyes that 
are sensitive to solvent polarity and hydrogen bond acidity and basicity.  
Preliminary UV-visible measurements were performed in methanol and water and the 
intramolecular charge transfer band (ICT) correlating to the longest wavelength 
absorption maxima of each dye was measured in nanometres and converted to 
wavenumbers where necessary, according to equations 2-6 in Chapter 2. The ET(30) 
and ETN parameters, defining the molar transition energy of Reichardt’s dye and the 
normalized polarity, respectively, are also included (Table 7.1). Since the measured 
values are in close agreement to those in literature, the experimental parameters could 
be confidently applied to PIL samples. 
Table 7.1. Kamlet-Taft parameters of water and methanol. 
Solvent ET(30) ETN π* α β 
Methanol 55.45 
(55.6)(433) 
0.76 
(0.762)(456) 
0.731 
(0.73)(436) 
1.080 
(1.05)(457) 
0.605 
(0.61)(437) 
Water 62.92 
 
0.99 
(1.000)(436) 
 
1.332 
(1.33)(456) 
 
1.010 
(1.12)(458) 
 
0.137 
(0.14)(456) 
 
Reported values are given in parentheses. 
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7.3.4.1 π* values 
Solvent dipolarity/polarizability (π*) is a measure of a solvent’s ability to stabilize a 
neighbouring charge or dipole by means of nonspecific dielectric interactions. The 
dipolarity/polarizability of each PIL solution was measured using the  
N,N-diethyl-4-nitroaniline dye according to equation 2. Although π* provides valuable 
information about the dipolarity and polarizability of the solvent system, it is the 
property of the solute that is actually being measured, that is, the differential 
stabilization of the more polar excited state of the solvatochromic dye. The interaction 
between the probe dye and the ions directly depend on the extent of coulombic 
interactions between them. For example, it has been reported that when the charge 
surrounding the anion of an ionic liquid becomes delocalized over more atoms, the 
polarizability of the solvent decreases due to stronger coulombic forces between the 
ions(433, 437). This weakens the interaction between the ions and probe dye, reducing the 
polarity on the solvatochromic scale. The π* values for each PIL as a function of 
concentration are illustrated in Figure 7.8.  
The non-fluorinated and fluorinated PILs have been separated for ease of 
interpretation. At low water content, all non-fluorinated and fluorinated PILs measured 
a π* value similar to that observed for nonaqueous molecular solvents and aprotic ionic 
liquids(433, 436, 437, 459). It has been reported that both hydrophobic character and size of 
the anion can impact the π* values(435). For example, ionic liquids designed with 
smaller and more compact anions, such as halogens or those in the tetrahedral 
geometry, lead to higher π* values. 
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Figure 7.8. Kamlet-Taft π* parameter for (a) nonfluorinated ILs TeaLa (purple), TeaMs 
(black), TeaHSO4 (red), TeaH2PO4 (dark blue) and choline dhp (white) and (b) fluorinated 
PILs TeaBF4 (pale blue), TeaTf (orange) and TeaTfac (green). 
In this case, the BF4-, H2PO4-, Ms- and HSO4- anions, all of which are tetrahedral in 
geometry, have a π* value above 1.1 at low water content. Also, as the hydrophobic 
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character of the fluorinated PILs increases from Tfac- to BF4-, the π* value increases, 
which is in agreement with previous trends(435). As the water content is increased, the 
π* value changes significantly, depending on the PIL anion. Both TeaH2PO4 and 
TeaHSO4 have π* values similar to water (1.332) at a volume fraction of water (ɸwater) 
>0.3, suggesting a water-like environment, even in the concentrated PIL state. 
Interestingly, Cammarata et al.(460) suggest that depending on the type of anion, water 
can either interact strongly with the anion or exist largely as bulk water. Since water 
involves ice-like structured pools and disordered zones, the addition of a highly 
ordered anion such H2PO4- or HSO4- may cause the disordered zones to become more 
ordered. This being the result of hydrogen bonding between the anion and water 
molecules, could indicate why a waterlike behaviour is seen in the kosmotropic PILs, 
which becomes more evident at higher PIL concentrations.  
TeaMs shows a sudden drop in the π* value at ɸwater = 0.8. Since this PIL has a lower 
π* value than TeaH2PO4 and TeaHSO4 at the same volume fraction of water, it is 
considered to be less waterlike. The fluorinated PILs show lower 
dipolarity/polarizability values at low water content in comparison with other PILs in 
this study. TeaTfac has the lowest π* value in the series suggesting that strong 
coulombic interactions exist between the ions of the PIL, which lead to weaker 
interactions with the probe dye. Interestingly, choline dhp shows the highest π* value, 
and as this IL concentration is increased, the dipolarity/polarizability effect becomes 
greater than water. Only one other ionic liquid has been reported to have a π* value 
greater than water at room temperature; 1-methylimidazolium propionate 
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[HmIm][CH3CH2COO] (1.50)(433). This large π* value for choline dhp implies strong 
interactions between the IL and probe dye, which may indicate why this IL interacts 
strongly with PNIPAM, as reflected in the LCST. 
Although the π* value seems to be greatly influenced by the basicity of the anion in an 
ionic liquid, it is reported that the cation has a very small effect on the polarity of a 
PIL(433). The dipolarity/polarizability for a series of ILs designed with different cations 
and the common lactate anion, were examined through the same principles and are 
illustrated in Figure 7.9.  
 
Figure 7.9. Kamlet-Taft parameter π* for ILs with various cations. ChoLa (green), EaLa 
(orange), TMGLa (black), DeaLa (red), ETALa (pale blue) and BaLa (dark blue).  
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Although none of these PILs share a similar π* value to that of water in the neat state, 
there is a significant difference between the dipolarity/polarizability in each IL sample. 
The aprotic ChoLa and protic BaLa registered the largest and smallest π* values in the 
series, respectively. In context with the LCST of PNIPAM, the large π* value obtained 
for ChoLa suggests that increased polarizability effects around the isopropyl side 
chains of PNIPAM effectively lowers the LCST. 
If EaLa and BaLa are compared, a significantly smaller π* value is obtained for BaLa, 
suggesting that increasing the alkyl chain length of the cation in the PIL leads to a 
lower polarity value. Similar results were obtained in a study by Bini et al.(461) who 
measured smaller π* values for methylimidazolium cations containing longer alkyl 
side chains. However, these are contrary to results reported in a recent study by Lee  
et al.(436), who showed that an increase in the alkyl chain length of pyrrolidinium-based 
ionic liquids leads to higher polarity values.  
To further understand the implications of hydrogen bonding sites on the cation, with 
respect to the effect on the π* value, ETALa provides an exceptional example when 
compared with EaLa. The presence of the terminal hydroxyl group on ETALa leads to 
a decrease in the π* value as a function of water. Conversely, Zhang et al.(462) showed 
that the polarity of hydroxyl substituted ionic liquids, in comparison to their 
corresponding non-hydroxyl ionic liquids, causes an increase in π* value. These 
findings suggest that aprotic ionic liquids and PILs are very different in terms of their 
polarity and dipolarity/polarizability effects. Finally, with the exception of EaLa, 
cations consisting of primary amines tend to register lower π* values than those of 
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secondary, tertiary and quaternary amines. Since primary amines carry additional 
hydrogen bonding sites, this enables them to interact more strongly with the probe dye 
in terms of coulombic interactions, which reduces the polarity of the PIL.    
7.3.4.2 β values 
The hydrogen bond acceptor (HBA) basicity of a solvent can be measured by the 
Kamlet-Taft parameter, β. The β parameter describes the basicity of the cation with 
the solvatochromic probe dye and is said to be largely determined by the nature of the 
anion(435, 463), with the cation having a secondary effect. For this study, the  
β values of each PIL as a function of water were measured using  
N,N-diethyl-4-nitroaniline and 4-nitroaniline dyes according to equation 3. It is 
generally accepted that large β values are associated with a strong basic character of 
the cation towards the probe dyes. Since this method relies on the comparative analysis 
in the UV-visible spectrum of two closely related dyes; one that is capable of hydrogen 
bond donation and the other that is not, differences in solvent HBA character can be 
determined. Again, it is important to note that the values being measured are the result 
of PIL-dye interactions. The HBA basicity of PILs bearing different anions, as a 
function of water, is shown in Figure 7.10.  
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Figure 7.10. Kamlet-Taft β parameter for (a) nonfluorinated ILs TeaLa (purple), TeaMs 
(black), TeaHSO4 (red), TeaH2PO4 (dark blue) and choline dhp (white) and (b) fluorinated 
PILs TeaBF4 (pale blue), TeaTf (orange) and TeaTfac (green).  
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The β values for TeaH2PO4, TeaHSO4, TeaMs and TeaLa show very little variation as 
a function of water, and in all cases the β value increases linearly as the volume fraction 
of water is reduced. Since TeaLa has a slightly larger β value at ɸwater = 0.1, this implies 
that the Tea+ cation has a greater tendency to accept protons from the probe dye when 
coupled with the La- anion than with H2PO4- and HSO4- anions. Additionally, since the 
ΔpKa is lower for TeaH2PO4 than TeaMs, we find the larger β value in TeaMs very 
interesting. Choline dhp had the lowest β value out of all ILs investigated here, which 
is consistent with aprotic ionic liquid values(435, 459, 461). Shukla et al.(433) proposed that 
for an ionic liquid to exhibit large β values, the precursor acid must undergo complete 
proton transfer with the base. 
The presence of ionic species (from strong precursor acids) favours large β values and 
a combination of neutral and ionic species (for weak precursor acids) favours low β 
values. Since choline dhp has a low β value, it is assumed that the H2PO4- anion is 
acting as a weak proton donor to its corresponding base pair. The β values for the 
fluorinated PILs TeaTfac, TeaTf and TeaBF4 show a much greater spread at ɸwater >0.5. 
The largest β value for the PILs in this study was measured for TeaTfac, indicating 
that in this complex, the Tea+ cation strongly accepts protons from the probe dye. Since 
the β value is large, TeaTfac exists mainly in an ionic state, which indicates that it is 
the least protonated in the series. It is also observed that as the hydrophobic character 
of the PIL is increased from Tfac- to BF4-, the Tea+ cation becomes a weaker hydrogen 
bond acceptor. Additionally, we measured the HBA for the primary and secondary 
amines in the PILs EaMs and DeaMs (Figure 7.11).  
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Figure 7.11. Kamlet-Taft β parameter of the TeaMs (black), DeaMs (pale blue) and EaMs 
(red) as a function of water. 
Here we determined that the primary amine has a lower β value across the dilution 
series. This implies that EaMs is more protonated than the tertiary TeaMs, which is in 
good agreement with findings from previous work completed by Stoimenovski  
et al.(464). In context with PNIPAM, Nayak et al.(429) discuss that low β values are 
associated with weak anion interactions with the amide of PNIPAM. 
TeaMs showed a larger β value than TeaH2PO4 and TeaHSO4, which supports the 
LCST trend observed earlier. Since hydrophobic effects play a secondary role in 
polymer phase behaviour, the less hydrophobic Tfac- anion is more likely to interact 
with PNIPAM because its conjugate acid is interacting strongly with the probe dye. 
There have been several instances in which ionic liquids designed with the BF4- anion 
have demonstrated low β values(429, 437, 465). The interaction between the BF4- anion and 
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PNIPAM is considered weak because of competitive hydrogen bonding between the 
cation and anion for the polymer. The low β values measured for TeaBF4 at low water 
content is evidence of weak anion-PNIPAM interaction. The β values for a series of 
PILs designed with various cations and the common anion, lactate, is shown in  
Figure 7.12.  
 
Figure 7.12. Kamlet-Taft parameter β for ILs with various cations. BaLa (dark blue), 
TMGLa (black), EaLa (orange), DeaLa (red), ChoLa (green) and ETALa (pale blue). 
In all PILs, the β values increased as the volume fraction of water was reduced and the 
range of these β values at high PIL content was in the relatively narrow range of  
0.6-0.9. In comparison to the anions discussed earlier, the cations in this PIL series 
have a greater tendency to accept protons from the probe dye, since larger β values 
were measured. When the cation alkyl chain length is increased from EaLa to BaLa, 
there is a significant increase in β value. BaLa, which measured the lowest π* value, 
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has the largest β value. Since the proton NMR analysis of water in the presence of 
BaLa showed a smaller chemical shift in comparison to EaLa, this suggested that 
increasing the alkyl chain length of the cation in the PIL weakened the interaction with 
water and increased the interaction with the probe dye. ChoLa, which measured the 
highest π* value, has one of the lowest β values in this series. This suggests that the 
choline cation has a weaker interaction with the probe dye across the dilution series. 
Also, ETALa drastically lowered the β value in comparison to EaLa, indicating that 
the addition of a hydroxyl group caused ETALa to become a weaker hydrogen bond 
acceptor with the probe dye. ETALa has a very similar β value to PILs bearing 
kosmotropic anions (TeaH2PO4 and TeaHSO4) at ɸwater = 0.1, and since water showed 
a larger downfield shift in proton NMR, ETALa had a stronger interaction with water 
molecules than the probe dye. This explains why ETALa showed one of the lowest 
phase transition temperatures for PNIPAM.   
7.3.4.3 α values 
The last Kamlet-Taft parameter describes the hydrogen bond donating (HBD) acidity 
α of the anion. This parameter is largely determined by the nature of the cation, with 
the anion playing a secondary role. The α values of each PIL as a function of water 
were measured using N,N-diethyl-4-nitroaniline and Reichardt’s dye according to 
equation 6. While ET30 values are unique for any given solvent, the α value is strongly 
influenced by the value of π* used. For example, the higher the π* value used, the 
smaller the α parameter measured. Due to the nature of the cations in the PILs 
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investigated, α values could only be measured for four PILs, and these are displayed 
in Figure 7.13.  
  
Figure 7.13. Kamlet-Taft α parameter for BaLa (dark blue), ETALa (pale blue), TMGLa 
(black) and ChoLa (green). 
No intramolecular charge transfer band was detected for Reichardt’s dye at ɸwater > 0.5 
in each PIL. The α values for each IL at ɸwater = 0.0 shows a direct relationship between 
the π* values determined earlier. BaLa, which measured the lowest π* value, has the 
largest α value, and vice versa for the aprotic ChoLa. Generally, cations that contain 
additional hydrogen bonding substituents such as hydroxyl groups, tend to have higher 
α values(434), which is consistent with the findings for ETALa in this study. The 
dilution profile of each IL system is unique. The aprotic ChoLa is the only IL in this 
study that measures a lower α value upon decreasing water content, suggesting that 
ion pairing between the cation and anion in ChoLa is strong. Nayak et al.(429) also 
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determined strong ion pairing in BMIMOAc, which was reflected by low α values at 
high ionic liquid concentration, which may be consistent to aprotic ionic liquids only. 
TMGLa displays low α values across the dilution series and also suggests strong ion 
interactions within the ionic liquid. Alternatively, both BaLa and ETALa are expected 
to have weak ion pairing between anion and cation, since their α values are larger at 
low water content. The Welton research group(434, 437) propose that there are two modes 
of competition occurring simultaneously between the anion, the cation and the probe 
dye. They show that as the anion becomes a better hydrogen bond acceptor, the 
concentration of free non-hydrogen bonded base decreases, which in turn reduces the 
amount of available base to interact with the probe dye. In the context of PILs in this 
study, where the acid is common in all systems, it is the cation hydrogen bond donor 
strength that is the determining factor.   
7.3.5 Polarity study of aqueous PIL solutions 
From preliminary experiments, Reichardt’s dye was determined to be unsuitable for 
polarity measurements in the triethylammonium-based PILs, since the intramolecular 
charge transfer band was not visible due to the formation of the phenoxide moiety of 
Reichardt’s dye(444, 466). Instead, Nile Red was used as the polarity probe since it is 
soluble over a wide range of solvents and ionic liquids. When dissolved in highly polar 
solvents, the wavelength of its visible absorption maximum (λmax) shifts to longer 
wavelengths. Table 2 illustrates the molar transition energies, ENR (kJ mol-1) of Nile 
Red in triethylammonium-based PILs, calculated according to equation 7.  
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Table 7.2. Spectroscopic data of the Nile Red polarity parameter calculated for a series of 
triethylammonium-based PILs as a function of water at 25 °C. 
PIL ɸwater λmax (nm) ENR (kJ mol-1) 
TeaHSO4 
0.1 595.2 200.9 
0.2 596.5 200.5 
0.3 597.5 200.2 
0.4 598.7 199.8 
0.5 599.2 199.6 
TeaH2PO4 
0.1 593.2 201.6 
0.2 594.8 201.0 
0.3 595.8 200.7 
0.4 597.2 200.3 
0.5 598.3 199.8 
TeaLa 
0.1 563.5 212.4 
0.2 571.1 209.0 
0.3 578.2 206.8 
0.4 584.1 204.9 
0.5 590.4 202.3 
TeaMs 
0.1 559.2 213.9 
0.2 570.6 209.6 
0.3 580.6 206.0 
0.4 587.5 203.6 
0.5 590.9 202.4 
TeaTf 
0.1 557.9 214.4 
0.2 569.2 210.1 
0.3 576.2 207.6 
0.4 579.8 206.3 
0.5 583.0 205.1 
TeaTfac 
0.1 548.4 218.1 
0.2 554.9 215.5 
0.3 561.6 212.9 
0.4 568.2 210.5 
0.5 575.2 207.9 
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The ENR values measured for TeaHSO4 and TeaH2PO4 show similar polarity to that of 
water (201.7 kJ mol-1)(443). When water is added to these two PILs, the variation in 
polarity is small, which further supports the kosmotropic nature of these anions and 
the strong water structuring effects, which occur for these PILs. In fact, oxyanions 
such as H2PO4- and HSO4- lead to highly polar PILs due to the extensive hydrogen 
bonding network in the anions(433). The lower polarity values for these two PILs arise 
from the increasing polarizability of the anions, which is consistent with the π* values 
determined earlier. The shorter wavelength shift of TeaTfac at ɸwater = 0.1 implies that 
TeaTfac is the least polar PIL in this series. TeaTfac has a polarity which is comparable 
to low molecular weight alcohols such as ethanol at 218.2 kJ mol-1(443).  
The polarity of TeaBF4 could not be numerically determined because the main 
absorption band split into two maxima (Figure 7.14). Because of the long wavelength 
shift of Nile Red in TeaBF4, this PIL is considered more polar than TeaHSO4, however 
it has been reported that band splitting of the main absorption band is associated with 
low solvent polarity, such as is the case with cyclohexane(467). 
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Figure 7.14. The UV-Visible absorbance spectra of Nile Red in 90 wt% PIL solutions. 
TeaTfac (green), TeaLa (purple), TeaMs (black), TeaTf (orange), TeaHSO4 (red), TeaH2PO4 
(dark blue) and TeaBF4 (pale blue). Note the band splitting on the TeaBF4 peak 
The ENR values for the lactate-based PIL series are summarised in Table 7.3. The 
polarity (ET(30)) and normalized polarity (ETN) values of Reichardt’s dye in four 
lactate-based PILs are also included. These were calculated according to  
equations 4 and 5.  
In comparison with the two spectroscopic dyes (Nile Red and Reichardt’s dye), pure 
ETALa exhibited the lowest ENR value and the highest ETN value in the series, which 
was anticipated due to its strong interaction with water as determined using proton 
chemical shift information. 
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Table 7.3. Spectroscopic data of Nile Red and Reichardt’s dye polarity parameters 
calculated for a series of lactate-based ILs as a function of water at 25 °C. 
 
PIL ɸwater λmax (nm) ENR (kJ mol-1) ET(30) ETN 
ETALa 
0.0 569.6 210.0 58.91 0.87 
0.1 578.6 206.7 59.33 0.89 
0.2 582.7 205.3 59.53 0.89 
0.3 585.8 204.3 59.93 0.90 
0.4 588.3 203.3 60.41 0.92 
TMGLa 
0.0 555.9 215.1 54.26 0.73 
0.1 564.6 211.8 54.47 0.73 
0.2 572.8 208.8 54.66 0.74 
0.3 578.6 206.7 55.11 0.75 
0.4 583.8 204.9 55.79 0.77 
ChoLa 
0.0 558.6 214.1 53.96 0.72 
0.1 564.2 212.0 55.13 0.75 
0.2 568.8 210.3 56.57 0.80 
0.3 576.5 207.5 58.41 0.86 
0.4 583.3 205.0 - - 
EaLa 
0.0 558.2 214.3 - - 
0.1 562.3 212.7 - - 
0.2 566.6 211.1 - - 
0.3 570.6 209.6 - - 
0.4 578.2 206.8 - - 
DeaLa 
0.0 552.6 216.4 - - 
0.1 558.6 214.1 - - 
0.2 563.6 212.2 - - 
0.3 571.5 209.3 - - 
0.4 577.9 207.0 - - 
BaLa 
0.0 549.6 217.6 56.36 0.79 
0.1 556.9 214.8 56.81 0.81 
0.2 564.7 211.8 56.93 0.81 
0.3 568.8 210.3 57.17 0.82 
0.4 572.5 208.9 - - 
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Since water has the largest ETN value (1.000)(436) and the lowest ENR value  
(201.7 kJ mol-1)(443) of all solvent systems, ETALa can be considered as a fairly polar 
PIL, although TeaH2PO4 and TeaHSO4 are still considerably more polar since their 
ENR values were equivalent to that of water. 
The influence of cation chain length is also noticeable, where an increase in chain 
length from EaLa to BaLa causes the PIL to be less polar. The longer chain length 
increases the hydrophobic character of the cation, resulting in a lowering of net 
polarization and polarity of the PIL, which is in agreement with previous observed 
trends(433, 443). In general, the polarity of the cation series is lower than that of the 
anions, and so the polarity effects in PILs are mainly driven by the anion, since anions 
are more polarizable and hydrate more strongly with water(327).  
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7.4 Conclusion 
In this chapter, the LCST of PNIPAM was investigated in a series of PILs designed 
with various anions and cations. It was found that the triethylammonium PILs, 
consisting of the kosmotropic anions H2PO4- and HSO4-, reduced the LCST of 
PNIPAM more effectively than the chaotropic anions. The aprotic IL choline dhp was 
shown to stabilize the globular form of PNIPAM the greatest. The fluorinated anions 
enhanced the chaotropic nature of the PILs, with TeaTf and TeaBF4 increasing the 
LCST of PNIPAM above that of water, as a function of concentration. This increase 
in LCST using fluorinated PILs is likely due to the presence of an enhanced hydration 
layer around the polymer, caused by unfavourable water-PIL interactions. The lactate-
based PILs showed a less pronounced effect on LCST in comparison to the anion 
series. However, ETALa and the aprotic ChoLa enhanced the LCST through additional 
hydrogen bonding sites on the PILs. 
The solvent properties of the hydrated PIL solutions were explored through  
Kamlet-Taft solvatochromic analysis and results indicate that the water-PIL 
interactions, mainly the hydrogen bond accepting β and dipolarity/polarizability π* 
parameters, are responsible for the observed differences in the PNIPAM LCST trend. 
Furthermore, the 1H NMR chemical shifts of water showed that the kosmotropic 
anions interact strongly with water, whereas no interaction was observed for the 
chaotropic anions. The strength of coulombic interactions between anion and cation 
pairs strongly influences the interaction strength between the ions and the probe dye, 
where ions that have a greater tendency to hydrogen bond lead to weaker interactions 
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with the solute. Overall, the hydrogen network of the hydrated PIL solution is likely 
the most important solvent property for protein stabilization.  
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CHAPTER 8: Concluding Remarks 
8.1 General 
In context to the work described in this thesis, protic ionic liquids have provided 
insight into understanding the complex interactions that comprise amyloid assembly 
in the context of the Aβ peptide. Ideally, to further the scope of this work, other 
amyloidogenic proteins such as the prion protein, TTR and α-synuclein, all which have 
their own unique aggregation mechanism, are worth investigating using ionic liquids. 
8.2 Investigating Aβ16-22 Fibrilization Kinetics in Protic Ionic 
Liquid Anions and the Hofmeister Series  
Investigations into the self-assembly of Aβ16-22 in PILs showed the importance of 
anion selection in peptide fibrilization. Kosmotropic anions such as H2PO4- and HSO4- 
significantly enhanced Aβ16-22 fibrilization via a ‘salting out’ scenario whereas 
chaotropic anions such as Ms- and BF4- inhibited fibrilization via a ‘salting in’ 
scenario. When analyzed by NMR spectroscopy, critical differences were observed 
between the proton chemical shift of water molecules between kosmotropic and 
chaotropic anions, suggesting that Aβ16-22 fibrilization kinetics are driven by 
competitive hydrogen bonding between the PIL anion and water. Additionally, an  
N-terminal acetylated analogue of the Aβ16-22 peptide revealed the co-existence of 
amyloid fibrils and oligomeric spheres in solution.   
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The accelerated fibrilization of Aβ16-22 holds considerable promise for 
biotechnological applications since amyloid fibrils are exceptionally strong materials. 
Furthermore, the ability to rapidly form amyloid fibres should facilitate  
higher-throughput amyloid inhibitor assay development, including screens for 
pyroglutamate Aβ fragments and the pathological form of Aβ in AD.  This work could 
be further applied to other amyloid-based diseases by tailoring the ionic liquid to suit 
the aggregation mechanism of these proteins. The controlled formation of amyloid 
over the short time scales demonstrated in this study may enable the exploration of 
fundamental mechanisms of amyloid formation, resulting in an improved 
understanding of amyloid formation in neurodegeneration.  
8.3 Enhanced Aβ Fibrilization in Protic Ionic Liquid Cations 
In addition to PIL anions, cations can be further tailored to accelerate or inhibit the 
fibrilization of Aβ16-22. PIL cations designed with a primary amine enhanced the 
conversion of Aβ16-22 monomers to amyloid fibrils, almost five-times greater than 
cations bearing tertiary amines. By substituting the phenylalanine residue located at 
position 19 with tryptophan, intrinsic fluorescence measurements showed that the  
five-fold enhancement in fibrilization was due to a direct interaction between the PIL 
cation and self-assembling peptide. The impact of these primary and tertiary amines 
were further explored in full-length Aβ, demonstrating greater structural inducing 
effects at higher PIL concentrations. However, further investigations need to be carried 
out on the spectroscopic analysis of full-length Aβ and its isoforms, particularly in the 
presence of higher PIL concentrations where signal interferences are probable.  
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8.4 Structural Induction and Fibrils Dissolution of Aβ1-40 in Ionic 
Liquids through the α-Helical Intermediate 
In exploring the structure inducing effects in full-length Aβ, low concentrations  
(<50 wt%) of the chaotropic PIL TeaMs led to the formation of amyloid fibrils with 
distinctive β-sheet structures. At higher TeaMs concentrations (>60 wt%), α-helical 
structure was preferred and fibrilization was inhibited. This fibril inhibition occurred 
with PILs containing the mesylate anion, which promoted solubilization of  
Aβ1-40 via the formation of intermolecular hydrogen bonds between the solvent and 
peptide, in a manner similar to helical-inducing solvents such as TFE and HFIP. 
Additionally, synthetic Aβ1-40 fibrils which were self-assembled in aqueous TeaMs 
solution could be dissolved in neat TeaMs, with the solubilization occurring through a 
β-sheet to α-helix conversion. However, neat TeaMs could not dissolve Aβ1-40 fibrils 
that were pre-assembled in 100% aqueous conditions, indicating the importance of 
intermolecular hydrogen bonding in the initial fibril state. Although x-ray scattering 
techniques were pursued to monitor this change in fibril structure, the results were 
inconclusive and suggested that further analysis of the microstructure within the ionic 
liquid region was necessary. Furthermore, the work outlined in chapter 5 was also 
attempted on the Aβ1-42 peptide, however given the greater aggregation propensity of 
this peptide and the hydrophobic nature of the ionic liquid conditions used, preliminary 
data collection was unsuccessful and requires further investigation in the future.   
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8.5 Crystalline to Amorphous Transition of the Central 
Alzheimer’s Aβ Dipeptide in Aqueous PIL Solution 
In addition to hydrogen bonding, the impact of π-π interactions were investigated in 
NH2-FF-COOH, a dipeptide representing the central hydrophobic domain in  
full-length Aβ. At low EAN concentrations (<0.5 M), NH2-FF-COOH formed large 
amyloid fibril-like microstructures with a highly ordered hexagonal crystal structure 
according to x-ray diffraction analysis. At higher EAN concentrations (>1.0 M),  
NH2-FF-COOH assembled into flat sheets and spheres with no definite crystalline 
structure. In diluted EAN conditions, ANS binding assays revealed that hydrophobic 
and π-π interactions, between peptide monomers dominate, initiating peptide 
unfolding and assembly into ordered crystalline structures. Although further studies 
are required to characterize these polymorphic structures and their mechanisms of  
self-assembly, these results provide further impetus for examining Aβ polymorphic 
models and their role in disease progression, and also for exploring the application of 
these materials as novel biomaterials. 
8.6 Evaluation of PIL Solvent Parameters on the Phase Behaviour 
of Poly(N-isopropylacrylamide) (PNIPAM) 
Using PNIPAM as a model for peptide folding, the impact of other solvent parameters 
including acidity, basicity, polarity and polarizability, which are also associated with 
protein folding in PILs, were measured by exploring the Kamlet-Taft solvatochromic 
parameters. Similarly to the trend observed for Aβ16-22 fibrilization, PNIPAM was 
able to achieve lower critical solution temperatures when incubated in kosmotropic 
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PILs, as opposed to in chaotropic PILs. The basicity of the PIL (reflected through the 
anion), and the polarizability of the anion (reflected through its kosmotropicity), were 
identified as the key properties for stabilizing the globular state of PNIPAM in PILs 
and impact protein stabilization and amyloid fibril formation. 
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